id	sid	tid	token	lemma	pos
aiua-9854	1	1	stesura	stesura	PROPN
aiua-9854	1	2	seveso	seveso	PROPN
aiua-9854	1	3	385archivio	385archivio	PROPN
aiua-9854	1	4	italiano	italiano	NOUN
aiua-9854	1	5	di	di	X
aiua-9854	1	6	urologia	urologia	PROPN
aiua-9854	1	7	e	e	PROPN
aiua-9854	1	8	andrologia	andrologia	NOUN
aiua-9854	1	9	2021	2021	NUM
aiua-9854	1	10	;	;	PUNCT
aiua-9854	1	11	93	93	NUM
aiua-9854	1	12	,	,	PUNCT
aiua-9854	1	13	4	4	NUM
aiua-9854	1	14	original	original	ADJ
aiua-9854	1	15	paper	paper	NOUN
aiua-9854	1	16	no	no	DET
aiua-9854	1	17	conflict	conflict	NOUN
aiua-9854	1	18	of	of	ADP
aiua-9854	1	19	interest	interest	NOUN
aiua-9854	1	20	declared	declare	VERB
aiua-9854	1	21	.	.	PUNCT
aiua-9854	2	1	tance	tance	NOUN
aiua-9854	2	2	of	of	ADP
aiua-9854	2	3	as	as	ADP
aiua-9854	2	4	lies	lie	NOUN
aiua-9854	2	5	in	in	ADP
aiua-9854	2	6	evading	evade	VERB
aiua-9854	2	7	unnecessary	unnecessary	ADJ
aiua-9854	2	8	treatments	treatment	NOUN
aiua-9854	2	9	,	,	PUNCT
aiua-9854	2	10	and	and	CCONJ
aiua-9854	2	11	so	so	ADV
aiua-9854	2	12	their	their	PRON
aiua-9854	2	13	potentially	potentially	ADV
aiua-9854	2	14	detrimental	detrimental	ADJ
aiua-9854	2	15	side	side	NOUN
aiua-9854	2	16	effects	effect	NOUN
aiua-9854	2	17	,	,	PUNCT
aiua-9854	2	18	through	through	ADP
aiua-9854	2	19	careful	careful	ADJ
aiua-9854	2	20	surveillance	surveillance	NOUN
aiua-9854	2	21	at	at	ADP
aiua-9854	2	22	specific	specific	ADJ
aiua-9854	2	23	intervals	interval	NOUN
aiua-9854	2	24	to	to	ADP
aiua-9854	2	25	disease	disease	NOUN
aiua-9854	2	26	progression	progression	NOUN
aiua-9854	2	27	and	and	CCONJ
aiua-9854	2	28	need	need	NOUN
aiua-9854	2	29	for	for	ADP
aiua-9854	2	30	intervention	intervention	NOUN
aiua-9854	2	31	(	(	PUNCT
aiua-9854	2	32	1	1	NUM
aiua-9854	2	33	)	)	PUNCT
aiua-9854	2	34	.	.	PUNCT
aiua-9854	3	1	the	the	DET
aiua-9854	3	2	rationale	rationale	NOUN
aiua-9854	3	3	justified	justify	VERB
aiua-9854	3	4	by	by	ADP
aiua-9854	3	5	the	the	DET
aiua-9854	3	6	slow	slow	ADJ
aiua-9854	3	7	and	and	CCONJ
aiua-9854	3	8	indolent	indolent	ADJ
aiua-9854	3	9	course	course	NOUN
aiua-9854	3	10	of	of	ADP
aiua-9854	3	11	low	low	ADJ
aiua-9854	3	12	-	-	PUNCT
aiua-9854	3	13	grade	grade	NOUN
aiua-9854	3	14	prostate	prostate	NOUN
aiua-9854	3	15	cancer	cancer	NOUN
aiua-9854	3	16	(	(	PUNCT
aiua-9854	3	17	2	2	NUM
aiua-9854	3	18	,	,	PUNCT
aiua-9854	3	19	3	3	NUM
aiua-9854	3	20	)	)	PUNCT
aiua-9854	3	21	.	.	PUNCT
aiua-9854	4	1	moreover	moreover	ADV
aiua-9854	4	2	,	,	PUNCT
aiua-9854	4	3	observational	observational	ADJ
aiua-9854	4	4	studies	study	NOUN
aiua-9854	4	5	revealed	reveal	VERB
aiua-9854	4	6	no	no	DET
aiua-9854	4	7	significant	significant	ADJ
aiua-9854	4	8	advantage	advantage	NOUN
aiua-9854	4	9	in	in	ADP
aiua-9854	4	10	patients	patient	NOUN
aiua-9854	4	11	that	that	PRON
aiua-9854	4	12	underwent	undergo	VERB
aiua-9854	4	13	surgery	surgery	NOUN
aiua-9854	4	14	versus	versus	ADP
aiua-9854	4	15	active	active	ADJ
aiua-9854	4	16	surveillance	surveillance	NOUN
aiua-9854	4	17	(	(	PUNCT
aiua-9854	4	18	4	4	NUM
aiua-9854	4	19	,	,	PUNCT
aiua-9854	4	20	5	5	NUM
aiua-9854	4	21	)	)	PUNCT
aiua-9854	4	22	.	.	PUNCT
aiua-9854	5	1	in	in	ADP
aiua-9854	5	2	particular	particular	ADJ
aiua-9854	5	3	,	,	PUNCT
aiua-9854	5	4	the	the	DET
aiua-9854	5	5	protect	protect	NOUN
aiua-9854	5	6	trial	trial	NOUN
aiua-9854	5	7	showed	show	VERB
aiua-9854	5	8	a	a	DET
aiua-9854	5	9	similar	similar	ADJ
aiua-9854	5	10	10	10	NUM
aiua-9854	5	11	-	-	PUNCT
aiua-9854	5	12	year	year	NOUN
aiua-9854	5	13	prostate	prostate	NOUN
aiua-9854	5	14	cancer	cancer	NOUN
aiua-9854	5	15	specific	specific	ADJ
aiua-9854	5	16	survival	survival	NOUN
aiua-9854	5	17	in	in	ADP
aiua-9854	5	18	patients	patient	NOUN
aiua-9854	5	19	with	with	ADP
aiua-9854	5	20	localized	localized	ADJ
aiua-9854	5	21	low	low	ADJ
aiua-9854	5	22	-	-	PUNCT
aiua-9854	5	23	grade	grade	NOUN
aiua-9854	5	24	prostate	prostate	NOUN
aiua-9854	5	25	cancer	cancer	NOUN
aiua-9854	5	26	that	that	PRON
aiua-9854	5	27	underwent	undergo	VERB
aiua-9854	5	28	monitoring	monitoring	NOUN
aiua-9854	5	29	,	,	PUNCT
aiua-9854	5	30	surgery	surgery	NOUN
aiua-9854	5	31	,	,	PUNCT
aiua-9854	5	32	or	or	CCONJ
aiua-9854	5	33	radiation	radiation	NOUN
aiua-9854	5	34	therapy	therapy	NOUN
aiua-9854	5	35	(	(	PUNCT
aiua-9854	5	36	6	6	NUM
aiua-9854	5	37	)	)	PUNCT
aiua-9854	5	38	.	.	PUNCT
aiua-9854	6	1	our	our	PRON
aiua-9854	6	2	purpose	purpose	NOUN
aiua-9854	6	3	is	be	AUX
aiua-9854	6	4	to	to	PART
aiua-9854	6	5	evaluate	evaluate	VERB
aiua-9854	6	6	our	our	PRON
aiua-9854	6	7	active	active	ADJ
aiua-9854	6	8	surveillance	surveillance	NOUN
aiua-9854	6	9	protocol	protocol	NOUN
aiua-9854	6	10	and	and	CCONJ
aiua-9854	6	11	its	its	PRON
aiua-9854	6	12	outcomes	outcome	NOUN
aiua-9854	6	13	in	in	ADP
aiua-9854	6	14	our	our	PRON
aiua-9854	6	15	middle	middle	ADJ
aiua-9854	6	16	eastern	eastern	ADJ
aiua-9854	6	17	cohort	cohort	NOUN
aiua-9854	6	18	over	over	ADP
aiua-9854	6	19	a	a	DET
aiua-9854	6	20	10year	10year	NUM
aiua-9854	6	21	span	span	NOUN
aiua-9854	6	22	.	.	PUNCT
aiua-9854	7	1	to	to	ADP
aiua-9854	7	2	our	our	PRON
aiua-9854	7	3	knowledge	knowledge	NOUN
aiua-9854	7	4	,	,	PUNCT
aiua-9854	7	5	this	this	PRON
aiua-9854	7	6	is	be	AUX
aiua-9854	7	7	the	the	DET
aiua-9854	7	8	first	first	ADJ
aiua-9854	7	9	as	as	SCONJ
aiua-9854	7	10	outcome	outcome	NOUN
aiua-9854	7	11	data	datum	NOUN
aiua-9854	7	12	reported	report	VERB
aiua-9854	7	13	outside	outside	ADP
aiua-9854	7	14	of	of	ADP
aiua-9854	7	15	north	north	PROPN
aiua-9854	7	16	america	america	PROPN
aiua-9854	7	17	and	and	CCONJ
aiua-9854	7	18	europe	europe	PROPN
aiua-9854	7	19	.	.	PUNCT
aiua-9854	8	1	methods	method	NOUN
aiua-9854	8	2	after	after	ADP
aiua-9854	8	3	obtaining	obtain	VERB
aiua-9854	8	4	institutional	institutional	ADJ
aiua-9854	8	5	review	review	NOUN
aiua-9854	8	6	board	board	NOUN
aiua-9854	8	7	approval	approval	NOUN
aiua-9854	8	8	,	,	PUNCT
aiua-9854	8	9	we	we	PRON
aiua-9854	8	10	performed	perform	VERB
aiua-9854	8	11	a	a	DET
aiua-9854	8	12	retrospective	retrospective	ADJ
aiua-9854	8	13	review	review	NOUN
aiua-9854	8	14	of	of	ADP
aiua-9854	8	15	our	our	PRON
aiua-9854	8	16	prostate	prostate	NOUN
aiua-9854	8	17	cancer	cancer	NOUN
aiua-9854	8	18	patients	patient	NOUN
aiua-9854	8	19	’	'	PUNCT
aiua-9854	8	20	data	datum	NOUN
aiua-9854	8	21	at	at	ADP
aiua-9854	8	22	the	the	DET
aiua-9854	8	23	american	american	PROPN
aiua-9854	8	24	university	university	PROPN
aiua-9854	8	25	of	of	ADP
aiua-9854	8	26	beirutmedical	beirutmedical	ADJ
aiua-9854	8	27	center	center	NOUN
aiua-9854	8	28	(	(	PUNCT
aiua-9854	8	29	aubmc	aubmc	PROPN
aiua-9854	8	30	)	)	PUNCT
aiua-9854	8	31	,	,	PUNCT
aiua-9854	8	32	a	a	DET
aiua-9854	8	33	middle	middle	ADJ
aiua-9854	8	34	eastern	eastern	ADJ
aiua-9854	8	35	tertiary	tertiary	ADJ
aiua-9854	8	36	care	care	NOUN
aiua-9854	8	37	center	center	NOUN
aiua-9854	8	38	,	,	PUNCT
aiua-9854	8	39	over	over	ADP
aiua-9854	8	40	a	a	DET
aiua-9854	8	41	span	span	NOUN
aiua-9854	8	42	of	of	ADP
aiua-9854	8	43	10	10	NUM
aiua-9854	8	44	years	year	NOUN
aiua-9854	8	45	(	(	PUNCT
aiua-9854	8	46	2008	2008	NUM
aiua-9854	8	47	-	-	SYM
aiua-9854	8	48	2018	2018	NUM
aiua-9854	8	49	)	)	PUNCT
aiua-9854	8	50	.	.	PUNCT
aiua-9854	9	1	43	43	NUM
aiua-9854	9	2	of	of	ADP
aiua-9854	9	3	them	they	PRON
aiua-9854	9	4	satisfied	satisfy	VERB
aiua-9854	9	5	the	the	DET
aiua-9854	9	6	inclusion	inclusion	NOUN
aiua-9854	9	7	criteria	criterion	NOUN
aiua-9854	9	8	into	into	ADP
aiua-9854	9	9	our	our	PRON
aiua-9854	9	10	institution	institution	NOUN
aiua-9854	9	11	’s	’s	PART
aiua-9854	9	12	active	active	ADJ
aiua-9854	9	13	surveillance	surveillance	NOUN
aiua-9854	9	14	protocol	protocol	NOUN
aiua-9854	9	15	.	.	PUNCT
aiua-9854	10	1	our	our	PRON
aiua-9854	10	2	inclusion	inclusion	NOUN
aiua-9854	10	3	criteria	criterion	NOUN
aiua-9854	10	4	included	include	VERB
aiua-9854	10	5	low	low	ADJ
aiua-9854	10	6	risk	risk	NOUN
aiua-9854	10	7	prostate	prostate	NOUN
aiua-9854	10	8	cancer	cancer	NOUN
aiua-9854	10	9	defined	define	VERB
aiua-9854	10	10	by	by	ADP
aiua-9854	10	11	the	the	DET
aiua-9854	10	12	following	follow	VERB
aiua-9854	10	13	parameters	parameter	NOUN
aiua-9854	10	14	:	:	PUNCT
aiua-9854	10	15	psa	psa	VERB
aiua-9854	10	16	less	less	ADJ
aiua-9854	10	17	than	than	ADP
aiua-9854	10	18	10	10	NUM
aiua-9854	10	19	,	,	PUNCT
aiua-9854	10	20	a	a	DET
aiua-9854	10	21	negative	negative	ADJ
aiua-9854	10	22	dre	dre	NOUN
aiua-9854	10	23	or	or	CCONJ
aiua-9854	10	24	a	a	DET
aiua-9854	10	25	localized	localized	ADJ
aiua-9854	10	26	nodule	nodule	NOUN
aiua-9854	10	27	(	(	PUNCT
aiua-9854	10	28	t1c	t1c	NOUN
aiua-9854	10	29	/	/	SYM
aiua-9854	10	30	t2a	t2a	NOUN
aiua-9854	10	31	)	)	PUNCT
aiua-9854	10	32	,	,	PUNCT
aiua-9854	10	33	biopsy	biopsy	PROPN
aiua-9854	10	34	gleason	gleason	PROPN
aiua-9854	10	35	group	group	PROPN
aiua-9854	10	36	grade	grade	PROPN
aiua-9854	10	37	1	1	NUM
aiua-9854	10	38	or	or	CCONJ
aiua-9854	10	39	2	2	NUM
aiua-9854	10	40	as	as	SCONJ
aiua-9854	10	41	defined	define	VERB
aiua-9854	10	42	by	by	ADP
aiua-9854	10	43	the	the	PRON
aiua-9854	10	44	who	who	PRON
aiua-9854	10	45	criteria	criteria	VERB
aiua-9854	10	46	,	,	PUNCT
aiua-9854	10	47	and	and	CCONJ
aiua-9854	10	48	unilateral	unilateral	ADJ
aiua-9854	10	49	disease	disease	NOUN
aiua-9854	10	50	involvement	involvement	NOUN
aiua-9854	10	51	on	on	ADP
aiua-9854	10	52	biopsy	biopsy	NOUN
aiua-9854	10	53	.	.	PUNCT
aiua-9854	11	1	magnetic	magnetic	ADJ
aiua-9854	11	2	resonance	resonance	NOUN
aiua-9854	11	3	imaging	imaging	NOUN
aiua-9854	11	4	(	(	PUNCT
aiua-9854	11	5	mri	mri	NOUN
aiua-9854	11	6	)	)	PUNCT
aiua-9854	11	7	was	be	AUX
aiua-9854	11	8	done	do	VERB
aiua-9854	11	9	to	to	PART
aiua-9854	11	10	characterize	characterize	VERB
aiua-9854	11	11	and	and	CCONJ
aiua-9854	11	12	guide	guide	VERB
aiua-9854	11	13	the	the	DET
aiua-9854	11	14	localization	localization	NOUN
aiua-9854	11	15	of	of	ADP
aiua-9854	11	16	prostatic	prostatic	ADJ
aiua-9854	11	17	lesions	lesion	NOUN
aiua-9854	11	18	for	for	ADP
aiua-9854	11	19	biopsy	biopsy	NOUN
aiua-9854	11	20	.	.	PUNCT
aiua-9854	12	1	consequently	consequently	ADV
aiua-9854	12	2	,	,	PUNCT
aiua-9854	12	3	targeted	target	VERB
aiua-9854	12	4	biopsies	biopsy	NOUN
aiua-9854	12	5	were	be	AUX
aiua-9854	12	6	taken	take	VERB
aiua-9854	12	7	from	from	ADP
aiua-9854	12	8	those	those	DET
aiua-9854	12	9	lesions	lesion	NOUN
aiua-9854	12	10	along	along	ADP
aiua-9854	12	11	with	with	ADP
aiua-9854	12	12	random	random	ADJ
aiua-9854	12	13	ones	one	NOUN
aiua-9854	12	14	.	.	PUNCT
aiua-9854	13	1	there	there	PRON
aiua-9854	13	2	was	be	VERB
aiua-9854	13	3	no	no	DET
aiua-9854	13	4	exclusion	exclusion	NOUN
aiua-9854	13	5	criteria	criterion	NOUN
aiua-9854	13	6	based	base	VERB
aiua-9854	13	7	on	on	ADP
aiua-9854	13	8	age	age	NOUN
aiua-9854	13	9	.	.	PUNCT
aiua-9854	14	1	to	to	PART
aiua-9854	14	2	note	note	VERB
aiua-9854	14	3	,	,	PUNCT
aiua-9854	14	4	patients	patient	NOUN
aiua-9854	14	5	that	that	PRON
aiua-9854	14	6	were	be	AUX
aiua-9854	14	7	enrolled	enrol	VERB
aiua-9854	14	8	into	into	ADP
aiua-9854	14	9	the	the	PRON
aiua-9854	14	10	as	as	SCONJ
aiua-9854	14	11	protocol	protocol	NOUN
aiua-9854	14	12	were	be	AUX
aiua-9854	14	13	thoroughly	thoroughly	ADV
aiua-9854	14	14	counseled	counsel	VERB
aiua-9854	14	15	about	about	ADP
aiua-9854	14	16	available	available	ADJ
aiua-9854	14	17	treatment	treatment	NOUN
aiua-9854	14	18	options	option	NOUN
aiua-9854	14	19	including	include	VERB
aiua-9854	14	20	their	their	PRON
aiua-9854	14	21	possible	possible	ADJ
aiua-9854	14	22	side	side	NOUN
aiua-9854	14	23	effects	effect	NOUN
aiua-9854	14	24	.	.	PUNCT
aiua-9854	15	1	our	our	PRON
aiua-9854	15	2	follow	follow	VERB
aiua-9854	15	3	-	-	PUNCT
aiua-9854	15	4	up	up	ADP
aiua-9854	15	5	strategy	strategy	NOUN
aiua-9854	15	6	based	base	VERB
aiua-9854	15	7	upon	upon	SCONJ
aiua-9854	15	8	a	a	DET
aiua-9854	15	9	psa	psa	NOUN
aiua-9854	15	10	and	and	CCONJ
aiua-9854	15	11	dre	dre	VERB
aiua-9854	15	12	every	every	DET
aiua-9854	15	13	4	4	NUM
aiua-9854	15	14	-	-	SYM
aiua-9854	15	15	6	6	NUM
aiua-9854	15	16	months	month	NOUN
aiua-9854	15	17	,	,	PUNCT
aiua-9854	15	18	an	an	DET
aiua-9854	15	19	initial	initial	ADJ
aiua-9854	15	20	prostate	prostate	NOUN
aiua-9854	15	21	biopsy	biopsy	NOUN
aiua-9854	15	22	at	at	ADP
aiua-9854	15	23	the	the	DET
aiua-9854	15	24	time	time	NOUN
aiua-9854	15	25	of	of	ADP
aiua-9854	15	26	enrollment	enrollment	NOUN
aiua-9854	15	27	,	,	PUNCT
aiua-9854	15	28	and	and	CCONJ
aiua-9854	15	29	a	a	DET
aiua-9854	15	30	second	second	ADJ
aiua-9854	15	31	biopsy	biopsy	NOUN
aiua-9854	15	32	at	at	ADP
aiua-9854	15	33	1	1	NUM
aiua-9854	15	34	year	year	NOUN
aiua-9854	15	35	.	.	PUNCT
aiua-9854	16	1	annual	annual	ADJ
aiua-9854	16	2	mri	mri	NOUN
aiua-9854	16	3	was	be	AUX
aiua-9854	16	4	not	not	PART
aiua-9854	16	5	initially	initially	ADV
aiua-9854	16	6	part	part	NOUN
aiua-9854	16	7	of	of	ADP
aiua-9854	16	8	the	the	DET
aiua-9854	16	9	protocol	protocol	NOUN
aiua-9854	16	10	,	,	PUNCT
aiua-9854	16	11	yet	yet	CCONJ
aiua-9854	16	12	it	it	PRON
aiua-9854	16	13	was	be	AUX
aiua-9854	16	14	introduced	introduce	VERB
aiua-9854	16	15	in	in	ADP
aiua-9854	16	16	the	the	DET
aiua-9854	16	17	last	last	ADJ
aiua-9854	16	18	few	few	ADJ
aiua-9854	16	19	years	year	NOUN
aiua-9854	16	20	.	.	PUNCT
aiua-9854	17	1	furthermore	furthermore	ADV
aiua-9854	17	2	,	,	PUNCT
aiua-9854	17	3	an	an	DET
aiua-9854	17	4	additional	additional	ADJ
aiua-9854	17	5	re	re	NOUN
aiua-9854	17	6	-	-	NOUN
aiua-9854	17	7	biopsy	biopsy	ADJ
aiua-9854	17	8	was	be	AUX
aiua-9854	17	9	done	do	VERB
aiua-9854	17	10	after	after	ADP
aiua-9854	17	11	the	the	DET
aiua-9854	17	12	first	first	ADJ
aiua-9854	17	13	year	year	NOUN
aiua-9854	17	14	with	with	ADP
aiua-9854	17	15	evident	evident	ADJ
aiua-9854	17	16	signs	sign	NOUN
aiua-9854	17	17	of	of	ADP
aiua-9854	17	18	clinical	clinical	ADJ
aiua-9854	17	19	progression	progression	NOUN
aiua-9854	17	20	such	such	ADJ
aiua-9854	17	21	as	as	ADP
aiua-9854	17	22	a	a	DET
aiua-9854	17	23	suspicious	suspicious	ADJ
aiua-9854	17	24	rise	rise	NOUN
aiua-9854	17	25	in	in	ADP
aiua-9854	17	26	psa	psa	NOUN
aiua-9854	17	27	,	,	PUNCT
aiua-9854	17	28	change	change	VERB
aiua-9854	17	29	in	in	ADP
aiua-9854	17	30	dre	dre	PROPN
aiua-9854	17	31	,	,	PUNCT
aiua-9854	17	32	or	or	CCONJ
aiua-9854	17	33	mri	mri	NOUN
aiua-9854	17	34	progression	progression	NOUN
aiua-9854	17	35	which	which	PRON
aiua-9854	17	36	included	include	VERB
aiua-9854	17	37	the	the	DET
aiua-9854	17	38	appearance	appearance	NOUN
aiua-9854	17	39	of	of	ADP
aiua-9854	17	40	a	a	DET
aiua-9854	17	41	new	new	ADJ
aiua-9854	17	42	lesion	lesion	NOUN
aiua-9854	17	43	,	,	PUNCT
aiua-9854	17	44	or	or	CCONJ
aiua-9854	17	45	an	an	DET
aiua-9854	17	46	increased	increase	VERB
aiua-9854	17	47	background	background	NOUN
aiua-9854	17	48	:	:	PUNCT
aiua-9854	17	49	the	the	DET
aiua-9854	17	50	aim	aim	NOUN
aiua-9854	17	51	of	of	ADP
aiua-9854	17	52	our	our	PRON
aiua-9854	17	53	study	study	NOUN
aiua-9854	17	54	was	be	AUX
aiua-9854	17	55	to	to	PART
aiua-9854	17	56	evaluate	evaluate	VERB
aiua-9854	17	57	the	the	DET
aiua-9854	17	58	outcome	outcome	NOUN
aiua-9854	17	59	of	of	ADP
aiua-9854	17	60	active	active	ADJ
aiua-9854	17	61	surveillance	surveillance	NOUN
aiua-9854	17	62	(	(	PUNCT
aiua-9854	17	63	as	as	ADP
aiua-9854	17	64	)	)	PUNCT
aiua-9854	17	65	for	for	ADP
aiua-9854	17	66	prostate	prostate	NOUN
aiua-9854	17	67	cancer	cancer	NOUN
aiua-9854	17	68	for	for	ADP
aiua-9854	17	69	a	a	DET
aiua-9854	17	70	cohort	cohort	NOUN
aiua-9854	17	71	of	of	ADP
aiua-9854	17	72	patients	patient	NOUN
aiua-9854	17	73	at	at	ADP
aiua-9854	17	74	our	our	PRON
aiua-9854	17	75	institution	institution	NOUN
aiua-9854	17	76	.	.	PUNCT
aiua-9854	18	1	methods	method	NOUN
aiua-9854	18	2	:	:	PUNCT
aiua-9854	18	3	a	a	DET
aiua-9854	18	4	total	total	NOUN
aiua-9854	18	5	of	of	ADP
aiua-9854	18	6	43	43	NUM
aiua-9854	18	7	patients	patient	NOUN
aiua-9854	18	8	with	with	ADP
aiua-9854	18	9	low	low	ADJ
aiua-9854	18	10	risk	risk	NOUN
aiua-9854	18	11	prostate	prostate	NOUN
aiua-9854	18	12	cancer	cancer	NOUN
aiua-9854	18	13	were	be	AUX
aiua-9854	18	14	enrolled	enrol	VERB
aiua-9854	18	15	in	in	ADP
aiua-9854	18	16	an	an	DET
aiua-9854	18	17	active	active	ADJ
aiua-9854	18	18	surveillance	surveillance	NOUN
aiua-9854	18	19	pilot	pilot	NOUN
aiua-9854	18	20	program	program	NOUN
aiua-9854	18	21	at	at	ADP
aiua-9854	18	22	our	our	PRON
aiua-9854	18	23	institution	institution	NOUN
aiua-9854	18	24	between	between	ADP
aiua-9854	18	25	2008	2008	NUM
aiua-9854	18	26	and	and	CCONJ
aiua-9854	18	27	2018	2018	NUM
aiua-9854	18	28	.	.	PUNCT
aiua-9854	19	1	follow	follow	VERB
aiua-9854	19	2	up	up	ADP
aiua-9854	19	3	protocols	protocol	NOUN
aiua-9854	19	4	included	include	VERB
aiua-9854	19	5	:	:	PUNCT
aiua-9854	19	6	periodic	periodic	ADJ
aiua-9854	19	7	prostate	prostate	NOUN
aiua-9854	19	8	specific	specific	ADJ
aiua-9854	19	9	antigen	antigen	NOUN
aiua-9854	19	10	(	(	PUNCT
aiua-9854	19	11	psa	psa	NOUN
aiua-9854	19	12	)	)	PUNCT
aiua-9854	19	13	,	,	PUNCT
aiua-9854	19	14	digital	digital	ADJ
aiua-9854	19	15	rectal	rectal	ADJ
aiua-9854	19	16	examination	examination	NOUN
aiua-9854	19	17	(	(	PUNCT
aiua-9854	19	18	dre	dre	PROPN
aiua-9854	19	19	)	)	PUNCT
aiua-9854	19	20	,	,	PUNCT
aiua-9854	19	21	multiparametric	multiparametric	ADJ
aiua-9854	19	22	mri	mri	NOUN
aiua-9854	19	23	,	,	PUNCT
aiua-9854	19	24	and	and	CCONJ
aiua-9854	19	25	prostate	prostate	NOUN
aiua-9854	19	26	biopsy	biopsy	NOUN
aiua-9854	19	27	at	at	ADP
aiua-9854	19	28	one	one	NUM
aiua-9854	19	29	year	year	NOUN
aiua-9854	19	30	.	.	PUNCT
aiua-9854	20	1	pertinent	pertinent	ADJ
aiua-9854	20	2	parameters	parameter	NOUN
aiua-9854	20	3	were	be	AUX
aiua-9854	20	4	collected	collect	VERB
aiua-9854	20	5	,	,	PUNCT
aiua-9854	20	6	and	and	CCONJ
aiua-9854	20	7	descriptive	descriptive	ADJ
aiua-9854	20	8	statistics	statistic	NOUN
aiua-9854	20	9	were	be	AUX
aiua-9854	20	10	reported	report	VERB
aiua-9854	20	11	along	along	ADP
aiua-9854	20	12	with	with	ADP
aiua-9854	20	13	a	a	DET
aiua-9854	20	14	subset	subset	ADJ
aiua-9854	20	15	analysis	analysis	NOUN
aiua-9854	20	16	of	of	ADP
aiua-9854	20	17	patients	patient	NOUN
aiua-9854	20	18	that	that	PRON
aiua-9854	20	19	dropped	drop	VERB
aiua-9854	20	20	out	out	ADP
aiua-9854	20	21	of	of	ADP
aiua-9854	20	22	the	the	DET
aiua-9854	20	23	protocol	protocol	NOUN
aiua-9854	20	24	to	to	PART
aiua-9854	20	25	receive	receive	VERB
aiua-9854	20	26	active	active	ADJ
aiua-9854	20	27	treatment	treatment	NOUN
aiua-9854	20	28	for	for	ADP
aiua-9854	20	29	disease	disease	NOUN
aiua-9854	20	30	progression	progression	NOUN
aiua-9854	20	31	.	.	PUNCT
aiua-9854	21	1	results	result	NOUN
aiua-9854	21	2	:	:	PUNCT
aiua-9854	21	3	out	out	ADP
aiua-9854	21	4	of	of	ADP
aiua-9854	21	5	43	43	NUM
aiua-9854	21	6	eligible	eligible	ADJ
aiua-9854	21	7	patients	patient	NOUN
aiua-9854	21	8	,	,	PUNCT
aiua-9854	21	9	46.5	46.5	NUM
aiua-9854	21	10	%	%	NOUN
aiua-9854	21	11	had	have	VERB
aiua-9854	21	12	a	a	DET
aiua-9854	21	13	significant	significant	ADJ
aiua-9854	21	14	rise	rise	NOUN
aiua-9854	21	15	in	in	ADP
aiua-9854	21	16	follow	follow	VERB
aiua-9854	21	17	up	up	ADP
aiua-9854	22	1	psa	psa	NOUN
aiua-9854	22	2	.	.	PROPN
aiua-9854	22	3	dre	dre	PROPN
aiua-9854	22	4	was	be	AUX
aiua-9854	22	5	initially	initially	ADV
aiua-9854	22	6	suspicious	suspicious	ADJ
aiua-9854	22	7	in	in	ADP
aiua-9854	22	8	27.9	27.9	NUM
aiua-9854	22	9	%	%	NOUN
aiua-9854	22	10	of	of	ADP
aiua-9854	22	11	patients	patient	NOUN
aiua-9854	22	12	,	,	PUNCT
aiua-9854	22	13	and	and	CCONJ
aiua-9854	22	14	none	none	NOUN
aiua-9854	22	15	had	have	VERB
aiua-9854	22	16	any	any	DET
aiua-9854	22	17	change	change	NOUN
aiua-9854	22	18	in	in	ADP
aiua-9854	22	19	dre	dre	NOUN
aiua-9854	22	20	on	on	AUX
aiua-9854	22	21	follow	follow	VERB
aiua-9854	22	22	up	up	ADP
aiua-9854	22	23	.	.	PUNCT
aiua-9854	23	1	initially	initially	ADV
aiua-9854	23	2	,	,	PUNCT
aiua-9854	23	3	prostate	prostate	NOUN
aiua-9854	23	4	mris	mris	PROPN
aiua-9854	23	5	showed	show	VERB
aiua-9854	23	6	pirads	pirad	NOUN
aiua-9854	23	7	3	3	NUM
aiua-9854	23	8	,	,	PUNCT
aiua-9854	23	9	4	4	NUM
aiua-9854	23	10	,	,	PUNCT
aiua-9854	23	11	and	and	CCONJ
aiua-9854	23	12	5	5	NUM
aiua-9854	23	13	in	in	ADP
aiua-9854	23	14	14	14	NUM
aiua-9854	23	15	%	%	NOUN
aiua-9854	23	16	,	,	PUNCT
aiua-9854	23	17	37.2	37.2	NUM
aiua-9854	23	18	%	%	NOUN
aiua-9854	23	19	,	,	PUNCT
aiua-9854	23	20	and	and	CCONJ
aiua-9854	23	21	11.6	11.6	NUM
aiua-9854	23	22	%	%	NOUN
aiua-9854	23	23	respectively	respectively	ADV
aiua-9854	23	24	,	,	PUNCT
aiua-9854	23	25	while	while	SCONJ
aiua-9854	23	26	23.2	23.2	NUM
aiua-9854	23	27	%	%	NOUN
aiua-9854	23	28	had	have	VERB
aiua-9854	23	29	a	a	DET
aiua-9854	23	30	negative	negative	ADJ
aiua-9854	23	31	initial	initial	ADJ
aiua-9854	23	32	mri	mri	NOUN
aiua-9854	23	33	.	.	PUNCT
aiua-9854	24	1	14	14	NUM
aiua-9854	24	2	%	%	NOUN
aiua-9854	24	3	did	do	AUX
aiua-9854	24	4	not	not	PART
aiua-9854	24	5	have	have	VERB
aiua-9854	24	6	an	an	DET
aiua-9854	24	7	mri	mri	NOUN
aiua-9854	24	8	.	.	PUNCT
aiua-9854	25	1	upon	upon	AUX
aiua-9854	25	2	follow	follow	VERB
aiua-9854	25	3	up	up	ADP
aiua-9854	25	4	,	,	PUNCT
aiua-9854	25	5	18.6	18.6	NUM
aiua-9854	25	6	%	%	NOUN
aiua-9854	25	7	of	of	ADP
aiua-9854	25	8	patients	patient	NOUN
aiua-9854	25	9	had	have	VERB
aiua-9854	25	10	progression	progression	NOUN
aiua-9854	25	11	on	on	ADP
aiua-9854	25	12	mri	mri	PROPN
aiua-9854	25	13	.	.	PUNCT
aiua-9854	26	1	initial	initial	ADJ
aiua-9854	26	2	biopsies	biopsy	NOUN
aiua-9854	26	3	revealed	reveal	VERB
aiua-9854	26	4	that	that	SCONJ
aiua-9854	26	5	86	86	NUM
aiua-9854	26	6	%	%	NOUN
aiua-9854	26	7	were	be	AUX
aiua-9854	26	8	classified	classify	VERB
aiua-9854	26	9	as	as	ADP
aiua-9854	26	10	who	who	PRON
aiua-9854	26	11	group	group	NOUN
aiua-9854	26	12	1	1	NUM
aiua-9854	26	13	,	,	PUNCT
aiua-9854	26	14	while	while	SCONJ
aiua-9854	26	15	14	14	NUM
aiua-9854	26	16	%	%	NOUN
aiua-9854	26	17	as	as	ADP
aiua-9854	26	18	who	who	PRON
aiua-9854	26	19	group	group	NOUN
aiua-9854	26	20	2	2	NUM
aiua-9854	26	21	.	.	PUNCT
aiua-9854	26	22	with	with	ADP
aiua-9854	26	23	regards	regard	NOUN
aiua-9854	26	24	to	to	ADP
aiua-9854	26	25	the	the	DET
aiua-9854	26	26	follow	follow	VERB
aiua-9854	26	27	up	up	ADP
aiua-9854	26	28	biopsies	biopsy	NOUN
aiua-9854	26	29	,	,	PUNCT
aiua-9854	26	30	11.6	11.6	NUM
aiua-9854	26	31	%	%	NOUN
aiua-9854	26	32	were	be	AUX
aiua-9854	26	33	upgraded	upgrade	VERB
aiua-9854	26	34	.	.	PUNCT
aiua-9854	27	1	20.9	20.9	NUM
aiua-9854	27	2	%	%	NOUN
aiua-9854	27	3	of	of	ADP
aiua-9854	27	4	our	our	PRON
aiua-9854	27	5	patients	patient	NOUN
aiua-9854	27	6	had	have	VERB
aiua-9854	27	7	active	active	ADJ
aiua-9854	27	8	treatment	treatment	NOUN
aiua-9854	27	9	;	;	PUNCT
aiua-9854	27	10	44.4	44.4	NUM
aiua-9854	27	11	%	%	NOUN
aiua-9854	27	12	due	due	ADJ
aiua-9854	27	13	to	to	ADP
aiua-9854	27	14	upgraded	upgrade	VERB
aiua-9854	27	15	biopsy	biopsy	NOUN
aiua-9854	27	16	results	result	NOUN
aiua-9854	27	17	,	,	PUNCT
aiua-9854	27	18	22.2	22.2	NUM
aiua-9854	27	19	%	%	NOUN
aiua-9854	27	20	due	due	ADP
aiua-9854	27	21	to	to	PART
aiua-9854	27	22	psa	psa	VERB
aiua-9854	27	23	progression	progression	NOUN
aiua-9854	27	24	,	,	PUNCT
aiua-9854	27	25	22.2	22.2	NUM
aiua-9854	27	26	%	%	NOUN
aiua-9854	27	27	due	due	ADP
aiua-9854	27	28	to	to	ADP
aiua-9854	27	29	strong	strong	ADJ
aiua-9854	27	30	patient	patient	ADJ
aiua-9854	27	31	preference	preference	NOUN
aiua-9854	27	32	,	,	PUNCT
aiua-9854	27	33	and	and	CCONJ
aiua-9854	27	34	11.1	11.1	NUM
aiua-9854	27	35	%	%	NOUN
aiua-9854	27	36	due	due	ADP
aiua-9854	27	37	to	to	ADP
aiua-9854	27	38	radiologic	radiologic	ADJ
aiua-9854	27	39	progression	progression	NOUN
aiua-9854	27	40	.	.	PUNCT
aiua-9854	28	1	conclusions	conclusion	NOUN
aiua-9854	28	2	:	:	PUNCT
aiua-9854	28	3	for	for	ADP
aiua-9854	28	4	selected	select	VERB
aiua-9854	28	5	men	man	NOUN
aiua-9854	28	6	with	with	ADP
aiua-9854	28	7	low	low	ADJ
aiua-9854	28	8	risk	risk	NOUN
aiua-9854	28	9	prostate	prostate	NOUN
aiua-9854	28	10	cancer	cancer	NOUN
aiua-9854	28	11	,	,	PUNCT
aiua-9854	28	12	as	as	SCONJ
aiua-9854	28	13	is	be	AUX
aiua-9854	28	14	a	a	DET
aiua-9854	28	15	reasonable	reasonable	ADJ
aiua-9854	28	16	alternative	alternative	NOUN
aiua-9854	28	17	.	.	PUNCT
aiua-9854	29	1	the	the	DET
aiua-9854	29	2	decision	decision	NOUN
aiua-9854	29	3	for	for	ADP
aiua-9854	29	4	active	active	ADJ
aiua-9854	29	5	treatment	treatment	NOUN
aiua-9854	29	6	should	should	AUX
aiua-9854	29	7	be	be	AUX
aiua-9854	29	8	tailored	tailor	VERB
aiua-9854	29	9	upon	upon	SCONJ
aiua-9854	29	10	changes	change	NOUN
aiua-9854	29	11	in	in	ADP
aiua-9854	29	12	psa	psa	NOUN
aiua-9854	29	13	,	,	PUNCT
aiua-9854	29	14	dre	dre	PROPN
aiua-9854	29	15	,	,	PUNCT
aiua-9854	29	16	mri	mri	NOUN
aiua-9854	29	17	,	,	PUNCT
aiua-9854	29	18	and	and	CCONJ
aiua-9854	29	19	biopsy	biopsy	NOUN
aiua-9854	29	20	results	result	NOUN
aiua-9854	29	21	.	.	PUNCT
aiua-9854	30	1	key	key	ADJ
aiua-9854	30	2	words	word	NOUN
aiua-9854	30	3	:	:	PUNCT
aiua-9854	30	4	active	active	ADJ
aiua-9854	30	5	surveillance	surveillance	NOUN
aiua-9854	30	6	;	;	PUNCT
aiua-9854	30	7	prostate	prostate	NOUN
aiua-9854	30	8	cancer	cancer	NOUN
aiua-9854	30	9	;	;	PUNCT
aiua-9854	30	10	men	man	NOUN
aiua-9854	30	11	’s	’s	PART
aiua-9854	30	12	health	health	NOUN
aiua-9854	30	13	;	;	PUNCT
aiua-9854	30	14	screening	screen	VERB
aiua-9854	30	15	;	;	PUNCT
aiua-9854	30	16	prostate	prostate	NOUN
aiua-9854	30	17	specific	specific	ADJ
aiua-9854	30	18	antigen	antigen	NOUN
aiua-9854	30	19	.	.	PUNCT
aiua-9854	31	1	submitted	submit	VERB
aiua-9854	31	2	14	14	NUM
aiua-9854	31	3	may	may	PROPN
aiua-9854	31	4	2021	2021	NUM
aiua-9854	31	5	;	;	PUNCT
aiua-9854	31	6	accepted	accept	VERB
aiua-9854	31	7	19	19	NUM
aiua-9854	31	8	july	july	PROPN
aiua-9854	31	9	2021	2021	NUM
aiua-9854	31	10	introduction	introduction	NOUN
aiua-9854	31	11	active	active	ADJ
aiua-9854	31	12	surveillance	surveillance	NOUN
aiua-9854	31	13	(	(	PUNCT
aiua-9854	31	14	as	as	ADP
aiua-9854	31	15	)	)	PUNCT
aiua-9854	31	16	as	as	ADP
aiua-9854	31	17	a	a	DET
aiua-9854	31	18	management	management	NOUN
aiua-9854	31	19	strategy	strategy	NOUN
aiua-9854	31	20	for	for	ADP
aiua-9854	31	21	low	low	ADJ
aiua-9854	31	22	grade	grade	NOUN
aiua-9854	31	23	prostate	prostate	NOUN
aiua-9854	31	24	cancer	cancer	NOUN
aiua-9854	31	25	is	be	AUX
aiua-9854	31	26	a	a	DET
aiua-9854	31	27	relatively	relatively	ADV
aiua-9854	31	28	new	new	ADJ
aiua-9854	31	29	approach	approach	NOUN
aiua-9854	31	30	increasingly	increasingly	ADV
aiua-9854	31	31	utilized	utilize	VERB
aiua-9854	31	32	by	by	ADP
aiua-9854	31	33	clinicians	clinician	NOUN
aiua-9854	31	34	in	in	ADP
aiua-9854	31	35	the	the	DET
aiua-9854	31	36	light	light	NOUN
aiua-9854	31	37	of	of	ADP
aiua-9854	31	38	better	well	ADJ
aiua-9854	31	39	comprehension	comprehension	NOUN
aiua-9854	31	40	of	of	ADP
aiua-9854	31	41	low	low	ADJ
aiua-9854	31	42	-	-	PUNCT
aiua-9854	31	43	grade	grade	NOUN
aiua-9854	31	44	prostate	prostate	NOUN
aiua-9854	31	45	cancer	cancer	NOUN
aiua-9854	31	46	behavior	behavior	NOUN
aiua-9854	31	47	.	.	PUNCT
aiua-9854	32	1	it	it	PRON
aiua-9854	32	2	is	be	AUX
aiua-9854	32	3	a	a	DET
aiua-9854	32	4	dynamic	dynamic	ADJ
aiua-9854	32	5	surveillance	surveillance	NOUN
aiua-9854	32	6	strategy	strategy	NOUN
aiua-9854	32	7	that	that	PRON
aiua-9854	32	8	may	may	AUX
aiua-9854	32	9	shift	shift	VERB
aiua-9854	32	10	into	into	ADP
aiua-9854	32	11	a	a	DET
aiua-9854	32	12	direct	direct	ADJ
aiua-9854	32	13	curative	curative	ADJ
aiua-9854	32	14	intervention	intervention	NOUN
aiua-9854	32	15	(	(	PUNCT
aiua-9854	32	16	1	1	NUM
aiua-9854	32	17	)	)	PUNCT
aiua-9854	32	18	.	.	PUNCT
aiua-9854	33	1	the	the	DET
aiua-9854	33	2	main	main	ADJ
aiua-9854	33	3	goal	goal	NOUN
aiua-9854	33	4	is	be	AUX
aiua-9854	33	5	to	to	PART
aiua-9854	33	6	follow	follow	VERB
aiua-9854	33	7	-	-	PUNCT
aiua-9854	33	8	up	up	ADP
aiua-9854	33	9	patients	patient	NOUN
aiua-9854	33	10	with	with	ADP
aiua-9854	33	11	clinical	clinical	ADJ
aiua-9854	33	12	parameters	parameter	NOUN
aiua-9854	33	13	such	such	ADJ
aiua-9854	33	14	as	as	ADP
aiua-9854	33	15	prostate	prostate	NOUN
aiua-9854	33	16	specific	specific	ADJ
aiua-9854	33	17	antigen	antigen	NOUN
aiua-9854	33	18	(	(	PUNCT
aiua-9854	33	19	psa	psa	NOUN
aiua-9854	33	20	)	)	PUNCT
aiua-9854	33	21	,	,	PUNCT
aiua-9854	33	22	digital	digital	ADJ
aiua-9854	33	23	rectal	rectal	ADJ
aiua-9854	33	24	examination	examination	NOUN
aiua-9854	33	25	(	(	PUNCT
aiua-9854	33	26	dre	dre	PROPN
aiua-9854	33	27	)	)	PUNCT
aiua-9854	33	28	,	,	PUNCT
aiua-9854	33	29	imaging	imaging	NOUN
aiua-9854	33	30	and	and	CCONJ
aiua-9854	33	31	biopsy	biopsy	NOUN
aiua-9854	33	32	according	accord	VERB
aiua-9854	33	33	to	to	ADP
aiua-9854	33	34	predetermined	predetermined	ADJ
aiua-9854	33	35	protocols	protocol	NOUN
aiua-9854	33	36	.	.	PUNCT
aiua-9854	34	1	the	the	DET
aiua-9854	34	2	imporoutcomes	imporoutcome	NOUN
aiua-9854	34	3	of	of	ADP
aiua-9854	34	4	active	active	ADJ
aiua-9854	34	5	surveillance	surveillance	NOUN
aiua-9854	34	6	for	for	ADP
aiua-9854	34	7	clinically	clinically	ADV
aiua-9854	34	8	localized	localize	VERB
aiua-9854	34	9	prostate	prostate	NOUN
aiua-9854	34	10	cancer	cancer	NOUN
aiua-9854	34	11	in	in	ADP
aiua-9854	34	12	a	a	DET
aiua-9854	34	13	middle	middle	ADJ
aiua-9854	34	14	eastern	eastern	ADJ
aiua-9854	34	15	tertiary	tertiary	ADJ
aiua-9854	34	16	care	care	NOUN
aiua-9854	34	17	center	center	PROPN
aiua-9854	34	18	mohammad	mohammad	PROPN
aiua-9854	34	19	hout	hout	PROPN
aiua-9854	34	20	1	1	NUM
aiua-9854	34	21	,	,	PUNCT
aiua-9854	34	22	ali	ali	PROPN
aiua-9854	34	23	merhe	merhe	PROPN
aiua-9854	34	24	1	1	NUM
aiua-9854	34	25	,	,	PUNCT
aiua-9854	34	26	nassib	nassib	NOUN
aiua-9854	34	27	abou	abou	PROPN
aiua-9854	34	28	heidar	heidar	PROPN
aiua-9854	34	29	1	1	NUM
aiua-9854	34	30	,	,	PUNCT
aiua-9854	34	31	jose	jose	PROPN
aiua-9854	34	32	m	m	PROPN
aiua-9854	34	33	el	el	PROPN
aiua-9854	34	34	-	-	PROPN
aiua-9854	34	35	asmar	asmar	ADJ
aiua-9854	34	36	1	1	NUM
aiua-9854	34	37	,	,	PUNCT
aiua-9854	34	38	wassim	wassim	NOUN
aiua-9854	34	39	wazzan	wazzan	NOUN
aiua-9854	34	40	1	1	NUM
aiua-9854	34	41	,	,	PUNCT
aiua-9854	34	42	bassel	bassel	NOUN
aiua-9854	34	43	bachir	bachir	VERB
aiua-9854	34	44	1	1	NUM
aiua-9854	34	45	,	,	PUNCT
aiua-9854	34	46	rola	rola	NOUN
aiua-9854	34	47	jaafar	jaafar	ADJ
aiua-9854	34	48	2	2	NUM
aiua-9854	34	49	,	,	PUNCT
aiua-9854	34	50	albert	albert	PROPN
aiua-9854	34	51	el	el	PROPN
aiua-9854	34	52	hajj	hajj	PROPN
aiua-9854	34	53	1	1	NUM
aiua-9854	34	54	,	,	PUNCT
aiua-9854	34	55	muhammad	muhammad	PROPN
aiua-9854	34	56	bulbul	bulbul	PROPN
aiua-9854	34	57	1	1	NUM
aiua-9854	34	58	1	1	NUM
aiua-9854	34	59	department	department	NOUN
aiua-9854	34	60	of	of	ADP
aiua-9854	34	61	surgery	surgery	NOUN
aiua-9854	34	62	,	,	PUNCT
aiua-9854	34	63	division	division	NOUN
aiua-9854	34	64	of	of	ADP
aiua-9854	34	65	urology	urology	NOUN
aiua-9854	34	66	,	,	PUNCT
aiua-9854	34	67	american	american	PROPN
aiua-9854	34	68	university	university	PROPN
aiua-9854	34	69	of	of	ADP
aiua-9854	34	70	beirut	beirut	PROPN
aiua-9854	34	71	medical	medical	ADJ
aiua-9854	34	72	center	center	NOUN
aiua-9854	34	73	,	,	PUNCT
aiua-9854	34	74	beirut	beirut	PROPN
aiua-9854	34	75	,	,	PUNCT
aiua-9854	34	76	lebanon	lebanon	PROPN
aiua-9854	34	77	;	;	PUNCT
aiua-9854	34	78	2	2	NUM
aiua-9854	34	79	department	department	NOUN
aiua-9854	34	80	of	of	ADP
aiua-9854	34	81	surgery	surgery	NOUN
aiua-9854	34	82	,	,	PUNCT
aiua-9854	34	83	american	american	PROPN
aiua-9854	34	84	university	university	PROPN
aiua-9854	34	85	of	of	ADP
aiua-9854	34	86	beirut	beirut	PROPN
aiua-9854	34	87	medical	medical	ADJ
aiua-9854	34	88	center	center	NOUN
aiua-9854	34	89	,	,	PUNCT
aiua-9854	34	90	beirut	beirut	PROPN
aiua-9854	34	91	,	,	PUNCT
aiua-9854	34	92	lebanon	lebanon	PROPN
aiua-9854	34	93	.	.	PUNCT
aiua-9854	35	1	doi	doi	PROPN
aiua-9854	35	2	:	:	PUNCT
aiua-9854	35	3	10.4081	10.4081	NUM
aiua-9854	35	4	/	/	SYM
aiua-9854	35	5	aiua.2021.4.385	aiua.2021.4.385	VERB
aiua-9854	35	6	summary	summary	NOUN
aiua-9854	35	7	archivio	archivio	NOUN
aiua-9854	35	8	italiano	italiano	X
aiua-9854	35	9	di	di	X
aiua-9854	35	10	urologia	urologia	PROPN
aiua-9854	35	11	e	e	PROPN
aiua-9854	35	12	andrologia	andrologia	NOUN
aiua-9854	35	13	2021	2021	NUM
aiua-9854	35	14	;	;	PUNCT
aiua-9854	35	15	93	93	NUM
aiua-9854	35	16	,	,	PUNCT
aiua-9854	35	17	4	4	NUM
aiua-9854	35	18	m.	m.	NOUN
aiua-9854	35	19	hout	hout	PROPN
aiua-9854	35	20	,	,	PUNCT
aiua-9854	35	21	a.	a.	NOUN
aiua-9854	35	22	merhe	merhe	NOUN
aiua-9854	35	23	,	,	PUNCT
aiua-9854	36	1	n.	n.	PROPN
aiua-9854	36	2	abou	abou	PROPN
aiua-9854	36	3	heidar	heidar	PROPN
aiua-9854	36	4	,	,	PUNCT
aiua-9854	36	5	et	et	PROPN
aiua-9854	36	6	al	al	PROPN
aiua-9854	36	7	.	.	PROPN
aiua-9854	36	8	386	386	NUM
aiua-9854	36	9	complexity	complexity	NOUN
aiua-9854	36	10	of	of	ADP
aiua-9854	36	11	a	a	DET
aiua-9854	36	12	previously	previously	ADV
aiua-9854	36	13	noted	note	VERB
aiua-9854	36	14	one	one	NUM
aiua-9854	36	15	as	as	SCONJ
aiua-9854	36	16	defined	define	VERB
aiua-9854	36	17	by	by	ADP
aiua-9854	36	18	the	the	DET
aiua-9854	36	19	pirads	pirad	NOUN
aiua-9854	36	20	system	system	NOUN
aiua-9854	36	21	.	.	PUNCT
aiua-9854	37	1	descriptive	descriptive	ADJ
aiua-9854	37	2	statistics	statistic	NOUN
aiua-9854	37	3	of	of	ADP
aiua-9854	37	4	patients	patient	NOUN
aiua-9854	37	5	and	and	CCONJ
aiua-9854	37	6	their	their	PRON
aiua-9854	37	7	above	above	ADJ
aiua-9854	37	8	parameters	parameter	NOUN
aiua-9854	37	9	were	be	AUX
aiua-9854	37	10	reported	report	VERB
aiua-9854	37	11	along	along	ADP
aiua-9854	37	12	with	with	ADP
aiua-9854	37	13	a	a	DET
aiua-9854	37	14	subset	subset	ADJ
aiua-9854	37	15	analysis	analysis	NOUN
aiua-9854	37	16	of	of	ADP
aiua-9854	37	17	patients	patient	NOUN
aiua-9854	37	18	that	that	PRON
aiua-9854	37	19	dropped	drop	VERB
aiua-9854	37	20	out	out	ADP
aiua-9854	37	21	of	of	ADP
aiua-9854	37	22	the	the	DET
aiua-9854	37	23	protocol	protocol	NOUN
aiua-9854	37	24	to	to	PART
aiua-9854	37	25	receive	receive	VERB
aiua-9854	37	26	treatment	treatment	NOUN
aiua-9854	37	27	for	for	ADP
aiua-9854	37	28	progression	progression	NOUN
aiua-9854	37	29	of	of	ADP
aiua-9854	37	30	disease	disease	NOUN
aiua-9854	37	31	.	.	PUNCT
aiua-9854	38	1	results	result	VERB
aiua-9854	38	2	our	our	PRON
aiua-9854	38	3	populations	population	NOUN
aiua-9854	38	4	’	'	PUNCT
aiua-9854	38	5	age	age	NOUN
aiua-9854	38	6	ranged	range	VERB
aiua-9854	38	7	between	between	ADP
aiua-9854	38	8	51	51	NUM
aiua-9854	38	9	-	-	SYM
aiua-9854	38	10	78	78	NUM
aiua-9854	38	11	with	with	ADP
aiua-9854	38	12	a	a	DET
aiua-9854	38	13	mean	mean	NOUN
aiua-9854	38	14	of	of	ADP
aiua-9854	38	15	63.88	63.88	NUM
aiua-9854	38	16	.	.	PUNCT
aiua-9854	39	1	psa	psa	NOUN
aiua-9854	39	2	values	value	NOUN
aiua-9854	39	3	ranged	range	VERB
aiua-9854	39	4	between	between	ADP
aiua-9854	39	5	1.87	1.87	NUM
aiua-9854	39	6	-	-	SYM
aiua-9854	39	7	15.9	15.9	NUM
aiua-9854	39	8	.	.	PUNCT
aiua-9854	40	1	at	at	ADP
aiua-9854	40	2	presentation	presentation	NOUN
aiua-9854	40	3	,	,	PUNCT
aiua-9854	40	4	a	a	DET
aiua-9854	40	5	positive	positive	ADJ
aiua-9854	40	6	dre	dre	NOUN
aiua-9854	40	7	was	be	AUX
aiua-9854	40	8	present	present	ADJ
aiua-9854	40	9	in	in	ADP
aiua-9854	40	10	27.9	27.9	NUM
aiua-9854	40	11	%	%	NOUN
aiua-9854	40	12	of	of	ADP
aiua-9854	40	13	included	include	VERB
aiua-9854	40	14	patients	patient	NOUN
aiua-9854	40	15	,	,	PUNCT
aiua-9854	40	16	whereas	whereas	SCONJ
aiua-9854	40	17	negative	negative	ADJ
aiua-9854	40	18	in	in	ADP
aiua-9854	40	19	72.1	72.1	NUM
aiua-9854	40	20	%	%	NOUN
aiua-9854	40	21	of	of	ADP
aiua-9854	40	22	them	they	PRON
aiua-9854	40	23	.	.	PUNCT
aiua-9854	41	1	initial	initial	ADJ
aiua-9854	41	2	mri	mri	PROPN
aiua-9854	41	3	’s	’s	PART
aiua-9854	41	4	harbored	harbor	VERB
aiua-9854	41	5	a	a	DET
aiua-9854	41	6	pirads	pirad	NOUN
aiua-9854	41	7	3	3	NUM
aiua-9854	41	8	lesions	lesion	NOUN
aiua-9854	41	9	in	in	ADP
aiua-9854	41	10	14	14	NUM
aiua-9854	41	11	%	%	NOUN
aiua-9854	41	12	of	of	ADP
aiua-9854	41	13	patients	patient	NOUN
aiua-9854	41	14	,	,	PUNCT
aiua-9854	41	15	pirads	pirad	NOUN
aiua-9854	41	16	4	4	NUM
aiua-9854	41	17	in	in	ADP
aiua-9854	41	18	37.2	37.2	NUM
aiua-9854	41	19	%	%	NOUN
aiua-9854	41	20	,	,	PUNCT
aiua-9854	41	21	pirads	pirad	NOUN
aiua-9854	41	22	5	5	NUM
aiua-9854	41	23	in	in	ADP
aiua-9854	41	24	11.6	11.6	NUM
aiua-9854	41	25	%	%	NOUN
aiua-9854	41	26	.	.	PUNCT
aiua-9854	42	1	23.2	23.2	NUM
aiua-9854	42	2	%	%	NOUN
aiua-9854	42	3	of	of	ADP
aiua-9854	42	4	patients	patient	NOUN
aiua-9854	42	5	had	have	VERB
aiua-9854	42	6	a	a	DET
aiua-9854	42	7	negative	negative	ADJ
aiua-9854	42	8	mri	mri	NOUN
aiua-9854	42	9	and	and	CCONJ
aiua-9854	42	10	14	14	NUM
aiua-9854	42	11	%	%	NOUN
aiua-9854	42	12	did	do	AUX
aiua-9854	42	13	not	not	PART
aiua-9854	42	14	have	have	VERB
aiua-9854	42	15	one	one	NUM
aiua-9854	42	16	.	.	PUNCT
aiua-9854	43	1	the	the	DET
aiua-9854	43	2	pathology	pathology	NOUN
aiua-9854	43	3	grade	grade	NOUN
aiua-9854	43	4	of	of	ADP
aiua-9854	43	5	our	our	PRON
aiua-9854	43	6	patients	patient	NOUN
aiua-9854	43	7	prostate	prostate	NOUN
aiua-9854	43	8	biopsy	biopsy	NOUN
aiua-9854	43	9	revealed	reveal	VERB
aiua-9854	43	10	a	a	DET
aiua-9854	43	11	who	who	PRON
aiua-9854	43	12	group	group	NOUN
aiua-9854	43	13	1	1	NUM
aiua-9854	43	14	in	in	ADP
aiua-9854	43	15	86	86	NUM
aiua-9854	43	16	%	%	NOUN
aiua-9854	43	17	of	of	ADP
aiua-9854	43	18	patients	patient	NOUN
aiua-9854	43	19	while	while	SCONJ
aiua-9854	43	20	a	a	DET
aiua-9854	43	21	who	who	PRON
aiua-9854	43	22	group	group	NOUN
aiua-9854	43	23	2	2	NUM
aiua-9854	43	24	in	in	ADP
aiua-9854	43	25	14	14	NUM
aiua-9854	43	26	%	%	NOUN
aiua-9854	43	27	of	of	ADP
aiua-9854	43	28	the	the	DET
aiua-9854	43	29	biopsies	biopsy	NOUN
aiua-9854	43	30	(	(	PUNCT
aiua-9854	43	31	table	table	NOUN
aiua-9854	43	32	1	1	NUM
aiua-9854	43	33	)	)	PUNCT
aiua-9854	43	34	.	.	PUNCT
aiua-9854	44	1	upon	upon	SCONJ
aiua-9854	44	2	regular	regular	ADJ
aiua-9854	44	3	follow	follow	NOUN
aiua-9854	44	4	-	-	PUNCT
aiua-9854	44	5	up	up	NOUN
aiua-9854	44	6	,	,	PUNCT
aiua-9854	44	7	46.5	46.5	NUM
aiua-9854	44	8	%	%	NOUN
aiua-9854	44	9	of	of	ADP
aiua-9854	44	10	patients	patient	NOUN
aiua-9854	44	11	(	(	PUNCT
aiua-9854	44	12	20/43	20/43	NUM
aiua-9854	44	13	)	)	PUNCT
aiua-9854	44	14	had	have	VERB
aiua-9854	44	15	a	a	DET
aiua-9854	44	16	significant	significant	ADJ
aiua-9854	44	17	rise	rise	NOUN
aiua-9854	44	18	in	in	ADP
aiua-9854	44	19	follow	follow	NOUN
aiua-9854	44	20	-	-	PUNCT
aiua-9854	44	21	up	up	ADP
aiua-9854	44	22	psa	psa	NOUN
aiua-9854	44	23	,	,	PUNCT
aiua-9854	44	24	46.5	46.5	NUM
aiua-9854	44	25	%	%	NOUN
aiua-9854	44	26	(	(	PUNCT
aiua-9854	44	27	20/43	20/43	NUM
aiua-9854	44	28	)	)	PUNCT
aiua-9854	44	29	had	have	VERB
aiua-9854	44	30	a	a	DET
aiua-9854	44	31	stable	stable	ADJ
aiua-9854	44	32	psa	psa	NOUN
aiua-9854	44	33	throughout	throughout	ADV
aiua-9854	44	34	,	,	PUNCT
aiua-9854	44	35	and	and	CCONJ
aiua-9854	44	36	7	7	NUM
aiua-9854	44	37	%	%	NOUN
aiua-9854	44	38	(	(	PUNCT
aiua-9854	44	39	3/43	3/43	NUM
aiua-9854	44	40	)	)	PUNCT
aiua-9854	44	41	did	do	AUX
aiua-9854	44	42	not	not	PART
aiua-9854	44	43	have	have	VERB
aiua-9854	44	44	a	a	DET
aiua-9854	44	45	follow	follow	VERB
aiua-9854	44	46	-	-	PUNCT
aiua-9854	44	47	up	up	ADP
aiua-9854	44	48	psa	psa	NOUN
aiua-9854	44	49	.	.	PROPN
aiua-9854	45	1	out	out	ADP
aiua-9854	45	2	of	of	ADP
aiua-9854	45	3	the	the	DET
aiua-9854	45	4	prostate	prostate	NOUN
aiua-9854	45	5	mris	mris	NOUN
aiua-9854	45	6	done	do	VERB
aiua-9854	45	7	,	,	PUNCT
aiua-9854	45	8	18.6	18.6	NUM
aiua-9854	45	9	%	%	NOUN
aiua-9854	45	10	(	(	PUNCT
aiua-9854	45	11	8/43	8/43	NUM
aiua-9854	45	12	)	)	PUNCT
aiua-9854	45	13	had	have	VERB
aiua-9854	45	14	imaging	imaging	NOUN
aiua-9854	45	15	progression	progression	NOUN
aiua-9854	45	16	as	as	ADP
aiua-9854	45	17	per	per	ADP
aiua-9854	45	18	the	the	DET
aiua-9854	45	19	previously	previously	ADV
aiua-9854	45	20	stated	state	VERB
aiua-9854	45	21	criteria	criterion	NOUN
aiua-9854	45	22	,	,	PUNCT
aiua-9854	45	23	39.5	39.5	NUM
aiua-9854	45	24	%	%	NOUN
aiua-9854	45	25	(	(	PUNCT
aiua-9854	45	26	17/43	17/43	NUM
aiua-9854	45	27	)	)	PUNCT
aiua-9854	45	28	of	of	ADP
aiua-9854	45	29	lesions	lesion	NOUN
aiua-9854	45	30	were	be	AUX
aiua-9854	45	31	stable	stable	ADJ
aiua-9854	45	32	,	,	PUNCT
aiua-9854	45	33	and	and	CCONJ
aiua-9854	45	34	41.9	41.9	NUM
aiua-9854	45	35	%	%	NOUN
aiua-9854	45	36	(	(	PUNCT
aiua-9854	45	37	18/43	18/43	NUM
aiua-9854	45	38	)	)	PUNCT
aiua-9854	45	39	did	do	AUX
aiua-9854	45	40	not	not	PART
aiua-9854	45	41	have	have	VERB
aiua-9854	45	42	a	a	DET
aiua-9854	45	43	follow	follow	VERB
aiua-9854	45	44	-	-	PUNCT
aiua-9854	45	45	up	up	ADP
aiua-9854	45	46	mri	mri	NOUN
aiua-9854	45	47	.	.	PUNCT
aiua-9854	46	1	with	with	ADP
aiua-9854	46	2	regards	regard	NOUN
aiua-9854	46	3	to	to	ADP
aiua-9854	46	4	the	the	DET
aiua-9854	46	5	follow	follow	VERB
aiua-9854	46	6	-	-	PUNCT
aiua-9854	46	7	up	up	ADP
aiua-9854	46	8	biopsies	biopsy	NOUN
aiua-9854	46	9	,	,	PUNCT
aiua-9854	46	10	11.6	11.6	NUM
aiua-9854	46	11	%	%	NOUN
aiua-9854	46	12	(	(	PUNCT
aiua-9854	46	13	5/43	5/43	NUM
aiua-9854	46	14	)	)	PUNCT
aiua-9854	46	15	were	be	AUX
aiua-9854	46	16	upgraded	upgrade	VERB
aiua-9854	46	17	to	to	ADP
aiua-9854	46	18	a	a	DET
aiua-9854	46	19	higher	high	ADJ
aiua-9854	46	20	who	who	PRON
aiua-9854	46	21	group	group	NOUN
aiua-9854	46	22	,	,	PUNCT
aiua-9854	46	23	46.5	46.5	NUM
aiua-9854	46	24	%	%	NOUN
aiua-9854	46	25	(	(	PUNCT
aiua-9854	46	26	20/43	20/43	NUM
aiua-9854	46	27	)	)	PUNCT
aiua-9854	46	28	were	be	AUX
aiua-9854	46	29	either	either	CCONJ
aiua-9854	46	30	stable	stable	ADJ
aiua-9854	46	31	or	or	CCONJ
aiua-9854	46	32	at	at	ADP
aiua-9854	46	33	a	a	DET
aiua-9854	46	34	lower	low	ADJ
aiua-9854	46	35	group	group	NOUN
aiua-9854	46	36	,	,	PUNCT
aiua-9854	46	37	while	while	SCONJ
aiua-9854	46	38	41.9	41.9	NUM
aiua-9854	46	39	%	%	NOUN
aiua-9854	46	40	(	(	PUNCT
aiua-9854	46	41	18/43	18/43	NUM
aiua-9854	46	42	)	)	PUNCT
aiua-9854	46	43	of	of	ADP
aiua-9854	46	44	the	the	DET
aiua-9854	46	45	repeat	repeat	NOUN
aiua-9854	46	46	biopsies	biopsy	NOUN
aiua-9854	46	47	were	be	AUX
aiua-9854	46	48	not	not	PART
aiua-9854	46	49	done	do	VERB
aiua-9854	46	50	(	(	PUNCT
aiua-9854	46	51	table	table	NOUN
aiua-9854	46	52	2	2	NUM
aiua-9854	46	53	)	)	PUNCT
aiua-9854	46	54	.	.	PUNCT
aiua-9854	47	1	a	a	DET
aiua-9854	47	2	descriptive	descriptive	ADJ
aiua-9854	47	3	analysis	analysis	NOUN
aiua-9854	47	4	of	of	ADP
aiua-9854	47	5	the	the	DET
aiua-9854	47	6	patients	patient	NOUN
aiua-9854	47	7	that	that	PRON
aiua-9854	47	8	dropped	drop	VERB
aiua-9854	47	9	out	out	ADP
aiua-9854	47	10	of	of	ADP
aiua-9854	47	11	active	active	ADJ
aiua-9854	47	12	surveillance	surveillance	NOUN
aiua-9854	47	13	for	for	ADP
aiua-9854	47	14	intervention	intervention	NOUN
aiua-9854	47	15	was	be	AUX
aiua-9854	47	16	performed	perform	VERB
aiua-9854	47	17	.	.	PUNCT
aiua-9854	48	1	20.9	20.9	NUM
aiua-9854	48	2	%	%	NOUN
aiua-9854	48	3	(	(	PUNCT
aiua-9854	48	4	9/43	9/43	NUM
aiua-9854	48	5	)	)	PUNCT
aiua-9854	48	6	of	of	ADP
aiua-9854	48	7	patients	patient	NOUN
aiua-9854	48	8	dropped	drop	VERB
aiua-9854	48	9	out	out	ADP
aiua-9854	48	10	.	.	PUNCT
aiua-9854	49	1	analysis	analysis	NOUN
aiua-9854	49	2	according	accord	VERB
aiua-9854	49	3	to	to	ADP
aiua-9854	49	4	changes	change	NOUN
aiua-9854	49	5	in	in	ADP
aiua-9854	49	6	clinical	clinical	ADJ
aiua-9854	49	7	parameters	parameter	NOUN
aiua-9854	49	8	was	be	AUX
aiua-9854	49	9	performed	perform	VERB
aiua-9854	49	10	and	and	CCONJ
aiua-9854	49	11	demonstrated	demonstrate	VERB
aiua-9854	49	12	the	the	DET
aiua-9854	49	13	following	following	NOUN
aiua-9854	49	14	:	:	PUNCT
aiua-9854	49	15	of	of	ADP
aiua-9854	49	16	the	the	DET
aiua-9854	49	17	20	20	NUM
aiua-9854	49	18	patients	patient	NOUN
aiua-9854	49	19	who	who	PRON
aiua-9854	49	20	progressed	progress	VERB
aiua-9854	49	21	by	by	ADP
aiua-9854	49	22	psa	psa	NOUN
aiua-9854	49	23	,	,	PUNCT
aiua-9854	49	24	only	only	ADV
aiua-9854	49	25	2	2	NUM
aiua-9854	49	26	patients	patient	NOUN
aiua-9854	49	27	(	(	PUNCT
aiua-9854	49	28	10	10	NUM
aiua-9854	49	29	%	%	NOUN
aiua-9854	49	30	)	)	PUNCT
aiua-9854	49	31	dropped	drop	VERB
aiua-9854	49	32	out	out	ADP
aiua-9854	49	33	of	of	ADP
aiua-9854	49	34	active	active	ADJ
aiua-9854	49	35	surveillance	surveillance	NOUN
aiua-9854	49	36	for	for	ADP
aiua-9854	49	37	intervention	intervention	NOUN
aiua-9854	49	38	.	.	PUNCT
aiua-9854	50	1	of	of	ADP
aiua-9854	50	2	the	the	DET
aiua-9854	50	3	8	8	NUM
aiua-9854	50	4	patients	patient	NOUN
aiua-9854	50	5	that	that	PRON
aiua-9854	50	6	progressed	progress	VERB
aiua-9854	50	7	on	on	ADP
aiua-9854	50	8	follow	follow	VERB
aiua-9854	50	9	-	-	PUNCT
aiua-9854	50	10	up	up	ADP
aiua-9854	50	11	mri	mri	NOUN
aiua-9854	50	12	,	,	PUNCT
aiua-9854	50	13	3	3	NUM
aiua-9854	50	14	patients	patient	NOUN
aiua-9854	50	15	(	(	PUNCT
aiua-9854	50	16	37.5	37.5	NUM
aiua-9854	50	17	%	%	NOUN
aiua-9854	50	18	)	)	PUNCT
aiua-9854	50	19	dropped	drop	VERB
aiua-9854	50	20	out	out	ADP
aiua-9854	50	21	for	for	ADP
aiua-9854	50	22	intervention	intervention	NOUN
aiua-9854	50	23	.	.	PUNCT
aiua-9854	51	1	of	of	ADP
aiua-9854	51	2	the	the	DET
aiua-9854	51	3	3	3	NUM
aiua-9854	51	4	patients	patient	NOUN
aiua-9854	51	5	who	who	PRON
aiua-9854	51	6	were	be	AUX
aiua-9854	51	7	upgraded	upgrade	VERB
aiua-9854	51	8	on	on	ADP
aiua-9854	51	9	followup	followup	ADJ
aiua-9854	51	10	biopsies	biopsy	NOUN
aiua-9854	51	11	,	,	PUNCT
aiua-9854	51	12	2	2	NUM
aiua-9854	51	13	patients	patient	NOUN
aiua-9854	51	14	(	(	PUNCT
aiua-9854	51	15	66.7	66.7	NUM
aiua-9854	51	16	%	%	NOUN
aiua-9854	51	17	)	)	PUNCT
aiua-9854	51	18	dropped	drop	VERB
aiua-9854	51	19	out	out	ADP
aiua-9854	51	20	for	for	ADP
aiua-9854	51	21	intervention	intervention	NOUN
aiua-9854	51	22	(	(	PUNCT
aiua-9854	51	23	figure	figure	NOUN
aiua-9854	51	24	1	1	NUM
aiua-9854	51	25	)	)	PUNCT
aiua-9854	51	26	.	.	PUNCT
aiua-9854	52	1	two	two	NUM
aiua-9854	52	2	patients	patient	NOUN
aiua-9854	52	3	elected	elect	VERB
aiua-9854	52	4	to	to	PART
aiua-9854	52	5	drop	drop	VERB
aiua-9854	52	6	out	out	ADP
aiua-9854	52	7	and	and	CCONJ
aiua-9854	52	8	seek	seek	VERB
aiua-9854	52	9	intervention	intervention	NOUN
aiua-9854	52	10	due	due	ADP
aiua-9854	52	11	to	to	ADP
aiua-9854	52	12	psychological	psychological	ADJ
aiua-9854	52	13	/	/	SYM
aiua-9854	52	14	patient	patient	NOUN
aiua-9854	52	15	preference	preference	NOUN
aiua-9854	52	16	.	.	PUNCT
aiua-9854	53	1	of	of	ADP
aiua-9854	53	2	the	the	DET
aiua-9854	53	3	patients	patient	NOUN
aiua-9854	53	4	that	that	PRON
aiua-9854	53	5	dropped	drop	VERB
aiua-9854	53	6	out	out	ADP
aiua-9854	53	7	of	of	ADP
aiua-9854	53	8	active	active	ADJ
aiua-9854	53	9	surveillance	surveillance	NOUN
aiua-9854	53	10	,	,	PUNCT
aiua-9854	53	11	44.4	44.4	NUM
aiua-9854	53	12	%	%	NOUN
aiua-9854	53	13	(	(	PUNCT
aiua-9854	53	14	4/9	4/9	NUM
aiua-9854	53	15	)	)	PUNCT
aiua-9854	53	16	underwent	underwent	ADJ
aiua-9854	53	17	radical	radical	ADJ
aiua-9854	53	18	prostatectomy	prostatectomy	NOUN
aiua-9854	53	19	,	,	PUNCT
aiua-9854	53	20	44.4	44.4	NUM
aiua-9854	53	21	%	%	NOUN
aiua-9854	53	22	(	(	PUNCT
aiua-9854	53	23	4/9	4/9	NUM
aiua-9854	53	24	)	)	PUNCT
aiua-9854	53	25	underwent	underwent	ADJ
aiua-9854	53	26	radiation	radiation	NOUN
aiua-9854	53	27	therapy	therapy	NOUN
aiua-9854	53	28	plus	plus	CCONJ
aiua-9854	53	29	adt	adt	NOUN
aiua-9854	53	30	,	,	PUNCT
aiua-9854	53	31	and	and	CCONJ
aiua-9854	53	32	11.1	11.1	NUM
aiua-9854	53	33	%	%	NOUN
aiua-9854	53	34	(	(	PUNCT
aiua-9854	53	35	1/9	1/9	NUM
aiua-9854	53	36	)	)	PUNCT
aiua-9854	53	37	took	take	VERB
aiua-9854	53	38	adt	adt	NOUN
aiua-9854	53	39	alone	alone	ADV
aiua-9854	53	40	(	(	PUNCT
aiua-9854	53	41	figure	figure	NOUN
aiua-9854	53	42	1	1	NUM
aiua-9854	53	43	)	)	PUNCT
aiua-9854	53	44	.	.	PUNCT
aiua-9854	54	1	of	of	ADP
aiua-9854	54	2	those	those	PRON
aiua-9854	54	3	who	who	PRON
aiua-9854	54	4	underwent	undergo	VERB
aiua-9854	54	5	radical	radical	ADJ
aiua-9854	54	6	prostatectomy	prostatectomy	NOUN
aiua-9854	54	7	,	,	PUNCT
aiua-9854	54	8	50	50	NUM
aiua-9854	54	9	%	%	NOUN
aiua-9854	54	10	(	(	PUNCT
aiua-9854	54	11	2/4	2/4	NUM
aiua-9854	54	12	)	)	PUNCT
aiua-9854	54	13	were	be	AUX
aiua-9854	54	14	upgraded	upgrade	VERB
aiua-9854	54	15	according	accord	VERB
aiua-9854	54	16	to	to	ADP
aiua-9854	54	17	the	the	DET
aiua-9854	54	18	final	final	ADJ
aiua-9854	54	19	pathology	pathology	NOUN
aiua-9854	54	20	,	,	PUNCT
aiua-9854	54	21	while	while	SCONJ
aiua-9854	54	22	50	50	NUM
aiua-9854	54	23	%	%	NOUN
aiua-9854	54	24	(	(	PUNCT
aiua-9854	54	25	2/4	2/4	NUM
aiua-9854	54	26	)	)	PUNCT
aiua-9854	54	27	maintained	maintain	VERB
aiua-9854	54	28	the	the	DET
aiua-9854	54	29	same	same	ADJ
aiua-9854	54	30	grade	grade	NOUN
aiua-9854	54	31	as	as	ADP
aiua-9854	54	32	the	the	DET
aiua-9854	54	33	last	last	ADJ
aiua-9854	54	34	biopsy	biopsy	NOUN
aiua-9854	54	35	result	result	NOUN
aiua-9854	54	36	.	.	PUNCT
aiua-9854	55	1	discussion	discussion	NOUN
aiua-9854	55	2	according	accord	VERB
aiua-9854	55	3	to	to	ADP
aiua-9854	55	4	the	the	DET
aiua-9854	55	5	nccn	nccn	ADJ
aiua-9854	55	6	2019	2019	NUM
aiua-9854	55	7	guidelines	guideline	NOUN
aiua-9854	55	8	,	,	PUNCT
aiua-9854	55	9	inclusion	inclusion	NOUN
aiua-9854	55	10	criteria	criterion	NOUN
aiua-9854	55	11	for	for	ADP
aiua-9854	55	12	active	active	ADJ
aiua-9854	55	13	surveillance	surveillance	NOUN
aiua-9854	55	14	for	for	ADP
aiua-9854	55	15	prostate	prostate	NOUN
aiua-9854	55	16	cancer	cancer	NOUN
aiua-9854	55	17	includes	include	VERB
aiua-9854	55	18	patients	patient	NOUN
aiua-9854	55	19	with	with	ADP
aiua-9854	55	20	very	very	ADV
aiua-9854	55	21	low	low	ADJ
aiua-9854	55	22	/	/	SYM
aiua-9854	55	23	low	low	ADJ
aiua-9854	55	24	-	-	PUNCT
aiua-9854	55	25	risk	risk	NOUN
aiua-9854	55	26	disease	disease	NOUN
aiua-9854	55	27	or	or	CCONJ
aiua-9854	55	28	intermediate	intermediate	ADJ
aiua-9854	55	29	risk	risk	NOUN
aiua-9854	55	30	disease	disease	NOUN
aiua-9854	55	31	with	with	ADP
aiua-9854	55	32	low	low	ADJ
aiua-9854	55	33	volume	volume	NOUN
aiua-9854	55	34	disease	disease	NOUN
aiua-9854	55	35	and	and	CCONJ
aiua-9854	55	36	a	a	DET
aiua-9854	55	37	outcome	outcome	NOUN
aiua-9854	55	38	with	with	ADP
aiua-9854	55	39	a	a	DET
aiua-9854	55	40	life	life	NOUN
aiua-9854	55	41	expectancy	expectancy	NOUN
aiua-9854	55	42	of	of	ADP
aiua-9854	55	43	10	10	NUM
aiua-9854	55	44	years	year	NOUN
aiua-9854	55	45	and	and	CCONJ
aiua-9854	55	46	beyond	beyond	ADP
aiua-9854	55	47	(	(	PUNCT
aiua-9854	55	48	7	7	NUM
aiua-9854	55	49	,	,	PUNCT
aiua-9854	55	50	8)	8)	NUM
aiua-9854	55	51	.	.	PUNCT
aiua-9854	56	1	follow	follow	VERB
aiua-9854	56	2	up	up	ADP
aiua-9854	56	3	criteria	criterion	NOUN
aiua-9854	56	4	vary	vary	VERB
aiua-9854	56	5	from	from	ADP
aiua-9854	56	6	one	one	NUM
aiua-9854	56	7	institution	institution	NOUN
aiua-9854	56	8	to	to	ADP
aiua-9854	56	9	another	another	PRON
aiua-9854	56	10	where	where	SCONJ
aiua-9854	56	11	most	most	ADV
aiua-9854	56	12	opt	opt	VERB
aiua-9854	56	13	for	for	ADP
aiua-9854	56	14	a	a	DET
aiua-9854	56	15	follow	follow	VERB
aiua-9854	56	16	-	-	PUNCT
aiua-9854	56	17	up	up	NOUN
aiua-9854	56	18	psa	psa	NOUN
aiua-9854	56	19	every	every	DET
aiua-9854	56	20	6	6	NUM
aiua-9854	56	21	months	month	NOUN
aiua-9854	56	22	,	,	PUNCT
aiua-9854	56	23	dre	dre	NOUN
aiua-9854	56	24	every	every	DET
aiua-9854	56	25	12	12	NUM
aiua-9854	56	26	months	month	NOUN
aiua-9854	56	27	,	,	PUNCT
aiua-9854	56	28	and	and	CCONJ
aiua-9854	56	29	biopsy	biopsy	VERB
aiua-9854	56	30	every	every	DET
aiua-9854	56	31	1	1	NUM
aiua-9854	56	32	-	-	SYM
aiua-9854	56	33	2	2	NUM
aiua-9854	56	34	years	year	NOUN
aiua-9854	56	35	.	.	PUNCT
aiua-9854	57	1	some	some	DET
aiua-9854	57	2	protocols	protocol	NOUN
aiua-9854	57	3	have	have	AUX
aiua-9854	57	4	incorporated	incorporate	VERB
aiua-9854	57	5	the	the	DET
aiua-9854	57	6	use	use	NOUN
aiua-9854	57	7	of	of	ADP
aiua-9854	57	8	mri	mri	NOUN
aiua-9854	57	9	every	every	DET
aiua-9854	57	10	12	12	NUM
aiua-9854	57	11	months	month	NOUN
aiua-9854	57	12	or	or	CCONJ
aiua-9854	57	13	more	more	ADJ
aiua-9854	57	14	(	(	PUNCT
aiua-9854	57	15	nccn	nccn	ADJ
aiua-9854	57	16	)	)	PUNCT
aiua-9854	57	17	(	(	PUNCT
aiua-9854	57	18	9	9	NUM
aiua-9854	57	19	)	)	PUNCT
aiua-9854	57	20	.	.	PUNCT
aiua-9854	58	1	our	our	PRON
aiua-9854	58	2	protocol	protocol	NOUN
aiua-9854	58	3	has	have	AUX
aiua-9854	58	4	been	be	AUX
aiua-9854	58	5	consistent	consistent	ADJ
aiua-9854	58	6	with	with	ADP
aiua-9854	58	7	the	the	DET
aiua-9854	58	8	above	above	ADJ
aiua-9854	58	9	recommendations	recommendation	NOUN
aiua-9854	58	10	whilst	whilst	SCONJ
aiua-9854	58	11	gradually	gradually	ADV
aiua-9854	58	12	incorporating	incorporate	VERB
aiua-9854	58	13	mri	mri	NOUN
aiua-9854	58	14	as	as	ADP
aiua-9854	58	15	a	a	DET
aiua-9854	58	16	valuable	valuable	ADJ
aiua-9854	58	17	aid	aid	NOUN
aiua-9854	58	18	in	in	ADP
aiua-9854	58	19	decision	decision	NOUN
aiua-9854	58	20	making	making	NOUN
aiua-9854	58	21	.	.	PUNCT
aiua-9854	59	1	serum	serum	NOUN
aiua-9854	59	2	marker	marker	NOUN
aiua-9854	59	3	psa	psa	NOUN
aiua-9854	59	4	is	be	AUX
aiua-9854	59	5	the	the	DET
aiua-9854	59	6	frontline	frontline	NOUN
aiua-9854	59	7	parameter	parameter	NOUN
aiua-9854	59	8	that	that	PRON
aiua-9854	59	9	triggers	trigger	VERB
aiua-9854	59	10	further	further	ADJ
aiua-9854	59	11	workup	workup	NOUN
aiua-9854	59	12	to	to	PART
aiua-9854	59	13	rule	rule	VERB
aiua-9854	59	14	out	out	ADP
aiua-9854	59	15	clinical	clinical	ADJ
aiua-9854	59	16	progression	progression	NOUN
aiua-9854	59	17	.	.	PUNCT
aiua-9854	60	1	this	this	PRON
aiua-9854	60	2	was	be	AUX
aiua-9854	60	3	table	table	NOUN
aiua-9854	60	4	1	1	NUM
aiua-9854	60	5	.	.	PUNCT
aiua-9854	61	1	mean	mean	PROPN
aiua-9854	61	2	age	age	NOUN
aiua-9854	61	3	,	,	PUNCT
aiua-9854	61	4	mean	mean	NOUN
aiua-9854	61	5	psa	psa	NOUN
aiua-9854	61	6	,	,	PUNCT
aiua-9854	61	7	rate	rate	NOUN
aiua-9854	61	8	of	of	ADP
aiua-9854	61	9	positive	positive	ADJ
aiua-9854	61	10	dre	dre	NOUN
aiua-9854	61	11	,	,	PUNCT
aiua-9854	61	12	mri	mri	NOUN
aiua-9854	61	13	results	result	NOUN
aiua-9854	61	14	and	and	CCONJ
aiua-9854	61	15	pathology	pathology	NOUN
aiua-9854	61	16	grade	grade	NOUN
aiua-9854	61	17	of	of	ADP
aiua-9854	61	18	our	our	PRON
aiua-9854	61	19	population	population	NOUN
aiua-9854	61	20	.	.	PUNCT
aiua-9854	62	1	figure	figure	NOUN
aiua-9854	62	2	1	1	NUM
aiua-9854	62	3	.	.	PUNCT
aiua-9854	62	4	mode	mode	NOUN
aiua-9854	62	5	of	of	ADP
aiua-9854	62	6	intervention	intervention	NOUN
aiua-9854	62	7	after	after	ADP
aiua-9854	62	8	dropping	drop	VERB
aiua-9854	62	9	out	out	ADP
aiua-9854	62	10	from	from	ADP
aiua-9854	62	11	active	active	ADJ
aiua-9854	62	12	surveillance	surveillance	NOUN
aiua-9854	62	13	.	.	PUNCT
aiua-9854	63	1	patient	patient	ADJ
aiua-9854	63	2	demographics	demographic	NOUN
aiua-9854	63	3	results	result	VERB
aiua-9854	63	4	age	age	NOUN
aiua-9854	63	5	63.88	63.88	NUM
aiua-9854	63	6	(	(	PUNCT
aiua-9854	63	7	51	51	NUM
aiua-9854	63	8	-	-	SYM
aiua-9854	63	9	78	78	NUM
aiua-9854	63	10	)	)	PUNCT
aiua-9854	63	11	psa	psa	VERB
aiua-9854	63	12	6.26	6.26	NUM
aiua-9854	63	13	(	(	PUNCT
aiua-9854	63	14	1.87	1.87	NUM
aiua-9854	63	15	-	-	SYM
aiua-9854	63	16	15.9	15.9	NUM
aiua-9854	63	17	)	)	PUNCT
aiua-9854	63	18	dre	dre	NOUN
aiua-9854	63	19	(	(	PUNCT
aiua-9854	63	20	negative	negative	ADJ
aiua-9854	63	21	)	)	PUNCT
aiua-9854	63	22	72.1	72.1	NUM
aiua-9854	63	23	%	%	NOUN
aiua-9854	63	24	(	(	PUNCT
aiua-9854	63	25	31/43	31/43	NUM
aiua-9854	63	26	)	)	PUNCT
aiua-9854	63	27	dre	dre	NOUN
aiua-9854	63	28	(	(	PUNCT
aiua-9854	63	29	positive	positive	ADJ
aiua-9854	63	30	)	)	PUNCT
aiua-9854	63	31	27.9	27.9	NUM
aiua-9854	63	32	%	%	NOUN
aiua-9854	63	33	(	(	PUNCT
aiua-9854	63	34	12/43	12/43	NUM
aiua-9854	63	35	)	)	PUNCT
aiua-9854	63	36	mri	mri	NOUN
aiua-9854	63	37	(	(	PUNCT
aiua-9854	63	38	not	not	PART
aiua-9854	63	39	done	do	VERB
aiua-9854	63	40	)	)	PUNCT
aiua-9854	63	41	14	14	NUM
aiua-9854	63	42	%	%	NOUN
aiua-9854	63	43	(	(	PUNCT
aiua-9854	63	44	6/43	6/43	NUM
aiua-9854	63	45	)	)	PUNCT
aiua-9854	63	46	mri	mri	NOUN
aiua-9854	63	47	(	(	PUNCT
aiua-9854	63	48	negative	negative	ADJ
aiua-9854	63	49	)	)	PUNCT
aiua-9854	63	50	23.2	23.2	NUM
aiua-9854	63	51	%	%	NOUN
aiua-9854	63	52	(	(	PUNCT
aiua-9854	63	53	10/43	10/43	NUM
aiua-9854	63	54	)	)	PUNCT
aiua-9854	63	55	mri	mri	NOUN
aiua-9854	63	56	(	(	PUNCT
aiua-9854	63	57	pirads	pirad	NOUN
aiua-9854	63	58	3	3	NUM
aiua-9854	63	59	)	)	PUNCT
aiua-9854	63	60	14	14	NUM
aiua-9854	63	61	%	%	NOUN
aiua-9854	63	62	(	(	PUNCT
aiua-9854	63	63	6/43	6/43	NUM
aiua-9854	63	64	)	)	PUNCT
aiua-9854	63	65	mri	mri	NOUN
aiua-9854	63	66	(	(	PUNCT
aiua-9854	63	67	pirads	pirad	NOUN
aiua-9854	63	68	4	4	NUM
aiua-9854	63	69	)	)	PUNCT
aiua-9854	63	70	37.2	37.2	NUM
aiua-9854	63	71	%	%	NOUN
aiua-9854	63	72	(	(	PUNCT
aiua-9854	63	73	16/43	16/43	NUM
aiua-9854	63	74	)	)	PUNCT
aiua-9854	63	75	mri	mri	NOUN
aiua-9854	63	76	(	(	PUNCT
aiua-9854	63	77	pirads	pirad	NOUN
aiua-9854	63	78	5	5	NUM
aiua-9854	63	79	)	)	PUNCT
aiua-9854	63	80	11.6	11.6	NUM
aiua-9854	63	81	%	%	NOUN
aiua-9854	63	82	(	(	PUNCT
aiua-9854	63	83	5/43	5/43	NUM
aiua-9854	63	84	)	)	PUNCT
aiua-9854	63	85	pathology	pathology	NOUN
aiua-9854	63	86	grade	grade	NOUN
aiua-9854	63	87	who	who	PRON
aiua-9854	63	88	group	group	VERB
aiua-9854	63	89	1	1	NUM
aiua-9854	63	90	86	86	NUM
aiua-9854	63	91	%	%	NOUN
aiua-9854	63	92	(	(	PUNCT
aiua-9854	63	93	37/43	37/43	NUM
aiua-9854	63	94	)	)	PUNCT
aiua-9854	63	95	who	who	PRON
aiua-9854	63	96	group	group	VERB
aiua-9854	63	97	2	2	NUM
aiua-9854	63	98	14	14	NUM
aiua-9854	63	99	%	%	NOUN
aiua-9854	63	100	(	(	PUNCT
aiua-9854	63	101	6/43	6/43	NUM
aiua-9854	63	102	)	)	PUNCT
aiua-9854	63	103	table	table	NOUN
aiua-9854	63	104	2	2	NUM
aiua-9854	63	105	.	.	X
aiua-9854	64	1	psa	psa	NOUN
aiua-9854	64	2	,	,	PUNCT
aiua-9854	64	3	mri	mri	NOUN
aiua-9854	64	4	and	and	CCONJ
aiua-9854	64	5	biopsies	biopsy	NOUN
aiua-9854	64	6	at	at	ADP
aiua-9854	64	7	follow	follow	NOUN
aiua-9854	64	8	-	-	PUNCT
aiua-9854	64	9	up	up	NOUN
aiua-9854	64	10	.	.	PUNCT
aiua-9854	65	1	clinical	clinical	ADJ
aiua-9854	65	2	parameter	parameter	NOUN
aiua-9854	65	3	progressed	progress	VERB
aiua-9854	65	4	stable	stable	ADJ
aiua-9854	65	5	n	n	CCONJ
aiua-9854	65	6	/	/	SYM
aiua-9854	65	7	a	a	DET
aiua-9854	65	8	psa	psa	NOUN
aiua-9854	65	9	46.5	46.5	NUM
aiua-9854	65	10	%	%	NOUN
aiua-9854	65	11	(	(	PUNCT
aiua-9854	65	12	20/43	20/43	NUM
aiua-9854	65	13	)	)	PUNCT
aiua-9854	65	14	46.5	46.5	NUM
aiua-9854	65	15	%	%	NOUN
aiua-9854	65	16	(	(	PUNCT
aiua-9854	65	17	20/43	20/43	NUM
aiua-9854	65	18	)	)	PUNCT
aiua-9854	65	19	7	7	NUM
aiua-9854	65	20	%	%	NOUN
aiua-9854	65	21	(	(	PUNCT
aiua-9854	65	22	3/43	3/43	NUM
aiua-9854	65	23	)	)	PUNCT
aiua-9854	65	24	mri	mri	NOUN
aiua-9854	65	25	18.6	18.6	NUM
aiua-9854	65	26	%	%	NOUN
aiua-9854	65	27	(	(	PUNCT
aiua-9854	65	28	8/43	8/43	NUM
aiua-9854	65	29	)	)	PUNCT
aiua-9854	65	30	39.5	39.5	NUM
aiua-9854	65	31	%	%	NOUN
aiua-9854	65	32	(	(	PUNCT
aiua-9854	65	33	17/43	17/43	NUM
aiua-9854	65	34	)	)	PUNCT
aiua-9854	65	35	41.9	41.9	NUM
aiua-9854	65	36	%	%	NOUN
aiua-9854	65	37	(	(	PUNCT
aiua-9854	65	38	18/43	18/43	NUM
aiua-9854	65	39	)	)	PUNCT
aiua-9854	65	40	pathology	pathology	NOUN
aiua-9854	65	41	11.6	11.6	NUM
aiua-9854	65	42	%	%	NOUN
aiua-9854	65	43	(	(	PUNCT
aiua-9854	65	44	5/43	5/43	NUM
aiua-9854	65	45	)	)	PUNCT
aiua-9854	65	46	46.5	46.5	NUM
aiua-9854	65	47	%	%	NOUN
aiua-9854	65	48	(	(	PUNCT
aiua-9854	65	49	20/43	20/43	NUM
aiua-9854	65	50	)	)	PUNCT
aiua-9854	65	51	41.9	41.9	NUM
aiua-9854	65	52	%	%	NOUN
aiua-9854	65	53	(	(	PUNCT
aiua-9854	65	54	18/43	18/43	NUM
aiua-9854	65	55	)	)	PUNCT
aiua-9854	65	56	table	table	NOUN
aiua-9854	65	57	3	3	NUM
aiua-9854	65	58	.	.	PUNCT
aiua-9854	65	59	comparison	comparison	NOUN
aiua-9854	65	60	of	of	ADP
aiua-9854	65	61	our	our	PRON
aiua-9854	65	62	results	result	NOUN
aiua-9854	65	63	to	to	ADP
aiua-9854	65	64	various	various	ADJ
aiua-9854	65	65	north	north	ADJ
aiua-9854	65	66	american	american	ADJ
aiua-9854	65	67	cohorts	cohort	NOUN
aiua-9854	65	68	studied	study	VERB
aiua-9854	65	69	in	in	ADP
aiua-9854	65	70	different	different	ADJ
aiua-9854	65	71	medical	medical	ADJ
aiua-9854	65	72	centers	center	NOUN
aiua-9854	65	73	.	.	PUNCT
aiua-9854	66	1	center	center	PROPN
aiua-9854	66	2	toronto	toronto	PROPN
aiua-9854	66	3	hopkins	hopkins	PROPN
aiua-9854	66	4	ucsf	ucsf	PROPN
aiua-9854	66	5	canary	canary	PROPN
aiua-9854	66	6	pass	pass	VERB
aiua-9854	66	7	aubmc	aubmc	X
aiua-9854	66	8	(	(	PUNCT
aiua-9854	66	9	8)	8)	NUM
aiua-9854	66	10	(	(	PUNCT
aiua-9854	66	11	29	29	NUM
aiua-9854	66	12	)	)	PUNCT
aiua-9854	66	13	(	(	PUNCT
aiua-9854	66	14	10	10	NUM
aiua-9854	66	15	)	)	PUNCT
aiua-9854	66	16	(	(	PUNCT
aiua-9854	66	17	30	30	NUM
aiua-9854	66	18	)	)	PUNCT
aiua-9854	66	19	no	no	NOUN
aiua-9854	66	20	of	of	ADP
aiua-9854	66	21	patients	patient	NOUN
aiua-9854	66	22	993	993	NUM
aiua-9854	66	23	1298	1298	NUM
aiua-9854	66	24	321	321	NUM
aiua-9854	66	25	905	905	NUM
aiua-9854	66	26	43	43	NUM
aiua-9854	66	27	median	median	ADJ
aiua-9854	66	28	age	age	NOUN
aiua-9854	66	29	68	68	NUM
aiua-9854	66	30	66	66	NUM
aiua-9854	66	31	63	63	NUM
aiua-9854	66	32	63	63	NUM
aiua-9854	66	33	65	65	NUM
aiua-9854	66	34	median	median	ADJ
aiua-9854	66	35	follow	follow	NOUN
aiua-9854	66	36	-	-	PUNCT
aiua-9854	66	37	up	up	NOUN
aiua-9854	66	38	77	77	NUM
aiua-9854	66	39	60	60	NUM
aiua-9854	66	40	43	43	NUM
aiua-9854	66	41	28	28	NUM
aiua-9854	66	42	40	40	NUM
aiua-9854	66	43	overall	overall	ADJ
aiua-9854	66	44	survival	survival	NOUN
aiua-9854	66	45	80	80	NUM
aiua-9854	66	46	%	%	NOUN
aiua-9854	66	47	93	93	NUM
aiua-9854	66	48	%	%	NOUN
aiua-9854	66	49	98	98	NUM
aiua-9854	66	50	%	%	NOUN
aiua-9854	66	51	n	n	CCONJ
aiua-9854	66	52	/	/	SYM
aiua-9854	66	53	a	a	DET
aiua-9854	66	54	cancer	cancer	NOUN
aiua-9854	66	55	specific	specific	ADJ
aiua-9854	66	56	survival	survival	NOUN
aiua-9854	66	57	98	98	NUM
aiua-9854	66	58	%	%	NOUN
aiua-9854	66	59	99.90	99.90	NUM
aiua-9854	66	60	%	%	NOUN
aiua-9854	66	61	100	100	NUM
aiua-9854	66	62	%	%	NOUN
aiua-9854	66	63	100	100	NUM
aiua-9854	66	64	%	%	NOUN
aiua-9854	66	65	conversion	conversion	NOUN
aiua-9854	66	66	to	to	ADP
aiua-9854	66	67	treatment	treatment	NOUN
aiua-9854	66	68	36.50	36.50	NUM
aiua-9854	66	69	%	%	NOUN
aiua-9854	66	70	50	50	NUM
aiua-9854	66	71	%	%	NOUN
aiua-9854	66	72	24	24	NUM
aiua-9854	66	73	%	%	NOUN
aiua-9854	66	74	19	19	NUM
aiua-9854	66	75	%	%	NOUN
aiua-9854	66	76	20.90	20.90	NUM
aiua-9854	66	77	%	%	NOUN
aiua-9854	66	78	(	(	PUNCT
aiua-9854	66	79	rot	rot	PROPN
aiua-9854	66	80	)	)	PUNCT
aiua-9854	66	81	gleason	gleason	PROPN
aiua-9854	66	82	grade	grade	NOUN
aiua-9854	66	83	change	change	NOUN
aiua-9854	66	84	9.50	9.50	NUM
aiua-9854	66	85	%	%	NOUN
aiua-9854	66	86	15.10	15.10	NUM
aiua-9854	66	87	%	%	NOUN
aiua-9854	66	88	38	38	NUM
aiua-9854	66	89	%	%	NOUN
aiua-9854	66	90	11.60	11.60	NUM
aiua-9854	66	91	%	%	NOUN
aiua-9854	66	92	(	(	PUNCT
aiua-9854	66	93	rot	rot	NOUN
aiua-9854	66	94	)	)	PUNCT
aiua-9854	66	95	psa	psa	VERB
aiua-9854	66	96	increase	increase	VERB
aiua-9854	66	97	11.70	11.70	NUM
aiua-9854	66	98	%	%	NOUN
aiua-9854	66	99	26	26	NUM
aiua-9854	66	100	%	%	NOUN
aiua-9854	66	101	4.65	4.65	NUM
aiua-9854	66	102	%	%	NOUN
aiua-9854	66	103	(	(	PUNCT
aiua-9854	66	104	rot	rot	NOUN
aiua-9854	66	105	)	)	PUNCT
aiua-9854	66	106	positive	positive	ADJ
aiua-9854	66	107	lns	lns	PROPN
aiua-9854	66	108	0.40	0.40	NUM
aiua-9854	66	109	%	%	NOUN
aiua-9854	66	110	(	(	PUNCT
aiua-9854	66	111	rot	rot	NOUN
aiua-9854	66	112	)	)	PUNCT
aiua-9854	66	113	personal	personal	ADJ
aiua-9854	66	114	choice	choice	NOUN
aiua-9854	66	115	1.60	1.60	NUM
aiua-9854	66	116	%	%	NOUN
aiua-9854	66	117	8	8	NUM
aiua-9854	66	118	%	%	NOUN
aiua-9854	66	119	8	8	NUM
aiua-9854	66	120	%	%	NOUN
aiua-9854	66	121	4.65	4.65	NUM
aiua-9854	66	122	%	%	NOUN
aiua-9854	66	123	387archivio	387archivio	PROPN
aiua-9854	66	124	italiano	italiano	NOUN
aiua-9854	66	125	di	di	NOUN
aiua-9854	66	126	urologia	urologia	PROPN
aiua-9854	66	127	e	e	PROPN
aiua-9854	66	128	andrologia	andrologia	NOUN
aiua-9854	66	129	2021	2021	NUM
aiua-9854	66	130	;	;	PUNCT
aiua-9854	66	131	93	93	NUM
aiua-9854	66	132	,	,	PUNCT
aiua-9854	66	133	4	4	NUM
aiua-9854	66	134	active	active	ADJ
aiua-9854	66	135	surveillance	surveillance	NOUN
aiua-9854	66	136	for	for	ADP
aiua-9854	66	137	prostate	prostate	NOUN
aiua-9854	66	138	cancer	cancer	NOUN
aiua-9854	66	139	similarly	similarly	ADV
aiua-9854	66	140	evident	evident	ADJ
aiua-9854	66	141	in	in	ADP
aiua-9854	66	142	our	our	PRON
aiua-9854	66	143	cohort	cohort	NOUN
aiua-9854	66	144	whereby	whereby	SCONJ
aiua-9854	66	145	almost	almost	ADV
aiua-9854	66	146	half	half	NOUN
aiua-9854	66	147	(	(	PUNCT
aiua-9854	66	148	46.5	46.5	NUM
aiua-9854	66	149	%	%	NOUN
aiua-9854	66	150	)	)	PUNCT
aiua-9854	66	151	of	of	ADP
aiua-9854	66	152	our	our	PRON
aiua-9854	66	153	patients	patient	NOUN
aiua-9854	66	154	had	have	AUX
aiua-9854	66	155	a	a	DET
aiua-9854	66	156	significant	significant	ADJ
aiua-9854	66	157	rise	rise	NOUN
aiua-9854	66	158	in	in	ADP
aiua-9854	66	159	psa	psa	NOUN
aiua-9854	66	160	that	that	PRON
aiua-9854	66	161	led	lead	VERB
aiua-9854	66	162	to	to	ADP
aiua-9854	66	163	the	the	DET
aiua-9854	66	164	decision	decision	NOUN
aiua-9854	66	165	of	of	ADP
aiua-9854	66	166	further	further	ADJ
aiua-9854	66	167	investigation	investigation	NOUN
aiua-9854	66	168	that	that	PRON
aiua-9854	66	169	included	include	VERB
aiua-9854	66	170	a	a	DET
aiua-9854	66	171	rebiopsy	rebiopsy	NOUN
aiua-9854	66	172	+	+	PROPN
aiua-9854	66	173	/mri	/mri	PROPN
aiua-9854	66	174	.	.	PUNCT
aiua-9854	67	1	of	of	ADP
aiua-9854	67	2	those	those	PRON
aiua-9854	67	3	with	with	ADP
aiua-9854	67	4	psa	psa	NOUN
aiua-9854	67	5	progression	progression	NOUN
aiua-9854	67	6	,	,	PUNCT
aiua-9854	67	7	10	10	NUM
aiua-9854	67	8	%	%	NOUN
aiua-9854	67	9	(	(	PUNCT
aiua-9854	67	10	2/20	2/20	NUM
aiua-9854	67	11	)	)	PUNCT
aiua-9854	67	12	had	have	VERB
aiua-9854	67	13	an	an	DET
aiua-9854	67	14	upgraded	upgrade	VERB
aiua-9854	67	15	pathology	pathology	NOUN
aiua-9854	67	16	on	on	ADP
aiua-9854	67	17	repeat	repeat	NOUN
aiua-9854	67	18	biopsy	biopsy	NOUN
aiua-9854	67	19	.	.	PUNCT
aiua-9854	68	1	one	one	NUM
aiua-9854	68	2	remained	remain	VERB
aiua-9854	68	3	eligible	eligible	ADJ
aiua-9854	68	4	for	for	ADP
aiua-9854	68	5	the	the	DET
aiua-9854	68	6	as	as	ADP
aiua-9854	68	7	group	group	NOUN
aiua-9854	68	8	,	,	PUNCT
aiua-9854	68	9	while	while	SCONJ
aiua-9854	68	10	the	the	DET
aiua-9854	68	11	other	other	ADJ
aiua-9854	68	12	was	be	AUX
aiua-9854	68	13	reclassified	reclassify	VERB
aiua-9854	68	14	from	from	ADP
aiua-9854	68	15	low	low	ADJ
aiua-9854	68	16	to	to	ADP
aiua-9854	68	17	intermediate	intermediate	ADJ
aiua-9854	68	18	risk	risk	NOUN
aiua-9854	68	19	group	group	NOUN
aiua-9854	68	20	leading	lead	VERB
aiua-9854	68	21	to	to	ADP
aiua-9854	68	22	an	an	DET
aiua-9854	68	23	intervention	intervention	NOUN
aiua-9854	68	24	.	.	PUNCT
aiua-9854	69	1	it	it	PRON
aiua-9854	69	2	is	be	AUX
aiua-9854	69	3	prudent	prudent	ADJ
aiua-9854	69	4	to	to	PART
aiua-9854	69	5	follow	follow	VERB
aiua-9854	69	6	-	-	PUNCT
aiua-9854	69	7	up	up	NOUN
aiua-9854	69	8	biannually	biannually	ADV
aiua-9854	69	9	with	with	ADP
aiua-9854	69	10	psa	psa	NOUN
aiua-9854	69	11	results	result	NOUN
aiua-9854	69	12	;	;	PUNCT
aiua-9854	69	13	however	however	ADV
aiua-9854	69	14	,	,	PUNCT
aiua-9854	69	15	it	it	PRON
aiua-9854	69	16	is	be	AUX
aiua-9854	69	17	rarely	rarely	ADV
aiua-9854	69	18	the	the	DET
aiua-9854	69	19	sole	sole	ADJ
aiua-9854	69	20	trigger	trigger	NOUN
aiua-9854	69	21	for	for	ADP
aiua-9854	69	22	intervention	intervention	NOUN
aiua-9854	69	23	.	.	PUNCT
aiua-9854	70	1	when	when	SCONJ
aiua-9854	70	2	suspicion	suspicion	NOUN
aiua-9854	70	3	arises	arise	VERB
aiua-9854	70	4	,	,	PUNCT
aiua-9854	70	5	further	far	ADV
aiua-9854	70	6	clinical	clinical	ADJ
aiua-9854	70	7	workup	workup	NOUN
aiua-9854	70	8	is	be	AUX
aiua-9854	70	9	warranted	warrant	VERB
aiua-9854	70	10	via	via	ADP
aiua-9854	70	11	mri	mri	NOUN
aiua-9854	70	12	and	and	CCONJ
aiua-9854	70	13	biopsy	biopsy	NOUN
aiua-9854	70	14	(	(	PUNCT
aiua-9854	70	15	10	10	NUM
aiua-9854	70	16	,	,	PUNCT
aiua-9854	70	17	11	11	NUM
aiua-9854	70	18	)	)	PUNCT
aiua-9854	70	19	.	.	PUNCT
aiua-9854	71	1	with	with	ADP
aiua-9854	71	2	regards	regard	NOUN
aiua-9854	71	3	to	to	ADP
aiua-9854	71	4	the	the	DET
aiua-9854	71	5	initial	initial	ADJ
aiua-9854	71	6	dre	dre	NOUN
aiua-9854	71	7	,	,	PUNCT
aiua-9854	71	8	all	all	DET
aiua-9854	71	9	patients	patient	NOUN
aiua-9854	71	10	were	be	AUX
aiua-9854	71	11	either	either	CCONJ
aiua-9854	71	12	negative	negative	ADJ
aiua-9854	71	13	(	(	PUNCT
aiua-9854	71	14	72.1	72.1	NUM
aiua-9854	71	15	%	%	NOUN
aiua-9854	71	16	)	)	PUNCT
aiua-9854	71	17	or	or	CCONJ
aiua-9854	71	18	suspicious	suspicious	ADJ
aiua-9854	71	19	to	to	PART
aiua-9854	71	20	have	have	VERB
aiua-9854	71	21	a	a	DET
aiua-9854	71	22	t2a	t2a	ADJ
aiua-9854	71	23	lesion	lesion	NOUN
aiua-9854	71	24	on	on	ADP
aiua-9854	71	25	exam	exam	NOUN
aiua-9854	71	26	(	(	PUNCT
aiua-9854	71	27	27.9	27.9	NUM
aiua-9854	71	28	%	%	NOUN
aiua-9854	71	29	)	)	PUNCT
aiua-9854	71	30	.	.	PUNCT
aiua-9854	72	1	patients	patient	NOUN
aiua-9854	72	2	with	with	ADP
aiua-9854	72	3	large	large	ADJ
aiua-9854	72	4	nodules	nodule	NOUN
aiua-9854	72	5	,	,	PUNCT
aiua-9854	72	6	bilateral	bilateral	ADJ
aiua-9854	72	7	nodules	nodule	NOUN
aiua-9854	72	8	,	,	PUNCT
aiua-9854	72	9	or	or	CCONJ
aiua-9854	72	10	involvement	involvement	NOUN
aiua-9854	72	11	of	of	ADP
aiua-9854	72	12	seminal	seminal	ADJ
aiua-9854	72	13	vesicles	vesicle	NOUN
aiua-9854	72	14	were	be	AUX
aiua-9854	72	15	excluded	exclude	VERB
aiua-9854	72	16	from	from	ADP
aiua-9854	72	17	active	active	ADJ
aiua-9854	72	18	surveillance	surveillance	NOUN
aiua-9854	72	19	(	(	PUNCT
aiua-9854	72	20	12	12	NUM
aiua-9854	72	21	)	)	PUNCT
aiua-9854	72	22	.	.	PUNCT
aiua-9854	73	1	abnormal	abnormal	ADJ
aiua-9854	73	2	dres	dre	NOUN
aiua-9854	73	3	are	be	AUX
aiua-9854	73	4	associated	associate	VERB
aiua-9854	73	5	with	with	ADP
aiua-9854	73	6	an	an	DET
aiua-9854	73	7	increased	increase	VERB
aiua-9854	73	8	risk	risk	NOUN
aiua-9854	73	9	of	of	ADP
aiua-9854	73	10	detecting	detect	VERB
aiua-9854	73	11	high	high	ADJ
aiua-9854	73	12	-	-	PUNCT
aiua-9854	73	13	grade	grade	NOUN
aiua-9854	73	14	disease	disease	NOUN
aiua-9854	73	15	(	(	PUNCT
aiua-9854	73	16	12	12	NUM
aiua-9854	73	17	)	)	PUNCT
aiua-9854	73	18	.	.	PUNCT
aiua-9854	74	1	any	any	DET
aiua-9854	74	2	sign	sign	NOUN
aiua-9854	74	3	of	of	ADP
aiua-9854	74	4	t3	t3	PROPN
aiua-9854	74	5	disease	disease	NOUN
aiua-9854	74	6	or	or	CCONJ
aiua-9854	74	7	progression	progression	NOUN
aiua-9854	74	8	in	in	ADP
aiua-9854	74	9	the	the	DET
aiua-9854	74	10	clinical	clinical	ADJ
aiua-9854	74	11	stage	stage	NOUN
aiua-9854	74	12	suggested	suggest	VERB
aiua-9854	74	13	by	by	ADP
aiua-9854	74	14	a	a	DET
aiua-9854	74	15	dre	dre	NOUN
aiua-9854	74	16	would	would	AUX
aiua-9854	74	17	warrant	warrant	VERB
aiua-9854	74	18	a	a	DET
aiua-9854	74	19	further	further	ADJ
aiua-9854	74	20	investigation	investigation	NOUN
aiua-9854	74	21	/	/	SYM
aiua-9854	74	22	intervention	intervention	NOUN
aiua-9854	74	23	in	in	ADP
aiua-9854	74	24	patients	patient	NOUN
aiua-9854	74	25	with	with	ADP
aiua-9854	74	26	as	as	ADP
aiua-9854	74	27	(	(	PUNCT
aiua-9854	74	28	13	13	NUM
aiua-9854	74	29	)	)	PUNCT
aiua-9854	74	30	.	.	PUNCT
aiua-9854	75	1	nevertheless	nevertheless	ADV
aiua-9854	75	2	,	,	PUNCT
aiua-9854	75	3	none	none	NOUN
aiua-9854	75	4	of	of	ADP
aiua-9854	75	5	our	our	PRON
aiua-9854	75	6	patients	patient	NOUN
aiua-9854	75	7	revealed	reveal	VERB
aiua-9854	75	8	signs	sign	NOUN
aiua-9854	75	9	of	of	ADP
aiua-9854	75	10	progression	progression	NOUN
aiua-9854	75	11	upon	upon	SCONJ
aiua-9854	75	12	dre	dre	PROPN
aiua-9854	75	13	.	.	PUNCT
aiua-9854	76	1	the	the	DET
aiua-9854	76	2	addition	addition	NOUN
aiua-9854	76	3	of	of	ADP
aiua-9854	76	4	mri	mri	NOUN
aiua-9854	76	5	evaluation	evaluation	NOUN
aiua-9854	76	6	proved	prove	VERB
aiua-9854	76	7	to	to	PART
aiua-9854	76	8	be	be	AUX
aiua-9854	76	9	a	a	DET
aiua-9854	76	10	resourceful	resourceful	ADJ
aiua-9854	76	11	tool	tool	NOUN
aiua-9854	76	12	in	in	ADP
aiua-9854	76	13	clinical	clinical	ADJ
aiua-9854	76	14	decision	decision	NOUN
aiua-9854	76	15	making	make	VERB
aiua-9854	76	16	for	for	ADP
aiua-9854	76	17	as	as	ADP
aiua-9854	76	18	patients	patient	NOUN
aiua-9854	76	19	(	(	PUNCT
aiua-9854	76	20	14	14	NUM
aiua-9854	76	21	-	-	SYM
aiua-9854	76	22	20	20	NUM
aiua-9854	76	23	)	)	PUNCT
aiua-9854	76	24	.	.	PUNCT
aiua-9854	77	1	it	it	PRON
aiua-9854	77	2	was	be	AUX
aiua-9854	77	3	similarly	similarly	ADV
aiua-9854	77	4	essential	essential	ADJ
aiua-9854	77	5	for	for	ADP
aiua-9854	77	6	our	our	PRON
aiua-9854	77	7	patients	patient	NOUN
aiua-9854	77	8	.	.	PUNCT
aiua-9854	78	1	upon	upon	SCONJ
aiua-9854	78	2	follow	follow	VERB
aiua-9854	78	3	-	-	PUNCT
aiua-9854	78	4	up	up	NOUN
aiua-9854	78	5	,	,	PUNCT
aiua-9854	78	6	18.6	18.6	NUM
aiua-9854	78	7	%	%	NOUN
aiua-9854	78	8	(	(	PUNCT
aiua-9854	78	9	8/43	8/43	NUM
aiua-9854	78	10	)	)	PUNCT
aiua-9854	78	11	of	of	ADP
aiua-9854	78	12	our	our	PRON
aiua-9854	78	13	patients	patient	NOUN
aiua-9854	78	14	progressed	progress	VERB
aiua-9854	78	15	on	on	ADP
aiua-9854	78	16	mri	mri	NOUN
aiua-9854	78	17	,	,	PUNCT
aiua-9854	78	18	37.5	37.5	NUM
aiua-9854	78	19	%	%	NOUN
aiua-9854	78	20	(	(	PUNCT
aiua-9854	78	21	3/8	3/8	NUM
aiua-9854	78	22	)	)	PUNCT
aiua-9854	78	23	of	of	ADP
aiua-9854	78	24	those	those	DET
aiua-9854	78	25	patients	patient	NOUN
aiua-9854	78	26	that	that	PRON
aiua-9854	78	27	progressed	progress	VERB
aiua-9854	78	28	were	be	AUX
aiua-9854	78	29	dropped	drop	VERB
aiua-9854	78	30	from	from	ADP
aiua-9854	78	31	as	as	ADP
aiua-9854	78	32	.	.	PUNCT
aiua-9854	79	1	one	one	NUM
aiua-9854	79	2	of	of	ADP
aiua-9854	79	3	those	those	PRON
aiua-9854	79	4	(	(	PUNCT
aiua-9854	79	5	1/3	1/3	NUM
aiua-9854	79	6	)	)	PUNCT
aiua-9854	79	7	,	,	PUNCT
aiua-9854	79	8	had	have	VERB
aiua-9854	79	9	a	a	DET
aiua-9854	79	10	suspicious	suspicious	ADJ
aiua-9854	79	11	capsule	capsule	NOUN
aiua-9854	79	12	involvement	involvement	NOUN
aiua-9854	79	13	on	on	ADP
aiua-9854	79	14	mri	mri	NOUN
aiua-9854	79	15	leading	lead	VERB
aiua-9854	79	16	to	to	ADP
aiua-9854	79	17	direct	direct	ADJ
aiua-9854	79	18	intervention	intervention	NOUN
aiua-9854	79	19	,	,	PUNCT
aiua-9854	79	20	whereas	whereas	SCONJ
aiua-9854	79	21	the	the	DET
aiua-9854	79	22	other	other	ADJ
aiua-9854	79	23	two	two	NUM
aiua-9854	79	24	(	(	PUNCT
aiua-9854	79	25	2/3	2/3	NUM
aiua-9854	79	26	)	)	PUNCT
aiua-9854	79	27	patients	patient	NOUN
aiua-9854	79	28	had	have	VERB
aiua-9854	79	29	a	a	DET
aiua-9854	79	30	rebiopsy	rebiopsy	NOUN
aiua-9854	79	31	that	that	PRON
aiua-9854	79	32	revealed	reveal	VERB
aiua-9854	79	33	upgrading	upgrading	NOUN
aiua-9854	79	34	of	of	ADP
aiua-9854	79	35	disease	disease	NOUN
aiua-9854	79	36	leading	lead	VERB
aiua-9854	79	37	to	to	ADP
aiua-9854	79	38	intervention	intervention	NOUN
aiua-9854	79	39	.	.	PUNCT
aiua-9854	80	1	from	from	ADP
aiua-9854	80	2	the	the	DET
aiua-9854	80	3	total	total	ADJ
aiua-9854	80	4	number	number	NOUN
aiua-9854	80	5	of	of	ADP
aiua-9854	80	6	patients	patient	NOUN
aiua-9854	80	7	,	,	PUNCT
aiua-9854	80	8	only	only	ADV
aiua-9854	80	9	13	13	NUM
aiua-9854	80	10	%	%	NOUN
aiua-9854	80	11	of	of	ADP
aiua-9854	80	12	them	they	PRON
aiua-9854	80	13	were	be	AUX
aiua-9854	80	14	not	not	PART
aiua-9854	80	15	imaged	image	VERB
aiua-9854	80	16	with	with	ADP
aiua-9854	80	17	mri	mri	NOUN
aiua-9854	80	18	despite	despite	SCONJ
aiua-9854	80	19	strong	strong	ADJ
aiua-9854	80	20	recommendation	recommendation	NOUN
aiua-9854	80	21	.	.	PUNCT
aiua-9854	81	1	imaging	imaging	NOUN
aiua-9854	81	2	for	for	ADP
aiua-9854	81	3	prostate	prostate	NOUN
aiua-9854	81	4	cancer	cancer	NOUN
aiua-9854	81	5	,	,	PUNCT
aiua-9854	81	6	mri	mri	NOUN
aiua-9854	81	7	has	have	AUX
aiua-9854	81	8	been	be	AUX
aiua-9854	81	9	integral	integral	ADJ
aiua-9854	81	10	for	for	ADP
aiua-9854	81	11	decision	decision	NOUN
aiua-9854	81	12	making	making	NOUN
aiua-9854	81	13	in	in	ADP
aiua-9854	81	14	as	as	ADP
aiua-9854	81	15	,	,	PUNCT
aiua-9854	81	16	as	as	SCONJ
aiua-9854	81	17	it	it	PRON
aiua-9854	81	18	significantly	significantly	ADV
aiua-9854	81	19	improved	improve	VERB
aiua-9854	81	20	detection	detection	NOUN
aiua-9854	81	21	rates	rate	NOUN
aiua-9854	81	22	of	of	ADP
aiua-9854	81	23	suspicious	suspicious	ADJ
aiua-9854	81	24	lesions	lesion	NOUN
aiua-9854	81	25	.	.	PUNCT
aiua-9854	82	1	biopsy	biopsy	NOUN
aiua-9854	82	2	without	without	ADP
aiua-9854	82	3	mri	mri	NOUN
aiua-9854	82	4	has	have	VERB
aiua-9854	82	5	a	a	DET
aiua-9854	82	6	misclassification	misclassification	NOUN
aiua-9854	82	7	rate	rate	NOUN
aiua-9854	82	8	of	of	ADP
aiua-9854	82	9	20	20	NUM
aiua-9854	82	10	-	-	SYM
aiua-9854	82	11	30	30	NUM
aiua-9854	82	12	%	%	NOUN
aiua-9854	82	13	(	(	PUNCT
aiua-9854	82	14	14	14	NUM
aiua-9854	82	15	)	)	PUNCT
aiua-9854	82	16	.	.	PUNCT
aiua-9854	83	1	in	in	ADP
aiua-9854	83	2	addition	addition	NOUN
aiua-9854	83	3	,	,	PUNCT
aiua-9854	83	4	berglund	berglund	PROPN
aiua-9854	83	5	et	et	PROPN
aiua-9854	83	6	al	al	PROPN
aiua-9854	83	7	.	.	PROPN
aiua-9854	83	8	showed	show	VERB
aiua-9854	83	9	that	that	SCONJ
aiua-9854	83	10	an	an	DET
aiua-9854	83	11	immediate	immediate	ADJ
aiua-9854	83	12	confirmatory	confirmatory	NOUN
aiua-9854	83	13	biopsy	biopsy	NOUN
aiua-9854	83	14	for	for	ADP
aiua-9854	83	15	as	as	SCONJ
aiua-9854	83	16	patients	patient	NOUN
aiua-9854	83	17	revealed	reveal	VERB
aiua-9854	83	18	an	an	DET
aiua-9854	83	19	upgrade	upgrade	NOUN
aiua-9854	83	20	in	in	ADP
aiua-9854	83	21	27	27	NUM
aiua-9854	83	22	%	%	NOUN
aiua-9854	83	23	of	of	ADP
aiua-9854	83	24	cases	case	NOUN
aiua-9854	83	25	to	to	ADP
aiua-9854	83	26	gleason	gleason	PROPN
aiua-9854	83	27	7	7	NUM
aiua-9854	83	28	and	and	CCONJ
aiua-9854	83	29	above	above	ADV
aiua-9854	83	30	(	(	PUNCT
aiua-9854	83	31	15	15	NUM
aiua-9854	83	32	)	)	PUNCT
aiua-9854	83	33	.	.	PUNCT
aiua-9854	84	1	as	as	ADP
aiua-9854	84	2	such	such	ADJ
aiua-9854	84	3	,	,	PUNCT
aiua-9854	84	4	an	an	DET
aiua-9854	84	5	mri	mri	NOUN
aiua-9854	84	6	is	be	AUX
aiua-9854	84	7	deemed	deem	VERB
aiua-9854	84	8	a	a	DET
aiua-9854	84	9	crucial	crucial	ADJ
aiua-9854	84	10	addition	addition	NOUN
aiua-9854	84	11	in	in	ADP
aiua-9854	84	12	the	the	DET
aiua-9854	84	13	diagnostics	diagnostic	NOUN
aiua-9854	84	14	of	of	ADP
aiua-9854	84	15	prostate	prostate	NOUN
aiua-9854	84	16	cancer	cancer	NOUN
aiua-9854	84	17	as	as	SCONJ
aiua-9854	84	18	it	it	PRON
aiua-9854	84	19	can	can	AUX
aiua-9854	84	20	accurately	accurately	ADV
aiua-9854	84	21	guide	guide	VERB
aiua-9854	84	22	targeting	target	VERB
aiua-9854	84	23	of	of	ADP
aiua-9854	84	24	clinically	clinically	ADV
aiua-9854	84	25	significant	significant	ADJ
aiua-9854	84	26	lesions	lesion	NOUN
aiua-9854	84	27	in	in	ADP
aiua-9854	84	28	2/3	2/3	NUM
aiua-9854	84	29	of	of	ADP
aiua-9854	84	30	men	man	NOUN
aiua-9854	84	31	eligible	eligible	ADJ
aiua-9854	84	32	for	for	ADP
aiua-9854	84	33	active	active	ADJ
aiua-9854	84	34	surveillance	surveillance	NOUN
aiua-9854	84	35	(	(	PUNCT
aiua-9854	84	36	16	16	NUM
aiua-9854	84	37	)	)	PUNCT
aiua-9854	84	38	.	.	PUNCT
aiua-9854	85	1	in	in	ADP
aiua-9854	85	2	addition	addition	NOUN
aiua-9854	85	3	,	,	PUNCT
aiua-9854	85	4	mri	mri	NOUN
aiua-9854	85	5	has	have	VERB
aiua-9854	85	6	a	a	DET
aiua-9854	85	7	high	high	ADJ
aiua-9854	85	8	negative	negative	ADJ
aiua-9854	85	9	predictive	predictive	ADJ
aiua-9854	85	10	value	value	NOUN
aiua-9854	85	11	90	90	NUM
aiua-9854	85	12	-	-	SYM
aiua-9854	85	13	100	100	NUM
aiua-9854	85	14	%	%	NOUN
aiua-9854	85	15	(	(	PUNCT
aiua-9854	85	16	17	17	NUM
aiua-9854	85	17	)	)	PUNCT
aiua-9854	85	18	,	,	PUNCT
aiua-9854	85	19	it	it	PRON
aiua-9854	85	20	also	also	ADV
aiua-9854	85	21	lacks	lack	VERB
aiua-9854	85	22	sensitivity	sensitivity	NOUN
aiua-9854	85	23	to	to	ADP
aiua-9854	85	24	low	low	ADJ
aiua-9854	85	25	grade	grade	NOUN
aiua-9854	85	26	tumors	tumor	NOUN
aiua-9854	85	27	of	of	ADP
aiua-9854	85	28	gleason	gleason	PROPN
aiua-9854	85	29	6	6	NUM
aiua-9854	85	30	(	(	PUNCT
aiua-9854	85	31	3	3	NUM
aiua-9854	85	32	+	+	NOUN
aiua-9854	85	33	3	3	NUM
aiua-9854	85	34	)	)	PUNCT
aiua-9854	85	35	.	.	PUNCT
aiua-9854	86	1	therefore	therefore	ADV
aiua-9854	86	2	,	,	PUNCT
aiua-9854	86	3	on	on	ADP
aiua-9854	86	4	initial	initial	ADJ
aiua-9854	86	5	workup	workup	NOUN
aiua-9854	86	6	a	a	DET
aiua-9854	86	7	negative	negative	ADJ
aiua-9854	86	8	mri	mri	NOUN
aiua-9854	86	9	may	may	AUX
aiua-9854	86	10	omit	omit	VERB
aiua-9854	86	11	the	the	DET
aiua-9854	86	12	need	need	NOUN
aiua-9854	86	13	for	for	SCONJ
aiua-9854	86	14	biopsy	biopsy	NOUN
aiua-9854	86	15	to	to	PART
aiua-9854	86	16	rule	rule	VERB
aiua-9854	86	17	out	out	ADP
aiua-9854	86	18	prostate	prostate	NOUN
aiua-9854	86	19	cancer	cancer	NOUN
aiua-9854	86	20	and	and	CCONJ
aiua-9854	86	21	may	may	AUX
aiua-9854	86	22	even	even	ADV
aiua-9854	86	23	be	be	AUX
aiua-9854	86	24	an	an	DET
aiua-9854	86	25	attractive	attractive	ADJ
aiua-9854	86	26	alternative	alternative	NOUN
aiua-9854	86	27	of	of	ADP
aiua-9854	86	28	recurrent	recurrent	ADJ
aiua-9854	86	29	biopsies	biopsy	NOUN
aiua-9854	86	30	leading	lead	VERB
aiua-9854	86	31	to	to	ADP
aiua-9854	86	32	a	a	DET
aiua-9854	86	33	decreased	decrease	VERB
aiua-9854	86	34	incidence	incidence	NOUN
aiua-9854	86	35	of	of	ADP
aiua-9854	86	36	diagnosing	diagnose	VERB
aiua-9854	86	37	low	low	ADJ
aiua-9854	86	38	grade	grade	NOUN
aiua-9854	86	39	prostate	prostate	NOUN
aiua-9854	86	40	cancer	cancer	NOUN
aiua-9854	86	41	(	(	PUNCT
aiua-9854	86	42	18	18	NUM
aiua-9854	86	43	,	,	PUNCT
aiua-9854	86	44	19	19	NUM
aiua-9854	86	45	)	)	PUNCT
aiua-9854	86	46	.	.	PUNCT
aiua-9854	87	1	yet	yet	ADV
aiua-9854	87	2	,	,	PUNCT
aiua-9854	87	3	the	the	DET
aiua-9854	87	4	use	use	NOUN
aiua-9854	87	5	of	of	ADP
aiua-9854	87	6	mri	mri	NOUN
aiua-9854	87	7	for	for	ADP
aiua-9854	87	8	follow	follow	VERB
aiua-9854	87	9	-	-	PUNCT
aiua-9854	87	10	up	up	NOUN
aiua-9854	87	11	on	on	ADV
aiua-9854	87	12	as	as	SCONJ
aiua-9854	87	13	patients	patient	NOUN
aiua-9854	87	14	should	should	AUX
aiua-9854	87	15	be	be	AUX
aiua-9854	87	16	subject	subject	ADJ
aiua-9854	87	17	to	to	ADP
aiua-9854	87	18	better	well	ADV
aiua-9854	87	19	defined	define	VERB
aiua-9854	87	20	radiological	radiological	ADJ
aiua-9854	87	21	parameters	parameter	NOUN
aiua-9854	87	22	(	(	PUNCT
aiua-9854	87	23	20	20	NUM
aiua-9854	87	24	)	)	PUNCT
aiua-9854	87	25	.	.	PUNCT
aiua-9854	88	1	biopsy	biopsy	NOUN
aiua-9854	88	2	results	result	NOUN
aiua-9854	88	3	belonging	belong	VERB
aiua-9854	88	4	to	to	ADP
aiua-9854	88	5	who	who	PRON
aiua-9854	88	6	group	group	NOUN
aiua-9854	88	7	1	1	NUM
aiua-9854	88	8	or	or	CCONJ
aiua-9854	88	9	2	2	NUM
aiua-9854	88	10	is	be	AUX
aiua-9854	88	11	the	the	DET
aiua-9854	88	12	final	final	ADJ
aiua-9854	88	13	determinant	determinant	NOUN
aiua-9854	88	14	of	of	ADP
aiua-9854	88	15	patient	patient	ADJ
aiua-9854	88	16	inclusion	inclusion	NOUN
aiua-9854	88	17	to	to	ADP
aiua-9854	88	18	the	the	PRON
aiua-9854	88	19	as	as	ADP
aiua-9854	88	20	protocol	protocol	NOUN
aiua-9854	88	21	of	of	ADP
aiua-9854	88	22	our	our	PRON
aiua-9854	88	23	study	study	NOUN
aiua-9854	88	24	.	.	PUNCT
aiua-9854	89	1	on	on	ADP
aiua-9854	89	2	follow	follow	VERB
aiua-9854	89	3	-	-	PUNCT
aiua-9854	89	4	up	up	NOUN
aiua-9854	89	5	,	,	PUNCT
aiua-9854	89	6	any	any	DET
aiua-9854	89	7	suspicious	suspicious	ADJ
aiua-9854	89	8	clinical	clinical	ADJ
aiua-9854	89	9	parameter	parameter	NOUN
aiua-9854	89	10	would	would	AUX
aiua-9854	89	11	warrant	warrant	VERB
aiua-9854	89	12	a	a	DET
aiua-9854	89	13	repeat	repeat	NOUN
aiua-9854	89	14	biopsy	biopsy	NOUN
aiua-9854	89	15	.	.	PUNCT
aiua-9854	90	1	of	of	ADP
aiua-9854	90	2	those	those	PRON
aiua-9854	90	3	,	,	PUNCT
aiua-9854	90	4	11.6	11.6	NUM
aiua-9854	90	5	%	%	NOUN
aiua-9854	90	6	(	(	PUNCT
aiua-9854	90	7	5/43	5/43	NUM
aiua-9854	90	8	)	)	PUNCT
aiua-9854	90	9	were	be	AUX
aiua-9854	90	10	upgraded	upgrade	VERB
aiua-9854	90	11	.	.	PUNCT
aiua-9854	91	1	of	of	ADP
aiua-9854	91	2	the	the	DET
aiua-9854	91	3	upgraded	upgrade	VERB
aiua-9854	91	4	biopsies	biopsy	NOUN
aiua-9854	91	5	80	80	NUM
aiua-9854	91	6	%	%	NOUN
aiua-9854	91	7	(	(	PUNCT
aiua-9854	91	8	4/5	4/5	NOUN
aiua-9854	91	9	)	)	PUNCT
aiua-9854	91	10	lead	lead	NOUN
aiua-9854	91	11	to	to	ADP
aiua-9854	91	12	an	an	DET
aiua-9854	91	13	intervention	intervention	NOUN
aiua-9854	91	14	.	.	PUNCT
aiua-9854	92	1	in	in	ADP
aiua-9854	92	2	addition	addition	NOUN
aiua-9854	92	3	,	,	PUNCT
aiua-9854	92	4	biopsy	biopsy	NOUN
aiua-9854	92	5	result	result	NOUN
aiua-9854	92	6	was	be	AUX
aiua-9854	92	7	the	the	DET
aiua-9854	92	8	trigger	trigger	NOUN
aiua-9854	92	9	for	for	ADP
aiua-9854	92	10	intervention	intervention	NOUN
aiua-9854	92	11	in	in	ADP
aiua-9854	92	12	44.4	44.4	NUM
aiua-9854	92	13	%	%	NOUN
aiua-9854	92	14	of	of	ADP
aiua-9854	92	15	patients	patient	NOUN
aiua-9854	92	16	that	that	PRON
aiua-9854	92	17	dropped	drop	VERB
aiua-9854	92	18	out	out	ADP
aiua-9854	92	19	of	of	ADP
aiua-9854	92	20	as	as	ADP
aiua-9854	92	21	.	.	PUNCT
aiua-9854	93	1	in	in	ADP
aiua-9854	93	2	a	a	DET
aiua-9854	93	3	41.9	41.9	NUM
aiua-9854	93	4	%	%	NOUN
aiua-9854	93	5	(	(	PUNCT
aiua-9854	93	6	20/43	20/43	NUM
aiua-9854	93	7	)	)	PUNCT
aiua-9854	93	8	of	of	ADP
aiua-9854	93	9	follow	follow	VERB
aiua-9854	93	10	-	-	PUNCT
aiua-9854	93	11	up	up	NOUN
aiua-9854	93	12	,	,	PUNCT
aiua-9854	93	13	biopsies	biopsy	NOUN
aiua-9854	93	14	at	at	ADP
aiua-9854	93	15	one	one	NUM
aiua-9854	93	16	year	year	NOUN
aiua-9854	93	17	were	be	AUX
aiua-9854	93	18	not	not	PART
aiua-9854	93	19	done	do	VERB
aiua-9854	93	20	.	.	PUNCT
aiua-9854	94	1	this	this	DET
aiua-9854	94	2	high	high	ADJ
aiua-9854	94	3	percentage	percentage	NOUN
aiua-9854	94	4	can	can	AUX
aiua-9854	94	5	be	be	AUX
aiua-9854	94	6	explained	explain	VERB
aiua-9854	94	7	by	by	ADP
aiua-9854	94	8	lack	lack	NOUN
aiua-9854	94	9	of	of	ADP
aiua-9854	94	10	patient	patient	ADJ
aiua-9854	94	11	commitment	commitment	NOUN
aiua-9854	94	12	to	to	ADP
aiua-9854	94	13	the	the	DET
aiua-9854	94	14	as	as	ADP
aiua-9854	94	15	protocol	protocol	NOUN
aiua-9854	94	16	mainly	mainly	ADV
aiua-9854	94	17	due	due	ADJ
aiua-9854	94	18	to	to	PART
aiua-9854	94	19	discomfort	discomfort	VERB
aiua-9854	94	20	from	from	ADP
aiua-9854	94	21	undergoing	undergo	VERB
aiua-9854	94	22	a	a	DET
aiua-9854	94	23	repeat	repeat	NOUN
aiua-9854	94	24	biopsy	biopsy	NOUN
aiua-9854	94	25	as	as	ADV
aiua-9854	94	26	well	well	ADV
aiua-9854	94	27	as	as	ADP
aiua-9854	94	28	false	false	ADJ
aiua-9854	94	29	reassurance	reassurance	NOUN
aiua-9854	94	30	from	from	ADP
aiua-9854	94	31	the	the	DET
aiua-9854	94	32	other	other	ADJ
aiua-9854	94	33	noninvasive	noninvasive	ADJ
aiua-9854	94	34	clinical	clinical	ADJ
aiua-9854	94	35	parameters	parameter	NOUN
aiua-9854	94	36	.	.	PUNCT
aiua-9854	95	1	to	to	PART
aiua-9854	95	2	note	note	VERB
aiua-9854	95	3	,	,	PUNCT
aiua-9854	95	4	none	none	NOUN
aiua-9854	95	5	of	of	ADP
aiua-9854	95	6	the	the	DET
aiua-9854	95	7	patients	patient	NOUN
aiua-9854	95	8	who	who	PRON
aiua-9854	95	9	underwent	undergo	VERB
aiua-9854	95	10	radical	radical	ADJ
aiua-9854	95	11	prostatectomy	prostatectomy	NOUN
aiua-9854	95	12	as	as	SCONJ
aiua-9854	95	13	the	the	DET
aiua-9854	95	14	intervention	intervention	NOUN
aiua-9854	95	15	of	of	ADP
aiua-9854	95	16	choice	choice	NOUN
aiua-9854	95	17	had	have	VERB
aiua-9854	95	18	a	a	DET
aiua-9854	95	19	high	high	ADJ
aiua-9854	95	20	-	-	PUNCT
aiua-9854	95	21	grade	grade	NOUN
aiua-9854	95	22	pathology	pathology	NOUN
aiua-9854	95	23	specimen	speciman	NOUN
aiua-9854	95	24	(	(	PUNCT
aiua-9854	95	25	gleason	gleason	PROPN
aiua-9854	95	26	8	8	NUM
aiua-9854	95	27	or	or	CCONJ
aiua-9854	95	28	above	above	ADV
aiua-9854	95	29	)	)	PUNCT
aiua-9854	95	30	.	.	PUNCT
aiua-9854	96	1	biopsy	biopsy	NOUN
aiua-9854	96	2	is	be	AUX
aiua-9854	96	3	indeed	indeed	ADV
aiua-9854	96	4	the	the	DET
aiua-9854	96	5	most	most	ADV
aiua-9854	96	6	solid	solid	ADJ
aiua-9854	96	7	parameter	parameter	NOUN
aiua-9854	96	8	for	for	ADP
aiua-9854	96	9	decision	decision	NOUN
aiua-9854	96	10	making	making	NOUN
aiua-9854	96	11	.	.	PUNCT
aiua-9854	97	1	according	accord	VERB
aiua-9854	97	2	to	to	ADP
aiua-9854	97	3	the	the	DET
aiua-9854	97	4	prias	prias	PROPN
aiua-9854	97	5	study	study	NOUN
aiua-9854	97	6	,	,	PUNCT
aiua-9854	97	7	switch	switch	VERB
aiua-9854	97	8	to	to	ADP
aiua-9854	97	9	active	active	ADJ
aiua-9854	97	10	treatment	treatment	NOUN
aiua-9854	97	11	should	should	AUX
aiua-9854	97	12	be	be	AUX
aiua-9854	97	13	guided	guide	VERB
aiua-9854	97	14	by	by	ADP
aiua-9854	97	15	biopsy	biopsy	NOUN
aiua-9854	97	16	upgrading	upgrading	NOUN
aiua-9854	97	17	and/or	and/or	CCONJ
aiua-9854	97	18	clinical	clinical	ADJ
aiua-9854	97	19	t3	t3	NOUN
aiua-9854	97	20	disease	disease	NOUN
aiua-9854	97	21	(	(	PUNCT
aiua-9854	97	22	13	13	NUM
aiua-9854	97	23	)	)	PUNCT
aiua-9854	97	24	.	.	PUNCT
aiua-9854	98	1	we	we	PRON
aiua-9854	98	2	compared	compare	VERB
aiua-9854	98	3	our	our	PRON
aiua-9854	98	4	results	result	NOUN
aiua-9854	98	5	to	to	ADP
aiua-9854	98	6	various	various	ADJ
aiua-9854	98	7	north	north	ADJ
aiua-9854	98	8	american	american	ADJ
aiua-9854	98	9	cohorts	cohort	NOUN
aiua-9854	98	10	studied	study	VERB
aiua-9854	98	11	in	in	ADP
aiua-9854	98	12	different	different	ADJ
aiua-9854	98	13	medical	medical	ADJ
aiua-9854	98	14	centers	center	NOUN
aiua-9854	98	15	.	.	PUNCT
aiua-9854	99	1	despite	despite	SCONJ
aiua-9854	99	2	our	our	PRON
aiua-9854	99	3	small	small	ADJ
aiua-9854	99	4	sample	sample	NOUN
aiua-9854	99	5	size	size	NOUN
aiua-9854	99	6	,	,	PUNCT
aiua-9854	99	7	our	our	PRON
aiua-9854	99	8	numbers	number	NOUN
aiua-9854	99	9	were	be	AUX
aiua-9854	99	10	consistent	consistent	ADJ
aiua-9854	99	11	with	with	ADP
aiua-9854	99	12	their	their	PRON
aiua-9854	99	13	results	result	NOUN
aiua-9854	99	14	.	.	PUNCT
aiua-9854	100	1	fortunately	fortunately	ADV
aiua-9854	100	2	,	,	PUNCT
aiua-9854	100	3	our	our	PRON
aiua-9854	100	4	os	os	NOUN
aiua-9854	100	5	and	and	CCONJ
aiua-9854	100	6	css	css	PROPN
aiua-9854	100	7	revealed	reveal	VERB
aiua-9854	100	8	no	no	DET
aiua-9854	100	9	deceased	deceased	ADJ
aiua-9854	100	10	patients	patient	NOUN
aiua-9854	100	11	.	.	PUNCT
aiua-9854	101	1	this	this	PRON
aiua-9854	101	2	could	could	AUX
aiua-9854	101	3	be	be	AUX
aiua-9854	101	4	explained	explain	VERB
aiua-9854	101	5	by	by	ADP
aiua-9854	101	6	our	our	PRON
aiua-9854	101	7	relatively	relatively	ADV
aiua-9854	101	8	short	short	ADJ
aiua-9854	101	9	median	median	ADJ
aiua-9854	101	10	follow	follow	NOUN
aiua-9854	101	11	-	-	PUNCT
aiua-9854	101	12	up	up	NOUN
aiua-9854	101	13	time	time	NOUN
aiua-9854	101	14	of	of	ADP
aiua-9854	101	15	40	40	NUM
aiua-9854	101	16	months	month	NOUN
aiua-9854	101	17	and	and	CCONJ
aiua-9854	101	18	our	our	PRON
aiua-9854	101	19	small	small	ADJ
aiua-9854	101	20	sample	sample	NOUN
aiua-9854	101	21	size	size	NOUN
aiua-9854	101	22	.	.	PUNCT
aiua-9854	102	1	moreover	moreover	ADV
aiua-9854	102	2	,	,	PUNCT
aiua-9854	102	3	our	our	PRON
aiua-9854	102	4	conversion	conversion	NOUN
aiua-9854	102	5	to	to	ADP
aiua-9854	102	6	treatment	treatment	NOUN
aiua-9854	102	7	rate	rate	NOUN
aiua-9854	102	8	was	be	AUX
aiua-9854	102	9	20.9	20.9	NUM
aiua-9854	102	10	%	%	NOUN
aiua-9854	102	11	which	which	PRON
aiua-9854	102	12	was	be	AUX
aiua-9854	102	13	comparable	comparable	ADJ
aiua-9854	102	14	to	to	ADP
aiua-9854	102	15	other	other	ADJ
aiua-9854	102	16	cohorts	cohort	NOUN
aiua-9854	102	17	(	(	PUNCT
aiua-9854	102	18	19	19	NUM
aiua-9854	102	19	-	-	SYM
aiua-9854	102	20	50	50	NUM
aiua-9854	102	21	%	%	NOUN
aiua-9854	102	22	)	)	PUNCT
aiua-9854	102	23	(	(	PUNCT
aiua-9854	102	24	table	table	NOUN
aiua-9854	102	25	3	3	NUM
aiua-9854	102	26	)	)	PUNCT
aiua-9854	102	27	.	.	PUNCT
aiua-9854	103	1	truly	truly	ADV
aiua-9854	103	2	one	one	NUM
aiua-9854	103	3	of	of	ADP
aiua-9854	103	4	the	the	DET
aiua-9854	103	5	biggest	big	ADJ
aiua-9854	103	6	and	and	CCONJ
aiua-9854	103	7	main	main	ADJ
aiua-9854	103	8	challenges	challenge	NOUN
aiua-9854	103	9	in	in	ADP
aiua-9854	103	10	prostate	prostate	NOUN
aiua-9854	103	11	cancer	cancer	NOUN
aiua-9854	103	12	is	be	AUX
aiua-9854	103	13	differentiating	differentiate	VERB
aiua-9854	103	14	low	low	ADJ
aiua-9854	103	15	risk	risk	NOUN
aiua-9854	103	16	pathology	pathology	NOUN
aiua-9854	103	17	from	from	ADP
aiua-9854	103	18	aggressive	aggressive	ADJ
aiua-9854	103	19	ones	one	NOUN
aiua-9854	103	20	.	.	PUNCT
aiua-9854	104	1	gleason	gleason	PROPN
aiua-9854	104	2	pathology	pathology	PROPN
aiua-9854	104	3	is	be	AUX
aiua-9854	104	4	currently	currently	ADV
aiua-9854	104	5	the	the	DET
aiua-9854	104	6	most	most	ADV
aiua-9854	104	7	reliable	reliable	ADJ
aiua-9854	104	8	method	method	NOUN
aiua-9854	104	9	.	.	PUNCT
aiua-9854	105	1	mri	mri	NOUN
aiua-9854	105	2	has	have	VERB
aiua-9854	105	3	an	an	DET
aiua-9854	105	4	emerging	emerge	VERB
aiua-9854	105	5	role	role	NOUN
aiua-9854	105	6	in	in	ADP
aiua-9854	105	7	aiding	aid	VERB
aiua-9854	105	8	clinicians	clinician	NOUN
aiua-9854	105	9	and	and	CCONJ
aiua-9854	105	10	is	be	AUX
aiua-9854	105	11	gaining	gain	VERB
aiua-9854	105	12	popularity	popularity	NOUN
aiua-9854	105	13	as	as	SCONJ
aiua-9854	105	14	new	new	ADJ
aiua-9854	105	15	studies	study	NOUN
aiua-9854	105	16	are	be	AUX
aiua-9854	105	17	in	in	ADP
aiua-9854	105	18	favor	favor	NOUN
aiua-9854	105	19	of	of	ADP
aiua-9854	105	20	its	its	PRON
aiua-9854	105	21	diagnostic	diagnostic	ADJ
aiua-9854	105	22	potential	potential	NOUN
aiua-9854	105	23	.	.	PUNCT
aiua-9854	106	1	biomarkers	biomarker	NOUN
aiua-9854	106	2	appear	appear	VERB
aiua-9854	106	3	to	to	PART
aiua-9854	106	4	be	be	AUX
aiua-9854	106	5	promising	promise	VERB
aiua-9854	106	6	but	but	CCONJ
aiua-9854	106	7	await	await	VERB
aiua-9854	106	8	prospective	prospective	ADJ
aiua-9854	106	9	studies	study	NOUN
aiua-9854	106	10	to	to	PART
aiua-9854	106	11	be	be	AUX
aiua-9854	106	12	fully	fully	ADV
aiua-9854	106	13	endorsed	endorse	VERB
aiua-9854	106	14	(	(	PUNCT
aiua-9854	106	15	1	1	NUM
aiua-9854	106	16	)	)	PUNCT
aiua-9854	106	17	.	.	PUNCT
aiua-9854	107	1	pca3	pca3	PROPN
aiua-9854	107	2	and	and	CCONJ
aiua-9854	107	3	tmprss2	tmprss2	ADV
aiua-9854	107	4	:	:	PUNCT
aiua-9854	107	5	erg	erg	PROPN
aiua-9854	107	6	may	may	AUX
aiua-9854	107	7	be	be	AUX
aiua-9854	107	8	able	able	ADJ
aiua-9854	107	9	to	to	PART
aiua-9854	107	10	assess	assess	VERB
aiua-9854	107	11	risk	risk	NOUN
aiua-9854	107	12	of	of	ADP
aiua-9854	107	13	aggressive	aggressive	ADJ
aiua-9854	107	14	disease	disease	NOUN
aiua-9854	107	15	yet	yet	ADV
aiua-9854	107	16	fail	fail	VERB
aiua-9854	107	17	to	to	PART
aiua-9854	107	18	reveal	reveal	VERB
aiua-9854	107	19	an	an	DET
aiua-9854	107	20	independent	independent	ADJ
aiua-9854	107	21	predictive	predictive	ADJ
aiua-9854	107	22	value	value	NOUN
aiua-9854	107	23	or	or	CCONJ
aiua-9854	107	24	benefit	benefit	VERB
aiua-9854	107	25	over	over	ADP
aiua-9854	107	26	psa	psa	NOUN
aiua-9854	107	27	(	(	PUNCT
aiua-9854	107	28	21	21	NUM
aiua-9854	107	29	)	)	PUNCT
aiua-9854	107	30	.	.	PUNCT
aiua-9854	108	1	4k	4k	NUM
aiua-9854	108	2	score	score	NOUN
aiua-9854	108	3	has	have	VERB
aiua-9854	108	4	a	a	DET
aiua-9854	108	5	significant	significant	ADJ
aiua-9854	108	6	association	association	NOUN
aiua-9854	108	7	with	with	ADP
aiua-9854	108	8	reclassification	reclassification	NOUN
aiua-9854	108	9	biopsy	biopsy	NOUN
aiua-9854	108	10	;	;	PUNCT
aiua-9854	108	11	however	however	ADV
aiua-9854	108	12	,	,	PUNCT
aiua-9854	108	13	it	it	PRON
aiua-9854	108	14	showed	show	VERB
aiua-9854	108	15	no	no	DET
aiua-9854	108	16	additional	additional	ADJ
aiua-9854	108	17	benefit	benefit	NOUN
aiua-9854	108	18	over	over	ADP
aiua-9854	108	19	psa	psa	NOUN
aiua-9854	108	20	in	in	ADP
aiua-9854	108	21	guiding	guide	VERB
aiua-9854	108	22	follow	follow	NOUN
aiua-9854	108	23	-	-	PUNCT
aiua-9854	108	24	up	up	NOUN
aiua-9854	108	25	biopsies	biopsy	NOUN
aiua-9854	108	26	in	in	ADV
aiua-9854	108	27	as	as	ADP
aiua-9854	108	28	(	(	PUNCT
aiua-9854	108	29	22	22	NUM
aiua-9854	108	30	)	)	PUNCT
aiua-9854	108	31	.	.	PUNCT
aiua-9854	109	1	genomic	genomic	ADJ
aiua-9854	109	2	markers	marker	NOUN
aiua-9854	109	3	include	include	VERB
aiua-9854	109	4	3	3	NUM
aiua-9854	109	5	genetic	genetic	ADJ
aiua-9854	109	6	tissue	tissue	NOUN
aiua-9854	109	7	assays	assay	NOUN
aiua-9854	109	8	that	that	PRON
aiua-9854	109	9	are	be	AUX
aiua-9854	109	10	currently	currently	ADV
aiua-9854	109	11	fda	fda	PROPN
aiua-9854	109	12	approved	approve	VERB
aiua-9854	109	13	.	.	PUNCT
aiua-9854	110	1	the	the	DET
aiua-9854	110	2	decifer	decifer	NOUN
aiua-9854	110	3	genomic	genomic	NOUN
aiua-9854	110	4	classifier	classifier	NOUN
aiua-9854	110	5	which	which	PRON
aiua-9854	110	6	consists	consist	VERB
aiua-9854	110	7	of	of	ADP
aiua-9854	110	8	22	22	NUM
aiua-9854	110	9	genes	gene	NOUN
aiua-9854	110	10	,	,	PUNCT
aiua-9854	110	11	gives	give	VERB
aiua-9854	110	12	a	a	DET
aiua-9854	110	13	score	score	NOUN
aiua-9854	110	14	0	0	NUM
aiua-9854	110	15	-	-	SYM
aiua-9854	110	16	1	1	NUM
aiua-9854	110	17	and	and	CCONJ
aiua-9854	110	18	classifies	classify	VERB
aiua-9854	110	19	patients	patient	NOUN
aiua-9854	110	20	into	into	ADP
aiua-9854	110	21	3	3	NUM
aiua-9854	110	22	risk	risk	NOUN
aiua-9854	110	23	groups	group	NOUN
aiua-9854	110	24	(	(	PUNCT
aiua-9854	110	25	23	23	NUM
aiua-9854	110	26	)	)	PUNCT
aiua-9854	110	27	.	.	PUNCT
aiua-9854	111	1	genomic	genomic	ADJ
aiua-9854	111	2	prostate	prostate	NOUN
aiua-9854	111	3	score	score	NOUN
aiua-9854	111	4	consists	consist	VERB
aiua-9854	111	5	of	of	ADP
aiua-9854	111	6	17	17	NUM
aiua-9854	111	7	genes	gene	NOUN
aiua-9854	111	8	and	and	CCONJ
aiua-9854	111	9	may	may	AUX
aiua-9854	111	10	potentially	potentially	ADV
aiua-9854	111	11	aid	aid	VERB
aiua-9854	111	12	the	the	DET
aiua-9854	111	13	initial	initial	ADJ
aiua-9854	111	14	decision	decision	NOUN
aiua-9854	111	15	for	for	ADP
aiua-9854	111	16	as	as	ADP
aiua-9854	111	17	enrollment	enrollment	NOUN
aiua-9854	111	18	(	(	PUNCT
aiua-9854	111	19	24	24	NUM
aiua-9854	111	20	)	)	PUNCT
aiua-9854	111	21	.	.	PUNCT
aiua-9854	112	1	cell	cell	NOUN
aiua-9854	112	2	cycle	cycle	NOUN
aiua-9854	112	3	progression	progression	NOUN
aiua-9854	112	4	test	test	NOUN
aiua-9854	112	5	may	may	AUX
aiua-9854	112	6	similarly	similarly	ADV
aiua-9854	112	7	aid	aid	VERB
aiua-9854	112	8	the	the	DET
aiua-9854	112	9	decision	decision	NOUN
aiua-9854	112	10	-	-	PUNCT
aiua-9854	112	11	making	make	VERB
aiua-9854	112	12	process	process	NOUN
aiua-9854	112	13	(	(	PUNCT
aiua-9854	112	14	25	25	NUM
aiua-9854	112	15	)	)	PUNCT
aiua-9854	112	16	.	.	PUNCT
aiua-9854	113	1	none	none	NOUN
aiua-9854	113	2	have	have	AUX
aiua-9854	113	3	been	be	AUX
aiua-9854	113	4	validated	validate	VERB
aiua-9854	113	5	for	for	ADP
aiua-9854	113	6	use	use	NOUN
aiua-9854	113	7	in	in	ADP
aiua-9854	113	8	as	as	SCONJ
aiua-9854	113	9	;	;	PUNCT
aiua-9854	113	10	however	however	ADV
aiua-9854	113	11	,	,	PUNCT
aiua-9854	113	12	they	they	PRON
aiua-9854	113	13	may	may	AUX
aiua-9854	113	14	be	be	AUX
aiua-9854	113	15	incorporated	incorporate	VERB
aiua-9854	113	16	in	in	ADP
aiua-9854	113	17	nomograms	nomogram	NOUN
aiua-9854	113	18	especially	especially	ADV
aiua-9854	113	19	in	in	ADP
aiua-9854	113	20	deciding	decide	VERB
aiua-9854	113	21	on	on	ADP
aiua-9854	113	22	as	as	ADP
aiua-9854	113	23	for	for	ADP
aiua-9854	113	24	intermediate	intermediate	ADJ
aiua-9854	113	25	risk	risk	NOUN
aiua-9854	113	26	patients	patient	NOUN
aiua-9854	113	27	(	(	PUNCT
aiua-9854	113	28	26	26	NUM
aiua-9854	113	29	)	)	PUNCT
aiua-9854	113	30	.	.	PUNCT
aiua-9854	114	1	patients	patient	NOUN
aiua-9854	114	2	with	with	ADP
aiua-9854	114	3	brca1/2	brca1/2	ADJ
aiua-9854	114	4	mutations	mutation	NOUN
aiua-9854	114	5	are	be	AUX
aiua-9854	114	6	not	not	PART
aiua-9854	114	7	recommended	recommend	VERB
aiua-9854	114	8	to	to	PART
aiua-9854	114	9	undergo	undergo	VERB
aiua-9854	114	10	active	active	ADJ
aiua-9854	114	11	surveillance	surveillance	NOUN
aiua-9854	114	12	.	.	PUNCT
aiua-9854	115	1	when	when	SCONJ
aiua-9854	115	2	present	present	ADJ
aiua-9854	115	3	,	,	PUNCT
aiua-9854	115	4	these	these	DET
aiua-9854	115	5	mutations	mutation	NOUN
aiua-9854	115	6	are	be	AUX
aiua-9854	115	7	associated	associate	VERB
aiua-9854	115	8	with	with	ADP
aiua-9854	115	9	increased	increase	VERB
aiua-9854	115	10	risk	risk	NOUN
aiua-9854	115	11	of	of	ADP
aiua-9854	115	12	nodal	nodal	NOUN
aiua-9854	115	13	and	and	CCONJ
aiua-9854	115	14	distant	distant	ADJ
aiua-9854	115	15	metastasis	metastasis	NOUN
aiua-9854	115	16	as	as	ADV
aiua-9854	115	17	well	well	ADV
aiua-9854	115	18	as	as	ADP
aiua-9854	115	19	poor	poor	ADJ
aiua-9854	115	20	survival	survival	NOUN
aiua-9854	115	21	outcomes	outcome	NOUN
aiua-9854	115	22	(	(	PUNCT
aiua-9854	115	23	27	27	NUM
aiua-9854	115	24	)	)	PUNCT
aiua-9854	115	25	.	.	PUNCT
aiua-9854	116	1	our	our	PRON
aiua-9854	116	2	as	as	SCONJ
aiua-9854	116	3	protocol	protocol	NOUN
aiua-9854	116	4	has	have	VERB
aiua-9854	116	5	some	some	DET
aiua-9854	116	6	limitations	limitation	NOUN
aiua-9854	116	7	.	.	PUNCT
aiua-9854	117	1	despite	despite	SCONJ
aiua-9854	117	2	an	an	DET
aiua-9854	117	3	agreed	agree	VERB
aiua-9854	117	4	upon	upon	SCONJ
aiua-9854	117	5	consensus	consensus	NOUN
aiua-9854	117	6	on	on	ADP
aiua-9854	117	7	the	the	DET
aiua-9854	117	8	active	active	ADJ
aiua-9854	117	9	surveillance	surveillance	NOUN
aiua-9854	117	10	protocol	protocol	NOUN
aiua-9854	117	11	,	,	PUNCT
aiua-9854	117	12	there	there	PRON
aiua-9854	117	13	was	be	VERB
aiua-9854	117	14	an	an	DET
aiua-9854	117	15	inter	inter	ADJ
aiua-9854	117	16	patient	patient	NOUN
aiua-9854	117	17	variability	variability	NOUN
aiua-9854	117	18	driven	drive	VERB
aiua-9854	117	19	by	by	ADP
aiua-9854	117	20	patient	patient	ADJ
aiua-9854	117	21	compliance	compliance	NOUN
aiua-9854	117	22	or	or	CCONJ
aiua-9854	117	23	financial	financial	ADJ
aiua-9854	117	24	/	/	SYM
aiua-9854	117	25	insurance	insurance	NOUN
aiua-9854	117	26	coverage	coverage	NOUN
aiua-9854	117	27	.	.	PUNCT
aiua-9854	118	1	in	in	ADP
aiua-9854	118	2	addition	addition	NOUN
aiua-9854	118	3	,	,	PUNCT
aiua-9854	118	4	treating	treat	VERB
aiua-9854	118	5	physicians	physician	NOUN
aiua-9854	118	6	in	in	ADP
aiua-9854	118	7	our	our	PRON
aiua-9854	118	8	region	region	NOUN
aiua-9854	118	9	are	be	AUX
aiua-9854	118	10	still	still	ADV
aiua-9854	118	11	reluctant	reluctant	ADJ
aiua-9854	118	12	to	to	PART
aiua-9854	118	13	initiate	initiate	VERB
aiua-9854	118	14	active	active	ADJ
aiua-9854	118	15	surveillance	surveillance	NOUN
aiua-9854	118	16	protocol	protocol	NOUN
aiua-9854	118	17	for	for	ADP
aiua-9854	118	18	various	various	ADJ
aiua-9854	118	19	reasons	reason	NOUN
aiua-9854	118	20	(	(	PUNCT
aiua-9854	118	21	28	28	NUM
aiua-9854	118	22	)	)	PUNCT
aiua-9854	118	23	.	.	PUNCT
aiua-9854	119	1	moreover	moreover	ADV
aiua-9854	119	2	,	,	PUNCT
aiua-9854	119	3	a	a	DET
aiua-9854	119	4	bigger	big	ADJ
aiua-9854	119	5	sample	sample	NOUN
aiua-9854	119	6	size	size	NOUN
aiua-9854	119	7	and	and	CCONJ
aiua-9854	119	8	longer	long	ADV
aiua-9854	119	9	follow	follow	VERB
aiua-9854	119	10	-	-	PUNCT
aiua-9854	119	11	up	up	ADP
aiua-9854	119	12	period	period	NOUN
aiua-9854	119	13	would	would	AUX
aiua-9854	119	14	further	far	ADV
aiua-9854	119	15	solidify	solidify	VERB
aiua-9854	119	16	our	our	PRON
aiua-9854	119	17	findings	finding	NOUN
aiua-9854	119	18	and	and	CCONJ
aiua-9854	119	19	improve	improve	VERB
aiua-9854	119	20	our	our	PRON
aiua-9854	119	21	understanding	understanding	NOUN
aiua-9854	119	22	of	of	ADP
aiua-9854	119	23	long	long	ADJ
aiua-9854	119	24	-	-	PUNCT
aiua-9854	119	25	term	term	NOUN
aiua-9854	119	26	patient	patient	ADJ
aiua-9854	119	27	outcomes	outcome	NOUN
aiua-9854	119	28	on	on	ADP
aiua-9854	119	29	active	active	ADJ
aiua-9854	119	30	surveillance	surveillance	NOUN
aiua-9854	119	31	(	(	PUNCT
aiua-9854	119	32	29	29	NUM
aiua-9854	119	33	,	,	PUNCT
aiua-9854	119	34	30	30	NUM
aiua-9854	119	35	)	)	PUNCT
aiua-9854	119	36	.	.	PUNCT
aiua-9854	120	1	conclusions	conclusion	NOUN
aiua-9854	120	2	in	in	ADP
aiua-9854	120	3	conclusion	conclusion	NOUN
aiua-9854	120	4	,	,	PUNCT
aiua-9854	120	5	active	active	ADJ
aiua-9854	120	6	surveillance	surveillance	NOUN
aiua-9854	120	7	is	be	AUX
aiua-9854	120	8	a	a	DET
aiua-9854	120	9	practical	practical	ADJ
aiua-9854	120	10	and	and	CCONJ
aiua-9854	120	11	appropriate	appropriate	ADJ
aiua-9854	120	12	clinical	clinical	ADJ
aiua-9854	120	13	strategy	strategy	NOUN
aiua-9854	120	14	that	that	PRON
aiua-9854	120	15	should	should	AUX
aiua-9854	120	16	be	be	AUX
aiua-9854	120	17	further	far	ADV
aiua-9854	120	18	employed	employ	VERB
aiua-9854	120	19	as	as	ADP
aiua-9854	120	20	part	part	NOUN
aiua-9854	120	21	of	of	ADP
aiua-9854	120	22	our	our	PRON
aiua-9854	120	23	patient	patient	NOUN
aiua-9854	120	24	care	care	NOUN
aiua-9854	120	25	arsenal	arsenal	NOUN
aiua-9854	120	26	.	.	PUNCT
aiua-9854	121	1	it	it	PRON
aiua-9854	121	2	is	be	AUX
aiua-9854	121	3	a	a	DET
aiua-9854	121	4	complex	complex	ADJ
aiua-9854	121	5	and	and	CCONJ
aiua-9854	121	6	demanding	demanding	ADJ
aiua-9854	121	7	process	process	NOUN
aiua-9854	121	8	for	for	ADP
aiua-9854	121	9	both	both	DET
aiua-9854	121	10	physician	physician	NOUN
aiua-9854	121	11	and	and	CCONJ
aiua-9854	121	12	patient	patient	NOUN
aiua-9854	121	13	alike	alike	ADV
aiua-9854	121	14	as	as	SCONJ
aiua-9854	121	15	it	it	PRON
aiua-9854	121	16	requires	require	VERB
aiua-9854	121	17	rigorous	rigorous	ADJ
aiua-9854	121	18	follow	follow	NOUN
aiua-9854	121	19	-	-	PUNCT
aiua-9854	121	20	up	up	NOUN
aiua-9854	121	21	with	with	ADP
aiua-9854	121	22	shrewd	shrewd	ADJ
aiua-9854	121	23	attention	attention	NOUN
aiua-9854	121	24	to	to	ADP
aiua-9854	121	25	multiple	multiple	ADJ
aiua-9854	121	26	combined	combine	VERB
aiua-9854	121	27	clinical	clinical	ADJ
aiua-9854	121	28	parameters	parameter	NOUN
aiua-9854	121	29	as	as	ADV
aiua-9854	121	30	well	well	ADV
aiua-9854	121	31	as	as	ADP
aiua-9854	121	32	patient	patient	ADJ
aiua-9854	121	33	commitment	commitment	NOUN
aiua-9854	121	34	and	and	CCONJ
aiua-9854	121	35	willingness	willingness	NOUN
aiua-9854	121	36	to	to	PART
aiua-9854	121	37	undergo	undergo	VERB
aiua-9854	121	38	periodic	periodic	ADJ
aiua-9854	121	39	assessments	assessment	NOUN
aiua-9854	121	40	.	.	PUNCT
aiua-9854	122	1	psa	psa	NOUN
aiua-9854	122	2	is	be	AUX
aiua-9854	122	3	an	an	DET
aiua-9854	122	4	essential	essential	ADJ
aiua-9854	122	5	clinical	clinical	ADJ
aiua-9854	122	6	marker	marker	NOUN
aiua-9854	122	7	for	for	ADP
aiua-9854	122	8	active	active	ADJ
aiua-9854	122	9	surveillance	surveillance	NOUN
aiua-9854	122	10	that	that	PRON
aiua-9854	122	11	may	may	AUX
aiua-9854	122	12	subtly	subtly	ADV
aiua-9854	122	13	guide	guide	VERB
aiua-9854	122	14	decision	decision	NOUN
aiua-9854	122	15	making	making	NOUN
aiua-9854	122	16	.	.	PUNCT
aiua-9854	123	1	archivio	archivio	NOUN
aiua-9854	123	2	italiano	italiano	PROPN
aiua-9854	123	3	di	di	X
aiua-9854	123	4	urologia	urologia	PROPN
aiua-9854	123	5	e	e	PROPN
aiua-9854	123	6	andrologia	andrologia	NOUN
aiua-9854	123	7	2021	2021	NUM
aiua-9854	123	8	;	;	PUNCT
aiua-9854	123	9	93	93	NUM
aiua-9854	123	10	,	,	PUNCT
aiua-9854	123	11	4	4	NUM
aiua-9854	123	12	m.	m.	NOUN
aiua-9854	123	13	hout	hout	PROPN
aiua-9854	123	14	,	,	PUNCT
aiua-9854	123	15	a.	a.	NOUN
aiua-9854	123	16	merhe	merhe	NOUN
aiua-9854	123	17	,	,	PUNCT
aiua-9854	123	18	n.	n.	PROPN
aiua-9854	123	19	abou	abou	PROPN
aiua-9854	123	20	heidar	heidar	PROPN
aiua-9854	123	21	,	,	PUNCT
aiua-9854	123	22	et	et	PROPN
aiua-9854	123	23	al	al	PROPN
aiua-9854	123	24	.	.	PROPN
aiua-9854	124	1	388	388	NUM
aiua-9854	124	2	mri	mri	NOUN
aiua-9854	124	3	is	be	AUX
aiua-9854	124	4	a	a	DET
aiua-9854	124	5	useful	useful	ADJ
aiua-9854	124	6	clinical	clinical	ADJ
aiua-9854	124	7	parameter	parameter	NOUN
aiua-9854	124	8	in	in	ADP
aiua-9854	124	9	as	as	SCONJ
aiua-9854	124	10	that	that	PRON
aiua-9854	124	11	may	may	AUX
aiua-9854	124	12	obviate	obviate	VERB
aiua-9854	124	13	need	need	NOUN
aiua-9854	124	14	for	for	ADP
aiua-9854	124	15	re	re	NOUN
aiua-9854	124	16	-	-	NOUN
aiua-9854	124	17	biopsy	biopsy	ADJ
aiua-9854	124	18	or	or	CCONJ
aiua-9854	124	19	even	even	ADV
aiua-9854	124	20	an	an	DET
aiua-9854	124	21	initial	initial	ADJ
aiua-9854	124	22	biopsy	biopsy	NOUN
aiua-9854	124	23	for	for	ADP
aiua-9854	124	24	prostate	prostate	NOUN
aiua-9854	124	25	cancer	cancer	NOUN
aiua-9854	124	26	.	.	PUNCT
aiua-9854	125	1	dre	dre	PROPN
aiua-9854	125	2	and	and	CCONJ
aiua-9854	125	3	biopsy	biopsy	NOUN
aiua-9854	125	4	are	be	AUX
aiua-9854	125	5	major	major	ADJ
aiua-9854	125	6	contributors	contributor	NOUN
aiua-9854	125	7	in	in	ADP
aiua-9854	125	8	halting	halt	VERB
aiua-9854	125	9	as	as	ADP
aiua-9854	125	10	and	and	CCONJ
aiua-9854	125	11	proceeding	proceed	VERB
aiua-9854	125	12	towards	towards	ADP
aiua-9854	125	13	an	an	DET
aiua-9854	125	14	intervention	intervention	NOUN
aiua-9854	125	15	especially	especially	ADV
aiua-9854	125	16	with	with	ADP
aiua-9854	125	17	evident	evident	ADJ
aiua-9854	125	18	disease	disease	NOUN
aiua-9854	125	19	progression	progression	NOUN
aiua-9854	125	20	either	either	CCONJ
aiua-9854	125	21	by	by	ADP
aiua-9854	125	22	an	an	DET
aiua-9854	125	23	upgraded	upgrade	VERB
aiua-9854	125	24	gleason	gleason	PROPN
aiua-9854	125	25	score	score	NOUN
aiua-9854	125	26	or	or	CCONJ
aiua-9854	125	27	an	an	DET
aiua-9854	125	28	upstaging	upstaging	ADJ
aiua-9854	125	29	upon	upon	SCONJ
aiua-9854	125	30	exam	exam	NOUN
aiua-9854	125	31	(	(	PUNCT
aiua-9854	125	32	ct3	ct3	PROPN
aiua-9854	125	33	)	)	PUNCT
aiua-9854	125	34	.	.	PUNCT
aiua-9854	126	1	references	reference	NOUN
aiua-9854	126	2	1	1	NUM
aiua-9854	126	3	.	.	PUNCT
aiua-9854	126	4	briganti	briganti	PROPN
aiua-9854	126	5	a	a	NOUN
aiua-9854	126	6	,	,	PUNCT
aiua-9854	126	7	fossati	fossati	NOUN
aiua-9854	126	8	n	n	CCONJ
aiua-9854	126	9	,	,	PUNCT
aiua-9854	126	10	catto	catto	NOUN
aiua-9854	126	11	jwf	jwf	PROPN
aiua-9854	126	12	,	,	PUNCT
aiua-9854	126	13	et	et	PROPN
aiua-9854	126	14	al	al	PROPN
aiua-9854	126	15	.	.	PUNCT
aiua-9854	127	1	active	active	ADJ
aiua-9854	127	2	surveillance	surveillance	NOUN
aiua-9854	127	3	for	for	ADP
aiua-9854	127	4	lowrisk	lowrisk	NOUN
aiua-9854	127	5	prostate	prostate	NOUN
aiua-9854	127	6	cancer	cancer	NOUN
aiua-9854	127	7	:	:	PUNCT
aiua-9854	127	8	the	the	DET
aiua-9854	127	9	european	european	PROPN
aiua-9854	127	10	association	association	PROPN
aiua-9854	127	11	of	of	ADP
aiua-9854	127	12	urology	urology	NOUN
aiua-9854	127	13	position	position	NOUN
aiua-9854	127	14	in	in	ADP
aiua-9854	127	15	2018	2018	NUM
aiua-9854	127	16	.	.	PUNCT
aiua-9854	128	1	eur	eur	PROPN
aiua-9854	128	2	urol	urol	PROPN
aiua-9854	128	3	.	.	PUNCT
aiua-9854	128	4	2018	2018	NUM
aiua-9854	128	5	;	;	PUNCT
aiua-9854	128	6	74:357	74:357	NUM
aiua-9854	128	7	-	-	SYM
aiua-9854	128	8	68	68	NUM
aiua-9854	128	9	.	.	NOUN
aiua-9854	129	1	2	2	NUM
aiua-9854	129	2	.	.	X
aiua-9854	129	3	popiolek	popiolek	PROPN
aiua-9854	129	4	m	m	PROPN
aiua-9854	129	5	,	,	PUNCT
aiua-9854	129	6	rider	rider	PROPN
aiua-9854	129	7	jr	jr	PROPN
aiua-9854	129	8	,	,	PUNCT
aiua-9854	129	9	andren	andren	PROPN
aiua-9854	129	10	o	o	NOUN
aiua-9854	129	11	,	,	PUNCT
aiua-9854	129	12	et	et	PROPN
aiua-9854	129	13	al	al	PROPN
aiua-9854	129	14	.	.	PROPN
aiua-9854	129	15	natural	natural	ADJ
aiua-9854	129	16	history	history	NOUN
aiua-9854	129	17	of	of	ADP
aiua-9854	129	18	early	early	ADJ
aiua-9854	129	19	,	,	PUNCT
aiua-9854	129	20	localized	localized	ADJ
aiua-9854	129	21	prostate	prostate	NOUN
aiua-9854	129	22	cancer	cancer	NOUN
aiua-9854	129	23	:	:	PUNCT
aiua-9854	129	24	a	a	DET
aiua-9854	129	25	final	final	ADJ
aiua-9854	129	26	report	report	NOUN
aiua-9854	129	27	from	from	ADP
aiua-9854	129	28	three	three	NUM
aiua-9854	129	29	decades	decade	NOUN
aiua-9854	129	30	of	of	ADP
aiua-9854	129	31	follow	follow	NOUN
aiua-9854	129	32	-	-	PUNCT
aiua-9854	129	33	up	up	NOUN
aiua-9854	129	34	.	.	PUNCT
aiua-9854	130	1	eur	eur	PROPN
aiua-9854	130	2	urol	urol	PROPN
aiua-9854	130	3	.	.	PUNCT
aiua-9854	131	1	2013	2013	NUM
aiua-9854	131	2	;	;	PUNCT
aiua-9854	131	3	63:428	63:428	NUM
aiua-9854	131	4	-	-	SYM
aiua-9854	131	5	35	35	NUM
aiua-9854	131	6	.	.	PUNCT
aiua-9854	132	1	3	3	X
aiua-9854	132	2	.	.	X
aiua-9854	132	3	albertsen	albertsen	PROPN
aiua-9854	132	4	pc	pc	PROPN
aiua-9854	132	5	,	,	PUNCT
aiua-9854	132	6	hanley	hanley	PROPN
aiua-9854	132	7	ja	ja	PROPN
aiua-9854	132	8	,	,	PUNCT
aiua-9854	132	9	fine	fine	ADJ
aiua-9854	132	10	j.	j.	PROPN
aiua-9854	132	11	20	20	NUM
aiua-9854	132	12	-	-	PUNCT
aiua-9854	132	13	year	year	NOUN
aiua-9854	132	14	outcomes	outcome	NOUN
aiua-9854	132	15	following	follow	VERB
aiua-9854	132	16	conservative	conservative	ADJ
aiua-9854	132	17	management	management	NOUN
aiua-9854	132	18	of	of	ADP
aiua-9854	132	19	clinically	clinically	ADV
aiua-9854	132	20	localized	localize	VERB
aiua-9854	132	21	prostate	prostate	NOUN
aiua-9854	132	22	cancer	cancer	NOUN
aiua-9854	132	23	.	.	PUNCT
aiua-9854	133	1	jama	jama	PROPN
aiua-9854	133	2	.	.	PUNCT
aiua-9854	134	1	2005	2005	NUM
aiua-9854	134	2	;	;	PUNCT
aiua-9854	134	3	293:2095	293:2095	NUM
aiua-9854	134	4	-	-	SYM
aiua-9854	134	5	101	101	NUM
aiua-9854	134	6	.	.	NOUN
aiua-9854	135	1	4	4	X
aiua-9854	135	2	.	.	X
aiua-9854	135	3	johansson	johansson	PROPN
aiua-9854	135	4	e	e	PROPN
aiua-9854	135	5	,	,	PUNCT
aiua-9854	135	6	steineck	steineck	VERB
aiua-9854	135	7	g	g	PROPN
aiua-9854	135	8	,	,	PUNCT
aiua-9854	135	9	holmberg	holmberg	PROPN
aiua-9854	135	10	l	l	PROPN
aiua-9854	135	11	,	,	PUNCT
aiua-9854	135	12	et	et	PROPN
aiua-9854	135	13	al	al	PROPN
aiua-9854	135	14	.	.	PUNCT
aiua-9854	136	1	long	long	ADJ
aiua-9854	136	2	-	-	PUNCT
aiua-9854	136	3	term	term	NOUN
aiua-9854	136	4	quality	quality	NOUN
aiua-9854	136	5	-	-	PUNCT
aiua-9854	136	6	of	of	ADP
aiua-9854	136	7	-	-	PUNCT
aiua-9854	136	8	life	life	NOUN
aiua-9854	136	9	outcomes	outcome	NOUN
aiua-9854	136	10	after	after	ADP
aiua-9854	136	11	radical	radical	ADJ
aiua-9854	136	12	prostatectomy	prostatectomy	NOUN
aiua-9854	136	13	or	or	CCONJ
aiua-9854	136	14	watchful	watchful	ADJ
aiua-9854	136	15	waiting	waiting	NOUN
aiua-9854	136	16	:	:	PUNCT
aiua-9854	136	17	the	the	DET
aiua-9854	136	18	scandinavian	scandinavian	ADJ
aiua-9854	136	19	prostate	prostate	NOUN
aiua-9854	136	20	cancer	cancer	NOUN
aiua-9854	136	21	group-4	group-4	NOUN
aiua-9854	136	22	randomised	randomise	VERB
aiua-9854	136	23	trial	trial	NOUN
aiua-9854	136	24	.	.	PUNCT
aiua-9854	137	1	the	the	DET
aiua-9854	137	2	lancet	lancet	PROPN
aiua-9854	137	3	oncology	oncology	NOUN
aiua-9854	137	4	.	.	PUNCT
aiua-9854	138	1	2011	2011	NUM
aiua-9854	138	2	;	;	PUNCT
aiua-9854	138	3	12:891	12:891	NUM
aiua-9854	138	4	-	-	SYM
aiua-9854	138	5	9	9	NUM
aiua-9854	138	6	.	.	NOUN
aiua-9854	138	7	5	5	NUM
aiua-9854	138	8	.	.	X
aiua-9854	138	9	grossman	grossman	PROPN
aiua-9854	138	10	dc	dc	PROPN
aiua-9854	138	11	,	,	PUNCT
aiua-9854	138	12	curry	curry	PROPN
aiua-9854	138	13	sj	sj	PROPN
aiua-9854	138	14	,	,	PUNCT
aiua-9854	138	15	owens	owens	PROPN
aiua-9854	139	1	dk	dk	PROPN
aiua-9854	139	2	,	,	PUNCT
aiua-9854	139	3	et	et	PROPN
aiua-9854	139	4	al	al	PROPN
aiua-9854	139	5	.	.	PUNCT
aiua-9854	139	6	screening	screen	VERB
aiua-9854	139	7	for	for	ADP
aiua-9854	139	8	prostate	prostate	NOUN
aiua-9854	139	9	cancer	cancer	NOUN
aiua-9854	139	10	:	:	PUNCT
aiua-9854	139	11	us	us	PROPN
aiua-9854	139	12	preventive	preventive	ADJ
aiua-9854	139	13	services	service	NOUN
aiua-9854	139	14	task	task	PROPN
aiua-9854	139	15	force	force	PROPN
aiua-9854	139	16	recommendation	recommendation	NOUN
aiua-9854	139	17	statement	statement	NOUN
aiua-9854	139	18	.	.	PUNCT
aiua-9854	140	1	jama	jama	PROPN
aiua-9854	140	2	.	.	PUNCT
aiua-9854	141	1	2018	2018	NUM
aiua-9854	141	2	;	;	PUNCT
aiua-9854	141	3	319:1901	319:1901	NUM
aiua-9854	141	4	-	-	SYM
aiua-9854	141	5	13	13	NUM
aiua-9854	141	6	.	.	NOUN
aiua-9854	142	1	6	6	NUM
aiua-9854	142	2	.	.	X
aiua-9854	142	3	hamdy	hamdy	PROPN
aiua-9854	142	4	fc	fc	PROPN
aiua-9854	142	5	,	,	PUNCT
aiua-9854	142	6	donovan	donovan	PROPN
aiua-9854	142	7	jl	jl	PROPN
aiua-9854	142	8	,	,	PUNCT
aiua-9854	142	9	lane	lane	PROPN
aiua-9854	142	10	ja	ja	PROPN
aiua-9854	142	11	,	,	PUNCT
aiua-9854	142	12	et	et	PROPN
aiua-9854	142	13	al	al	PROPN
aiua-9854	142	14	.	.	PROPN
aiua-9854	143	1	10	10	NUM
aiua-9854	143	2	-	-	PUNCT
aiua-9854	143	3	year	year	NOUN
aiua-9854	143	4	outcomes	outcome	NOUN
aiua-9854	143	5	after	after	ADP
aiua-9854	143	6	monitoring	monitoring	NOUN
aiua-9854	143	7	,	,	PUNCT
aiua-9854	143	8	surgery	surgery	NOUN
aiua-9854	143	9	,	,	PUNCT
aiua-9854	143	10	or	or	CCONJ
aiua-9854	143	11	radiotherapy	radiotherapy	NOUN
aiua-9854	143	12	for	for	ADP
aiua-9854	143	13	localized	localized	ADJ
aiua-9854	143	14	prostate	prostate	NOUN
aiua-9854	143	15	cancer	cancer	NOUN
aiua-9854	143	16	.	.	PUNCT
aiua-9854	144	1	new	new	ADJ
aiua-9854	144	2	engl	engl	PROPN
aiua-9854	144	3	j	j	PROPN
aiua-9854	144	4	med	med	PROPN
aiua-9854	144	5	2016	2016	NUM
aiua-9854	144	6	;	;	PUNCT
aiua-9854	144	7	375:1415	375:1415	NUM
aiua-9854	144	8	-	-	SYM
aiua-9854	144	9	24	24	NUM
aiua-9854	144	10	.	.	PUNCT
aiua-9854	145	1	7	7	X
aiua-9854	145	2	.	.	X
aiua-9854	145	3	klotz	klotz	PROPN
aiua-9854	145	4	l.	l.	PROPN
aiua-9854	145	5	active	active	ADJ
aiua-9854	145	6	surveillance	surveillance	NOUN
aiua-9854	145	7	in	in	ADP
aiua-9854	145	8	intermediate	intermediate	ADJ
aiua-9854	145	9	-	-	PUNCT
aiua-9854	145	10	risk	risk	NOUN
aiua-9854	145	11	prostate	prostate	NOUN
aiua-9854	145	12	cancer	cancer	NOUN
aiua-9854	145	13	.	.	PUNCT
aiua-9854	146	1	bju	bju	NOUN
aiua-9854	146	2	int	int	PROPN
aiua-9854	146	3	.	.	PUNCT
aiua-9854	147	1	2020	2020	NUM
aiua-9854	147	2	;	;	PUNCT
aiua-9854	147	3	125:346	125:346	NUM
aiua-9854	147	4	-	-	SYM
aiua-9854	147	5	54	54	NUM
aiua-9854	147	6	.	.	PUNCT
aiua-9854	148	1	8	8	NUM
aiua-9854	148	2	.	.	PUNCT
aiua-9854	148	3	klotz	klotz	PROPN
aiua-9854	148	4	l	l	PROPN
aiua-9854	148	5	,	,	PUNCT
aiua-9854	148	6	vesprini	vesprini	PROPN
aiua-9854	148	7	d	d	PROPN
aiua-9854	148	8	,	,	PUNCT
aiua-9854	148	9	sethukavalan	sethukavalan	PROPN
aiua-9854	148	10	p	p	X
aiua-9854	148	11	,	,	PUNCT
aiua-9854	148	12	et	et	PROPN
aiua-9854	148	13	al	al	PROPN
aiua-9854	148	14	.	.	PUNCT
aiua-9854	149	1	long	long	ADJ
aiua-9854	149	2	-	-	PUNCT
aiua-9854	149	3	term	term	NOUN
aiua-9854	149	4	follow	follow	NOUN
aiua-9854	149	5	-	-	PUNCT
aiua-9854	149	6	up	up	NOUN
aiua-9854	149	7	of	of	ADP
aiua-9854	149	8	a	a	DET
aiua-9854	149	9	large	large	ADJ
aiua-9854	149	10	active	active	ADJ
aiua-9854	149	11	surveillance	surveillance	NOUN
aiua-9854	149	12	cohort	cohort	NOUN
aiua-9854	149	13	of	of	ADP
aiua-9854	149	14	patients	patient	NOUN
aiua-9854	149	15	with	with	ADP
aiua-9854	149	16	prostate	prostate	NOUN
aiua-9854	149	17	cancer	cancer	NOUN
aiua-9854	149	18	.	.	PUNCT
aiua-9854	150	1	j	j	PROPN
aiua-9854	150	2	clin	clin	PROPN
aiua-9854	150	3	oncol	oncol	PROPN
aiua-9854	150	4	.	.	PUNCT
aiua-9854	151	1	2015	2015	NUM
aiua-9854	151	2	;	;	PUNCT
aiua-9854	151	3	33:272	33:272	NUM
aiua-9854	151	4	-	-	SYM
aiua-9854	151	5	7	7	NUM
aiua-9854	151	6	.	.	NOUN
aiua-9854	151	7	9	9	NUM
aiua-9854	151	8	.	.	X
aiua-9854	152	1	carroll	carroll	PROPN
aiua-9854	152	2	pr	pr	PROPN
aiua-9854	152	3	,	,	PUNCT
aiua-9854	152	4	parsons	parsons	PROPN
aiua-9854	152	5	jk	jk	PROPN
aiua-9854	152	6	,	,	PUNCT
aiua-9854	152	7	andriole	andriole	PROPN
aiua-9854	152	8	g	g	PROPN
aiua-9854	152	9	,	,	PUNCT
aiua-9854	152	10	et	et	PROPN
aiua-9854	152	11	al	al	PROPN
aiua-9854	152	12	.	.	PROPN
aiua-9854	153	1	nccn	nccn	PROPN
aiua-9854	153	2	guidelines	guideline	NOUN
aiua-9854	153	3	insights	insight	NOUN
aiua-9854	153	4	:	:	PUNCT
aiua-9854	153	5	prostate	prostate	NOUN
aiua-9854	153	6	cancer	cancer	NOUN
aiua-9854	153	7	early	early	ADJ
aiua-9854	153	8	detection	detection	NOUN
aiua-9854	153	9	,	,	PUNCT
aiua-9854	153	10	version	version	NOUN
aiua-9854	153	11	2.2016	2.2016	NUM
aiua-9854	153	12	.	.	PUNCT
aiua-9854	154	1	jnccn	jnccn	PROPN
aiua-9854	154	2	.	.	PUNCT
aiua-9854	155	1	2016	2016	NUM
aiua-9854	155	2	;	;	PUNCT
aiua-9854	155	3	14:50919	14:50919	NUM
aiua-9854	155	4	.	.	PUNCT
aiua-9854	156	1	10	10	NUM
aiua-9854	156	2	.	.	PUNCT
aiua-9854	157	1	welty	welty	PROPN
aiua-9854	157	2	cj	cj	PROPN
aiua-9854	157	3	,	,	PUNCT
aiua-9854	157	4	cowan	cowan	PROPN
aiua-9854	157	5	je	je	PROPN
aiua-9854	157	6	,	,	PUNCT
aiua-9854	157	7	nguyen	nguyen	PROPN
aiua-9854	157	8	h	h	PROPN
aiua-9854	157	9	,	,	PUNCT
aiua-9854	157	10	et	et	PROPN
aiua-9854	157	11	al	al	PROPN
aiua-9854	157	12	.	.	PROPN
aiua-9854	157	13	extended	extend	VERB
aiua-9854	157	14	followup	followup	NOUN
aiua-9854	157	15	and	and	CCONJ
aiua-9854	157	16	risk	risk	NOUN
aiua-9854	157	17	factors	factor	NOUN
aiua-9854	157	18	for	for	ADP
aiua-9854	157	19	disease	disease	NOUN
aiua-9854	157	20	reclassification	reclassification	NOUN
aiua-9854	157	21	in	in	ADP
aiua-9854	157	22	a	a	DET
aiua-9854	157	23	large	large	ADJ
aiua-9854	157	24	active	active	ADJ
aiua-9854	157	25	surveillance	surveillance	NOUN
aiua-9854	157	26	cohort	cohort	NOUN
aiua-9854	157	27	for	for	ADP
aiua-9854	157	28	localized	localized	ADJ
aiua-9854	157	29	prostate	prostate	NOUN
aiua-9854	157	30	cancer	cancer	NOUN
aiua-9854	157	31	.	.	PUNCT
aiua-9854	158	1	j	j	PROPN
aiua-9854	158	2	urol	urol	PROPN
aiua-9854	158	3	2015	2015	NUM
aiua-9854	158	4	;	;	PUNCT
aiua-9854	158	5	193:807	193:807	NOUN
aiua-9854	158	6	-	-	SYM
aiua-9854	158	7	11	11	NUM
aiua-9854	158	8	.	.	PUNCT
aiua-9854	158	9	11	11	NUM
aiua-9854	158	10	.	.	PUNCT
aiua-9854	159	1	garisto	garisto	PROPN
aiua-9854	159	2	jd	jd	PROPN
aiua-9854	159	3	,	,	PUNCT
aiua-9854	159	4	klotz	klotz	PROPN
aiua-9854	159	5	l.	l.	PROPN
aiua-9854	159	6	active	active	ADJ
aiua-9854	159	7	surveillance	surveillance	NOUN
aiua-9854	159	8	for	for	ADP
aiua-9854	159	9	prostate	prostate	NOUN
aiua-9854	159	10	cancer	cancer	NOUN
aiua-9854	159	11	:	:	PUNCT
aiua-9854	159	12	how	how	SCONJ
aiua-9854	159	13	to	to	PART
aiua-9854	159	14	do	do	AUX
aiua-9854	159	15	it	it	PRON
aiua-9854	159	16	ight	ight	ADJ
aiua-9854	159	17	.	.	PUNCT
aiua-9854	160	1	oncology	oncology	NOUN
aiua-9854	160	2	(	(	PUNCT
aiua-9854	160	3	williston	williston	PROPN
aiua-9854	160	4	park	park	PROPN
aiua-9854	160	5	)	)	PUNCT
aiua-9854	160	6	2017	2017	NUM
aiua-9854	160	7	;	;	PUNCT
aiua-9854	160	8	31:333	31:333	NUM
aiua-9854	160	9	-	-	SYM
aiua-9854	160	10	40	40	NUM
aiua-9854	160	11	.	.	PUNCT
aiua-9854	160	12	12	12	NUM
aiua-9854	160	13	.	.	PUNCT
aiua-9854	161	1	gosselaar	gosselaar	NOUN
aiua-9854	161	2	c	c	PROPN
aiua-9854	161	3	,	,	PUNCT
aiua-9854	161	4	roobol	roobol	PROPN
aiua-9854	161	5	mj	mj	PROPN
aiua-9854	161	6	,	,	PUNCT
aiua-9854	161	7	roemeling	roemele	VERB
aiua-9854	161	8	s	s	PROPN
aiua-9854	161	9	,	,	PUNCT
aiua-9854	161	10	schroder	schroder	PROPN
aiua-9854	161	11	fh	fh	PROPN
aiua-9854	161	12	.	.	PUNCT
aiua-9854	162	1	the	the	DET
aiua-9854	162	2	role	role	NOUN
aiua-9854	162	3	of	of	ADP
aiua-9854	162	4	the	the	DET
aiua-9854	162	5	digital	digital	ADJ
aiua-9854	162	6	rectal	rectal	ADJ
aiua-9854	162	7	examination	examination	NOUN
aiua-9854	162	8	in	in	ADP
aiua-9854	162	9	subsequent	subsequent	ADJ
aiua-9854	162	10	screening	screening	NOUN
aiua-9854	162	11	visits	visit	NOUN
aiua-9854	162	12	in	in	ADP
aiua-9854	162	13	the	the	DET
aiua-9854	162	14	european	european	ADJ
aiua-9854	162	15	randomized	randomized	ADJ
aiua-9854	162	16	study	study	NOUN
aiua-9854	162	17	of	of	ADP
aiua-9854	162	18	screening	screen	VERB
aiua-9854	162	19	for	for	ADP
aiua-9854	162	20	prostate	prostate	NOUN
aiua-9854	162	21	cancer	cancer	NOUN
aiua-9854	162	22	(	(	PUNCT
aiua-9854	162	23	erspc	erspc	PROPN
aiua-9854	162	24	)	)	PUNCT
aiua-9854	162	25	,	,	PUNCT
aiua-9854	162	26	rotterdam	rotterdam	PROPN
aiua-9854	162	27	.	.	PUNCT
aiua-9854	163	1	eur	eur	PROPN
aiua-9854	163	2	urol	urol	PROPN
aiua-9854	163	3	.	.	PUNCT
aiua-9854	163	4	2008	2008	NUM
aiua-9854	163	5	;	;	PUNCT
aiua-9854	163	6	54:581	54:581	NUM
aiua-9854	163	7	-	-	SYM
aiua-9854	163	8	8	8	NUM
aiua-9854	163	9	.	.	NOUN
aiua-9854	163	10	13	13	NUM
aiua-9854	163	11	.	.	PUNCT
aiua-9854	164	1	bokhorst	bokhorst	PROPN
aiua-9854	164	2	lp	lp	NOUN
aiua-9854	164	3	,	,	PUNCT
aiua-9854	164	4	lepisto	lepisto	PROPN
aiua-9854	164	5	i	i	PROPN
aiua-9854	164	6	,	,	PUNCT
aiua-9854	164	7	kakehi	kakehi	PROPN
aiua-9854	164	8	y	y	PROPN
aiua-9854	164	9	,	,	PUNCT
aiua-9854	164	10	et	et	PROPN
aiua-9854	164	11	al	al	PROPN
aiua-9854	164	12	.	.	PUNCT
aiua-9854	165	1	complications	complication	NOUN
aiua-9854	165	2	after	after	ADP
aiua-9854	165	3	prostate	prostate	NOUN
aiua-9854	165	4	biopsies	biopsy	NOUN
aiua-9854	165	5	in	in	ADP
aiua-9854	165	6	men	man	NOUN
aiua-9854	165	7	on	on	ADP
aiua-9854	165	8	active	active	ADJ
aiua-9854	165	9	surveillance	surveillance	NOUN
aiua-9854	165	10	and	and	CCONJ
aiua-9854	165	11	its	its	PRON
aiua-9854	165	12	effects	effect	NOUN
aiua-9854	165	13	on	on	ADP
aiua-9854	165	14	receiving	receive	VERB
aiua-9854	165	15	further	further	ADJ
aiua-9854	165	16	biopsies	biopsy	NOUN
aiua-9854	165	17	in	in	ADP
aiua-9854	165	18	the	the	DET
aiua-9854	165	19	prostate	prostate	NOUN
aiua-9854	165	20	cancer	cancer	NOUN
aiua-9854	165	21	research	research	PROPN
aiua-9854	165	22	international	international	ADJ
aiua-9854	165	23	:	:	PUNCT
aiua-9854	165	24	active	active	ADJ
aiua-9854	165	25	surveillance	surveillance	NOUN
aiua-9854	165	26	(	(	PUNCT
aiua-9854	165	27	prias	prias	PROPN
aiua-9854	165	28	)	)	PUNCT
aiua-9854	165	29	study	study	NOUN
aiua-9854	165	30	.	.	PUNCT
aiua-9854	166	1	bju	bju	NOUN
aiua-9854	166	2	int	int	PROPN
aiua-9854	166	3	.	.	PUNCT
aiua-9854	167	1	2016	2016	NUM
aiua-9854	167	2	;	;	PUNCT
aiua-9854	167	3	118:366	118:366	NUM
aiua-9854	167	4	-	-	SYM
aiua-9854	167	5	71	71	NUM
aiua-9854	167	6	.	.	PUNCT
aiua-9854	168	1	14	14	NUM
aiua-9854	168	2	.	.	PUNCT
aiua-9854	169	1	ploussard	ploussard	PROPN
aiua-9854	169	2	g	g	PROPN
aiua-9854	169	3	,	,	PUNCT
aiua-9854	169	4	salomon	salomon	PROPN
aiua-9854	169	5	l	l	PROPN
aiua-9854	169	6	,	,	PUNCT
aiua-9854	169	7	xylinas	xylinas	PROPN
aiua-9854	169	8	e	e	NOUN
aiua-9854	169	9	,	,	PUNCT
aiua-9854	169	10	et	et	PROPN
aiua-9854	169	11	al	al	PROPN
aiua-9854	169	12	.	.	PUNCT
aiua-9854	170	1	pathological	pathological	ADJ
aiua-9854	170	2	findings	finding	NOUN
aiua-9854	170	3	and	and	CCONJ
aiua-9854	170	4	prostate	prostate	NOUN
aiua-9854	170	5	specific	specific	ADJ
aiua-9854	170	6	antigen	antigen	ADJ
aiua-9854	170	7	outcomes	outcome	NOUN
aiua-9854	170	8	after	after	ADP
aiua-9854	170	9	radical	radical	ADJ
aiua-9854	170	10	prostatectomy	prostatectomy	NOUN
aiua-9854	170	11	in	in	ADP
aiua-9854	170	12	men	man	NOUN
aiua-9854	170	13	eligible	eligible	ADJ
aiua-9854	170	14	for	for	ADP
aiua-9854	170	15	active	active	ADJ
aiua-9854	170	16	surveillance	surveillance	NOUN
aiua-9854	170	17	--	--	PUNCT
aiua-9854	170	18	does	do	AUX
aiua-9854	170	19	the	the	DET
aiua-9854	170	20	risk	risk	NOUN
aiua-9854	170	21	of	of	ADP
aiua-9854	170	22	misclassification	misclassification	NOUN
aiua-9854	170	23	vary	vary	VERB
aiua-9854	170	24	according	accord	VERB
aiua-9854	170	25	to	to	ADP
aiua-9854	170	26	biopsy	biopsy	NOUN
aiua-9854	170	27	criteria	criterion	NOUN
aiua-9854	170	28	?	?	PUNCT
aiua-9854	171	1	j	j	PROPN
aiua-9854	171	2	urol	urol	PROPN
aiua-9854	171	3	.	.	PUNCT
aiua-9854	172	1	2010	2010	NUM
aiua-9854	172	2	;	;	PUNCT
aiua-9854	172	3	183:539	183:539	NUM
aiua-9854	172	4	-	-	SYM
aiua-9854	172	5	44	44	NUM
aiua-9854	172	6	.	.	PUNCT
aiua-9854	172	7	15	15	NUM
aiua-9854	172	8	.	.	X
aiua-9854	173	1	berglund	berglund	PROPN
aiua-9854	173	2	rk	rk	PROPN
aiua-9854	173	3	,	,	PUNCT
aiua-9854	173	4	masterson	masterson	PROPN
aiua-9854	173	5	ta	ta	PROPN
aiua-9854	173	6	,	,	PUNCT
aiua-9854	173	7	vora	vora	PROPN
aiua-9854	173	8	kc	kc	PROPN
aiua-9854	173	9	,	,	PUNCT
aiua-9854	173	10	et	et	PROPN
aiua-9854	173	11	al	al	PROPN
aiua-9854	173	12	.	.	PROPN
aiua-9854	174	1	pathological	pathological	ADJ
aiua-9854	174	2	upgrading	upgrading	NOUN
aiua-9854	174	3	and	and	CCONJ
aiua-9854	174	4	up	up	ADP
aiua-9854	174	5	staging	stage	VERB
aiua-9854	174	6	with	with	ADP
aiua-9854	174	7	immediate	immediate	ADJ
aiua-9854	174	8	repeat	repeat	NOUN
aiua-9854	174	9	biopsy	biopsy	NOUN
aiua-9854	174	10	in	in	ADP
aiua-9854	174	11	patients	patient	NOUN
aiua-9854	174	12	eligible	eligible	ADJ
aiua-9854	174	13	for	for	ADP
aiua-9854	174	14	active	active	ADJ
aiua-9854	174	15	surveillance	surveillance	NOUN
aiua-9854	174	16	.	.	PUNCT
aiua-9854	175	1	j	j	PROPN
aiua-9854	175	2	urol	urol	PROPN
aiua-9854	175	3	2008	2008	NUM
aiua-9854	175	4	;	;	PUNCT
aiua-9854	175	5	180:1964	180:1964	NUM
aiua-9854	175	6	-	-	SYM
aiua-9854	175	7	7	7	NUM
aiua-9854	175	8	.	.	NOUN
aiua-9854	175	9	16	16	NUM
aiua-9854	175	10	.	.	PUNCT
aiua-9854	176	1	de	de	PROPN
aiua-9854	176	2	rooij	rooij	PROPN
aiua-9854	176	3	m	m	PROPN
aiua-9854	176	4	,	,	PUNCT
aiua-9854	176	5	hamoen	hamoen	PROPN
aiua-9854	176	6	eh	eh	INTJ
aiua-9854	176	7	,	,	PUNCT
aiua-9854	176	8	futterer	futterer	PROPN
aiua-9854	176	9	jj	jj	PROPN
aiua-9854	176	10	,	,	PUNCT
aiua-9854	176	11	et	et	PROPN
aiua-9854	176	12	al	al	PROPN
aiua-9854	176	13	.	.	PROPN
aiua-9854	176	14	accuracy	accuracy	NOUN
aiua-9854	176	15	of	of	ADP
aiua-9854	176	16	multiparametric	multiparametric	ADJ
aiua-9854	176	17	mri	mri	NOUN
aiua-9854	176	18	for	for	ADP
aiua-9854	176	19	prostate	prostate	NOUN
aiua-9854	176	20	cancer	cancer	NOUN
aiua-9854	176	21	detection	detection	NOUN
aiua-9854	176	22	:	:	PUNCT
aiua-9854	176	23	a	a	DET
aiua-9854	176	24	meta	meta	ADJ
aiua-9854	176	25	-	-	PUNCT
aiua-9854	176	26	analysis	analysis	NOUN
aiua-9854	176	27	.	.	PUNCT
aiua-9854	177	1	ajr	ajr	PROPN
aiua-9854	177	2	2014	2014	NUM
aiua-9854	177	3	;	;	PUNCT
aiua-9854	177	4	202:343	202:343	PROPN
aiua-9854	177	5	-	-	SYM
aiua-9854	177	6	51	51	NUM
aiua-9854	177	7	.	.	PUNCT
aiua-9854	177	8	17	17	NUM
aiua-9854	177	9	.	.	PUNCT
aiua-9854	178	1	gaziev	gaziev	NOUN
aiua-9854	178	2	g	g	NOUN
aiua-9854	178	3	,	,	PUNCT
aiua-9854	178	4	wadhwa	wadhwa	PROPN
aiua-9854	178	5	k	k	PROPN
aiua-9854	178	6	,	,	PUNCT
aiua-9854	178	7	barrett	barrett	PROPN
aiua-9854	178	8	t	t	PROPN
aiua-9854	178	9	,	,	PUNCT
aiua-9854	178	10	et	et	PROPN
aiua-9854	178	11	al	al	PROPN
aiua-9854	178	12	.	.	PUNCT
aiua-9854	179	1	defining	define	VERB
aiua-9854	179	2	the	the	DET
aiua-9854	179	3	learning	learning	NOUN
aiua-9854	179	4	curve	curve	NOUN
aiua-9854	179	5	for	for	ADP
aiua-9854	179	6	multiparametric	multiparametric	ADJ
aiua-9854	179	7	magnetic	magnetic	ADJ
aiua-9854	179	8	resonance	resonance	NOUN
aiua-9854	179	9	imaging	imaging	NOUN
aiua-9854	179	10	(	(	PUNCT
aiua-9854	179	11	mri	mri	NOUN
aiua-9854	179	12	)	)	PUNCT
aiua-9854	179	13	of	of	ADP
aiua-9854	179	14	the	the	DET
aiua-9854	179	15	prostate	prostate	NOUN
aiua-9854	179	16	using	use	VERB
aiua-9854	179	17	mri	mri	NOUN
aiua-9854	179	18	-	-	PUNCT
aiua-9854	179	19	transrectal	transrectal	ADJ
aiua-9854	179	20	ultrasonography	ultrasonography	NOUN
aiua-9854	179	21	(	(	PUNCT
aiua-9854	179	22	trus	trus	NOUN
aiua-9854	179	23	)	)	PUNCT
aiua-9854	179	24	fusion	fusion	NOUN
aiua-9854	179	25	-	-	PUNCT
aiua-9854	179	26	guided	guide	VERB
aiua-9854	179	27	transperineal	transperineal	NOUN
aiua-9854	179	28	prostate	prostate	NOUN
aiua-9854	179	29	biopsies	biopsy	NOUN
aiua-9854	179	30	as	as	ADP
aiua-9854	179	31	a	a	DET
aiua-9854	179	32	validation	validation	NOUN
aiua-9854	179	33	tool	tool	NOUN
aiua-9854	179	34	.	.	PUNCT
aiua-9854	180	1	bju	bju	NOUN
aiua-9854	180	2	int	int	PROPN
aiua-9854	180	3	.	.	PUNCT
aiua-9854	181	1	2016	2016	NUM
aiua-9854	181	2	;	;	PUNCT
aiua-9854	181	3	117:80	117:80	NUM
aiua-9854	181	4	-	-	SYM
aiua-9854	181	5	6	6	NUM
aiua-9854	181	6	.	.	NOUN
aiua-9854	181	7	18	18	NUM
aiua-9854	181	8	.	.	PUNCT
aiua-9854	182	1	barentsz	barentsz	PROPN
aiua-9854	182	2	jo	jo	PROPN
aiua-9854	182	3	,	,	PUNCT
aiua-9854	182	4	richenberg	richenberg	PROPN
aiua-9854	182	5	j	j	PROPN
aiua-9854	182	6	,	,	PUNCT
aiua-9854	182	7	clements	clements	PROPN
aiua-9854	182	8	r	r	PROPN
aiua-9854	182	9	,	,	PUNCT
aiua-9854	182	10	et	et	PROPN
aiua-9854	182	11	al	al	PROPN
aiua-9854	182	12	.	.	PROPN
aiua-9854	182	13	esur	esur	PROPN
aiua-9854	182	14	prostate	prostate	NOUN
aiua-9854	182	15	mr	mr	PROPN
aiua-9854	182	16	guidelines	guideline	NOUN
aiua-9854	182	17	2012	2012	NUM
aiua-9854	182	18	.	.	PUNCT
aiua-9854	183	1	eur	eur	NOUN
aiua-9854	183	2	radiol	radiol	NOUN
aiua-9854	183	3	.	.	PUNCT
aiua-9854	184	1	2012	2012	NUM
aiua-9854	184	2	;	;	PUNCT
aiua-9854	184	3	22:746	22:746	NUM
aiua-9854	184	4	-	-	SYM
aiua-9854	184	5	57	57	NUM
aiua-9854	184	6	.	.	PUNCT
aiua-9854	185	1	19	19	NUM
aiua-9854	185	2	.	.	PUNCT
aiua-9854	185	3	dianat	dianat	PROPN
aiua-9854	185	4	ss	ss	PROPN
aiua-9854	185	5	,	,	PUNCT
aiua-9854	185	6	carter	carter	PROPN
aiua-9854	185	7	hb	hb	PROPN
aiua-9854	185	8	,	,	PUNCT
aiua-9854	185	9	pienta	pienta	NOUN
aiua-9854	185	10	kj	kj	PROPN
aiua-9854	185	11	,	,	PUNCT
aiua-9854	185	12	et	et	PROPN
aiua-9854	185	13	al	al	PROPN
aiua-9854	185	14	.	.	PROPN
aiua-9854	185	15	magnetic	magnetic	ADJ
aiua-9854	185	16	resonance	resonance	NOUN
aiua-9854	185	17	-	-	PUNCT
aiua-9854	185	18	invisible	invisible	ADJ
aiua-9854	185	19	versus	versus	ADP
aiua-9854	185	20	magnetic	magnetic	ADJ
aiua-9854	185	21	resonance	resonance	NOUN
aiua-9854	185	22	-	-	PUNCT
aiua-9854	185	23	visible	visible	ADJ
aiua-9854	185	24	prostate	prostate	NOUN
aiua-9854	185	25	cancer	cancer	NOUN
aiua-9854	185	26	in	in	ADP
aiua-9854	185	27	active	active	ADJ
aiua-9854	185	28	surveillance	surveillance	NOUN
aiua-9854	185	29	:	:	PUNCT
aiua-9854	185	30	a	a	DET
aiua-9854	185	31	preliminary	preliminary	ADJ
aiua-9854	185	32	report	report	NOUN
aiua-9854	185	33	on	on	ADP
aiua-9854	185	34	disease	disease	NOUN
aiua-9854	185	35	outcomes	outcome	NOUN
aiua-9854	185	36	.	.	PUNCT
aiua-9854	186	1	urology	urology	NOUN
aiua-9854	186	2	.	.	PUNCT
aiua-9854	187	1	2015	2015	NUM
aiua-9854	187	2	;	;	PUNCT
aiua-9854	187	3	85:147	85:147	NUM
aiua-9854	187	4	-	-	SYM
aiua-9854	187	5	53	53	NUM
aiua-9854	187	6	.	.	NOUN
aiua-9854	187	7	20	20	NUM
aiua-9854	187	8	.	.	PUNCT
aiua-9854	187	9	schoots	schoot	VERB
aiua-9854	187	10	ig	ig	PROPN
aiua-9854	187	11	,	,	PUNCT
aiua-9854	187	12	petrides	petride	NOUN
aiua-9854	187	13	n	n	CCONJ
aiua-9854	187	14	,	,	PUNCT
aiua-9854	187	15	giganti	giganti	VERB
aiua-9854	187	16	f	f	X
aiua-9854	187	17	,	,	PUNCT
aiua-9854	188	1	et	et	PROPN
aiua-9854	188	2	al	al	PROPN
aiua-9854	188	3	.	.	PUNCT
aiua-9854	188	4	magnetic	magnetic	ADJ
aiua-9854	188	5	resonance	resonance	NOUN
aiua-9854	188	6	imaging	imaging	NOUN
aiua-9854	188	7	in	in	ADP
aiua-9854	188	8	active	active	ADJ
aiua-9854	188	9	surveillance	surveillance	NOUN
aiua-9854	188	10	of	of	ADP
aiua-9854	188	11	prostate	prostate	NOUN
aiua-9854	188	12	cancer	cancer	NOUN
aiua-9854	188	13	:	:	PUNCT
aiua-9854	188	14	a	a	DET
aiua-9854	188	15	systematic	systematic	ADJ
aiua-9854	188	16	review	review	NOUN
aiua-9854	188	17	.	.	PUNCT
aiua-9854	189	1	eur	eur	PROPN
aiua-9854	189	2	urol	urol	PROPN
aiua-9854	189	3	.	.	PUNCT
aiua-9854	190	1	2015	2015	NUM
aiua-9854	190	2	;	;	PUNCT
aiua-9854	190	3	67:627	67:627	NUM
aiua-9854	190	4	-	-	SYM
aiua-9854	190	5	36	36	NUM
aiua-9854	190	6	.	.	PUNCT
aiua-9854	191	1	21	21	NUM
aiua-9854	191	2	.	.	PUNCT
aiua-9854	192	1	lin	lin	PROPN
aiua-9854	192	2	dw	dw	PROPN
aiua-9854	192	3	,	,	PUNCT
aiua-9854	192	4	newcomb	newcomb	PROPN
aiua-9854	192	5	lf	lf	PROPN
aiua-9854	192	6	,	,	PUNCT
aiua-9854	192	7	brown	brown	PROPN
aiua-9854	192	8	ec	ec	PROPN
aiua-9854	192	9	,	,	PUNCT
aiua-9854	192	10	et	et	PROPN
aiua-9854	192	11	al	al	PROPN
aiua-9854	192	12	.	.	PUNCT
aiua-9854	192	13	urinary	urinary	PROPN
aiua-9854	192	14	tmprss2	tmprss2	PROPN
aiua-9854	192	15	:	:	PUNCT
aiua-9854	192	16	erg	erg	PROPN
aiua-9854	192	17	and	and	CCONJ
aiua-9854	192	18	pca3	pca3	PROPN
aiua-9854	192	19	in	in	ADP
aiua-9854	192	20	an	an	DET
aiua-9854	192	21	active	active	ADJ
aiua-9854	192	22	surveillance	surveillance	NOUN
aiua-9854	192	23	cohort	cohort	NOUN
aiua-9854	192	24	:	:	PUNCT
aiua-9854	192	25	results	result	VERB
aiua-9854	192	26	from	from	ADP
aiua-9854	192	27	a	a	DET
aiua-9854	192	28	baseline	baseline	ADJ
aiua-9854	192	29	analysis	analysis	NOUN
aiua-9854	192	30	in	in	ADP
aiua-9854	192	31	the	the	DET
aiua-9854	192	32	canary	canary	ADJ
aiua-9854	192	33	prostate	prostate	NOUN
aiua-9854	192	34	active	active	ADJ
aiua-9854	192	35	surveillance	surveillance	NOUN
aiua-9854	192	36	study	study	NOUN
aiua-9854	192	37	.	.	PUNCT
aiua-9854	193	1	clin	clin	PROPN
aiua-9854	193	2	cancer	cancer	NOUN
aiua-9854	193	3	res	re	NOUN
aiua-9854	193	4	2013	2013	NUM
aiua-9854	193	5	;	;	PUNCT
aiua-9854	193	6	19:2442	19:2442	NUM
aiua-9854	193	7	-	-	SYM
aiua-9854	193	8	50	50	NUM
aiua-9854	193	9	.	.	PUNCT
aiua-9854	194	1	22	22	NUM
aiua-9854	194	2	.	.	PUNCT
aiua-9854	195	1	lin	lin	PROPN
aiua-9854	195	2	dw	dw	PROPN
aiua-9854	195	3	,	,	PUNCT
aiua-9854	195	4	newcomb	newcomb	PROPN
aiua-9854	195	5	lf	lf	PROPN
aiua-9854	195	6	,	,	PUNCT
aiua-9854	195	7	brown	brown	PROPN
aiua-9854	195	8	md	md	PROPN
aiua-9854	195	9	,	,	PUNCT
aiua-9854	195	10	et	et	PROPN
aiua-9854	195	11	al	al	PROPN
aiua-9854	195	12	.	.	PUNCT
aiua-9854	195	13	evaluating	evaluate	VERB
aiua-9854	195	14	the	the	DET
aiua-9854	195	15	four	four	NUM
aiua-9854	195	16	kallikrein	kallikrein	ADJ
aiua-9854	195	17	panel	panel	NOUN
aiua-9854	195	18	of	of	ADP
aiua-9854	195	19	the	the	DET
aiua-9854	195	20	4kscore	4kscore	PROPN
aiua-9854	195	21	for	for	ADP
aiua-9854	195	22	prediction	prediction	NOUN
aiua-9854	195	23	of	of	ADP
aiua-9854	195	24	high	high	ADJ
aiua-9854	195	25	-	-	PUNCT
aiua-9854	195	26	grade	grade	NOUN
aiua-9854	195	27	prostate	prostate	NOUN
aiua-9854	195	28	cancer	cancer	NOUN
aiua-9854	195	29	in	in	ADP
aiua-9854	195	30	men	man	NOUN
aiua-9854	195	31	in	in	ADP
aiua-9854	195	32	the	the	DET
aiua-9854	195	33	canary	canary	ADJ
aiua-9854	195	34	prostate	prostate	NOUN
aiua-9854	195	35	active	active	ADJ
aiua-9854	195	36	surveillance	surveillance	NOUN
aiua-9854	195	37	study	study	NOUN
aiua-9854	195	38	.	.	PUNCT
aiua-9854	196	1	eur	eur	PROPN
aiua-9854	196	2	urol	urol	PROPN
aiua-9854	196	3	.	.	PROPN
aiua-9854	196	4	2017	2017	NUM
aiua-9854	196	5	;	;	PUNCT
aiua-9854	196	6	72:448	72:448	NUM
aiua-9854	196	7	-	-	SYM
aiua-9854	196	8	54	54	NUM
aiua-9854	196	9	.	.	PUNCT
aiua-9854	197	1	23	23	NUM
aiua-9854	197	2	.	.	PUNCT
aiua-9854	198	1	klein	klein	PROPN
aiua-9854	198	2	ea	ea	PROPN
aiua-9854	198	3	,	,	PUNCT
aiua-9854	198	4	haddad	haddad	PROPN
aiua-9854	198	5	z	z	PROPN
aiua-9854	198	6	,	,	PUNCT
aiua-9854	198	7	yousefi	yousefi	PROPN
aiua-9854	198	8	k	k	PROPN
aiua-9854	198	9	,	,	PUNCT
aiua-9854	198	10	et	et	PROPN
aiua-9854	198	11	al	al	PROPN
aiua-9854	198	12	.	.	PUNCT
aiua-9854	199	1	decipher	decipher	PROPN
aiua-9854	199	2	genomic	genomic	NOUN
aiua-9854	199	3	classifier	classifier	NOUN
aiua-9854	199	4	measured	measure	VERB
aiua-9854	199	5	on	on	ADP
aiua-9854	199	6	prostate	prostate	NOUN
aiua-9854	199	7	biopsy	biopsy	NOUN
aiua-9854	199	8	predicts	predict	VERB
aiua-9854	199	9	metastasis	metastasis	NOUN
aiua-9854	199	10	risk	risk	NOUN
aiua-9854	199	11	.	.	PUNCT
aiua-9854	200	1	urology	urology	NOUN
aiua-9854	200	2	.	.	PUNCT
aiua-9854	201	1	2016	2016	NUM
aiua-9854	201	2	;	;	PUNCT
aiua-9854	201	3	90:148	90:148	NUM
aiua-9854	201	4	-	-	PUNCT
aiua-9854	201	5	52	52	NUM
aiua-9854	201	6	.	.	PUNCT
aiua-9854	202	1	24	24	NUM
aiua-9854	202	2	.	.	PUNCT
aiua-9854	203	1	klein	klein	PROPN
aiua-9854	203	2	ea	ea	PROPN
aiua-9854	203	3	,	,	PUNCT
aiua-9854	203	4	cooperberg	cooperberg	PROPN
aiua-9854	203	5	mr	mr	PROPN
aiua-9854	203	6	,	,	PUNCT
aiua-9854	203	7	magi	magi	NOUN
aiua-9854	203	8	-	-	PUNCT
aiua-9854	203	9	galluzzi	galluzzi	NOUN
aiua-9854	203	10	c	c	NOUN
aiua-9854	203	11	,	,	PUNCT
aiua-9854	203	12	et	et	PROPN
aiua-9854	203	13	al	al	PROPN
aiua-9854	203	14	.	.	PUNCT
aiua-9854	204	1	a	a	DET
aiua-9854	204	2	17	17	NUM
aiua-9854	204	3	-	-	PUNCT
aiua-9854	204	4	gene	gene	NOUN
aiua-9854	204	5	assay	assay	NOUN
aiua-9854	204	6	to	to	PART
aiua-9854	204	7	predict	predict	VERB
aiua-9854	204	8	prostate	prostate	NOUN
aiua-9854	204	9	cancer	cancer	NOUN
aiua-9854	204	10	aggressiveness	aggressiveness	NOUN
aiua-9854	204	11	in	in	ADP
aiua-9854	204	12	the	the	DET
aiua-9854	204	13	context	context	NOUN
aiua-9854	204	14	of	of	ADP
aiua-9854	204	15	gleason	gleason	PROPN
aiua-9854	204	16	grade	grade	PROPN
aiua-9854	204	17	heterogeneity	heterogeneity	NOUN
aiua-9854	204	18	,	,	PUNCT
aiua-9854	204	19	tumor	tumor	NOUN
aiua-9854	204	20	multifocality	multifocality	NOUN
aiua-9854	204	21	,	,	PUNCT
aiua-9854	204	22	and	and	CCONJ
aiua-9854	204	23	biopsy	biopsy	NOUN
aiua-9854	204	24	undersampling	undersampling	ADJ
aiua-9854	204	25	.	.	PUNCT
aiua-9854	205	1	eur	eur	PROPN
aiua-9854	205	2	urol	urol	PROPN
aiua-9854	205	3	.	.	PUNCT
aiua-9854	205	4	2014	2014	NUM
aiua-9854	205	5	;	;	PUNCT
aiua-9854	205	6	66:550	66:550	NUM
aiua-9854	205	7	-	-	SYM
aiua-9854	205	8	60	60	NUM
aiua-9854	205	9	.	.	PUNCT
aiua-9854	206	1	25	25	NUM
aiua-9854	206	2	.	.	X
aiua-9854	207	1	shore	shore	PROPN
aiua-9854	207	2	nd	nd	SYM
aiua-9854	207	3	,	,	PUNCT
aiua-9854	207	4	kella	kella	PROPN
aiua-9854	207	5	n	n	PROPN
aiua-9854	207	6	,	,	PUNCT
aiua-9854	207	7	moran	moran	PROPN
aiua-9854	207	8	b	b	PROPN
aiua-9854	207	9	,	,	PUNCT
aiua-9854	207	10	et	et	PROPN
aiua-9854	207	11	al	al	PROPN
aiua-9854	207	12	.	.	PROPN
aiua-9854	207	13	impact	impact	NOUN
aiua-9854	207	14	of	of	ADP
aiua-9854	207	15	the	the	DET
aiua-9854	207	16	cell	cell	NOUN
aiua-9854	207	17	cycle	cycle	NOUN
aiua-9854	207	18	progression	progression	NOUN
aiua-9854	207	19	test	test	NOUN
aiua-9854	207	20	on	on	ADP
aiua-9854	207	21	physician	physician	NOUN
aiua-9854	207	22	and	and	CCONJ
aiua-9854	207	23	patient	patient	ADJ
aiua-9854	207	24	treatment	treatment	NOUN
aiua-9854	207	25	selection	selection	NOUN
aiua-9854	207	26	for	for	ADP
aiua-9854	207	27	localized	localized	ADJ
aiua-9854	207	28	prostate	prostate	NOUN
aiua-9854	207	29	cancer	cancer	NOUN
aiua-9854	207	30	.	.	PUNCT
aiua-9854	208	1	j	j	PROPN
aiua-9854	208	2	urol	urol	PROPN
aiua-9854	208	3	.	.	PROPN
aiua-9854	209	1	2016	2016	NUM
aiua-9854	209	2	;	;	PUNCT
aiua-9854	209	3	195:612	195:612	NUM
aiua-9854	209	4	-	-	SYM
aiua-9854	209	5	8	8	NUM
aiua-9854	209	6	.	.	NOUN
aiua-9854	210	1	26	26	NUM
aiua-9854	210	2	.	.	PUNCT
aiua-9854	211	1	wang	wang	PROPN
aiua-9854	211	2	sy	sy	PROPN
aiua-9854	211	3	,	,	PUNCT
aiua-9854	211	4	cowan	cowan	PROPN
aiua-9854	211	5	je	je	PROPN
aiua-9854	211	6	,	,	PUNCT
aiua-9854	211	7	cary	cary	PROPN
aiua-9854	211	8	kc	kc	PROPN
aiua-9854	211	9	,	,	PUNCT
aiua-9854	211	10	et	et	PROPN
aiua-9854	211	11	al	al	PROPN
aiua-9854	211	12	.	.	PROPN
aiua-9854	211	13	limited	limited	ADJ
aiua-9854	211	14	ability	ability	NOUN
aiua-9854	211	15	of	of	ADP
aiua-9854	211	16	existing	exist	VERB
aiua-9854	211	17	nomograms	nomogram	NOUN
aiua-9854	211	18	to	to	PART
aiua-9854	211	19	predict	predict	VERB
aiua-9854	211	20	outcomes	outcome	NOUN
aiua-9854	211	21	in	in	ADP
aiua-9854	211	22	men	man	NOUN
aiua-9854	211	23	undergoing	undergo	VERB
aiua-9854	211	24	active	active	ADJ
aiua-9854	211	25	surveillance	surveillance	NOUN
aiua-9854	211	26	for	for	ADP
aiua-9854	211	27	prostate	prostate	NOUN
aiua-9854	211	28	cancer	cancer	NOUN
aiua-9854	211	29	.	.	PUNCT
aiua-9854	212	1	bju	bju	NOUN
aiua-9854	212	2	int	int	PROPN
aiua-9854	212	3	.	.	PUNCT
aiua-9854	213	1	2014	2014	NUM
aiua-9854	213	2	;	;	PUNCT
aiua-9854	213	3	114	114	NUM
aiua-9854	213	4	:	:	PUNCT
aiua-9854	213	5	e18	e18	PROPN
aiua-9854	213	6	-	-	PUNCT
aiua-9854	213	7	e24	e24	NOUN
aiua-9854	213	8	.	.	PROPN
aiua-9854	213	9	27	27	NUM
aiua-9854	213	10	.	.	X
aiua-9854	214	1	castro	castro	PROPN
aiua-9854	214	2	e	e	PROPN
aiua-9854	214	3	,	,	PUNCT
aiua-9854	214	4	goh	goh	PROPN
aiua-9854	214	5	c	c	PROPN
aiua-9854	214	6	,	,	PUNCT
aiua-9854	214	7	olmos	olmos	PROPN
aiua-9854	214	8	d	d	PROPN
aiua-9854	214	9	,	,	PUNCT
aiua-9854	214	10	et	et	PROPN
aiua-9854	214	11	al	al	PROPN
aiua-9854	214	12	.	.	PROPN
aiua-9854	214	13	germline	germline	PROPN
aiua-9854	214	14	brca	brca	PROPN
aiua-9854	214	15	mutations	mutation	NOUN
aiua-9854	214	16	are	be	AUX
aiua-9854	214	17	associated	associate	VERB
aiua-9854	214	18	with	with	ADP
aiua-9854	214	19	higher	high	ADJ
aiua-9854	214	20	risk	risk	NOUN
aiua-9854	214	21	of	of	ADP
aiua-9854	214	22	nodal	nodal	NOUN
aiua-9854	214	23	involvement	involvement	NOUN
aiua-9854	214	24	,	,	PUNCT
aiua-9854	214	25	distant	distant	ADJ
aiua-9854	214	26	metastasis	metastasis	NOUN
aiua-9854	214	27	,	,	PUNCT
aiua-9854	214	28	and	and	CCONJ
aiua-9854	214	29	poor	poor	ADJ
aiua-9854	214	30	survival	survival	NOUN
aiua-9854	214	31	outcomes	outcome	NOUN
aiua-9854	214	32	in	in	ADP
aiua-9854	214	33	prostate	prostate	NOUN
aiua-9854	214	34	cancer	cancer	NOUN
aiua-9854	214	35	.	.	PUNCT
aiua-9854	215	1	j	j	PROPN
aiua-9854	215	2	clin	clin	PROPN
aiua-9854	215	3	oncol	oncol	PROPN
aiua-9854	215	4	.	.	PUNCT
aiua-9854	216	1	2013	2013	NUM
aiua-9854	216	2	;	;	PUNCT
aiua-9854	216	3	31:1748	31:1748	NUM
aiua-9854	216	4	-	-	SYM
aiua-9854	216	5	57	57	NUM
aiua-9854	216	6	.	.	PUNCT
aiua-9854	217	1	28	28	NUM
aiua-9854	217	2	.	.	PUNCT
aiua-9854	218	1	el	el	PROPN
aiua-9854	218	2	sebaaly	sebaaly	PROPN
aiua-9854	218	3	r	r	PROPN
aiua-9854	218	4	,	,	PUNCT
aiua-9854	218	5	mansour	mansour	PROPN
aiua-9854	218	6	m	m	PROPN
aiua-9854	218	7	,	,	PUNCT
aiua-9854	218	8	labban	labban	PROPN
aiua-9854	218	9	m	m	PROPN
aiua-9854	218	10	,	,	PUNCT
aiua-9854	218	11	et	et	PROPN
aiua-9854	218	12	al	al	PROPN
aiua-9854	218	13	.	.	PROPN
aiua-9854	218	14	survey	survey	NOUN
aiua-9854	218	15	on	on	ADP
aiua-9854	218	16	the	the	DET
aiua-9854	218	17	practice	practice	NOUN
aiua-9854	218	18	of	of	ADP
aiua-9854	218	19	active	active	ADJ
aiua-9854	218	20	surveillance	surveillance	NOUN
aiua-9854	218	21	for	for	ADP
aiua-9854	218	22	prostate	prostate	NOUN
aiua-9854	218	23	cancer	cancer	NOUN
aiua-9854	218	24	from	from	ADP
aiua-9854	218	25	the	the	DET
aiua-9854	218	26	middle	middle	PROPN
aiua-9854	218	27	east	east	PROPN
aiua-9854	218	28	.	.	PUNCT
aiua-9854	219	1	prostate	prostate	NOUN
aiua-9854	219	2	int	int	PROPN
aiua-9854	219	3	.	.	PUNCT
aiua-9854	220	1	2020	2020	NUM
aiua-9854	220	2	;	;	PUNCT
aiua-9854	220	3	8:41	8:41	NUM
aiua-9854	220	4	-	-	SYM
aiua-9854	220	5	8	8	NUM
aiua-9854	220	6	.	.	NOUN
aiua-9854	220	7	29	29	NUM
aiua-9854	220	8	.	.	PUNCT
aiua-9854	221	1	tosoian	tosoian	PROPN
aiua-9854	221	2	jj	jj	PROPN
aiua-9854	221	3	,	,	PUNCT
aiua-9854	221	4	mamawala	mamawala	PROPN
aiua-9854	221	5	m	m	PROPN
aiua-9854	221	6	,	,	PUNCT
aiua-9854	221	7	epstein	epstein	PROPN
aiua-9854	221	8	ji	ji	PROPN
aiua-9854	221	9	,	,	PUNCT
aiua-9854	221	10	et	et	PROPN
aiua-9854	221	11	al	al	PROPN
aiua-9854	221	12	.	.	PROPN
aiua-9854	221	13	intermediate	intermediate	ADJ
aiua-9854	221	14	and	and	CCONJ
aiua-9854	221	15	longerterm	longerterm	NOUN
aiua-9854	221	16	outcomes	outcome	NOUN
aiua-9854	221	17	from	from	ADP
aiua-9854	221	18	a	a	DET
aiua-9854	221	19	prospective	prospective	ADJ
aiua-9854	221	20	active	active	ADJ
aiua-9854	221	21	-	-	PUNCT
aiua-9854	221	22	surveillance	surveillance	NOUN
aiua-9854	221	23	program	program	NOUN
aiua-9854	221	24	for	for	ADP
aiua-9854	221	25	favorable	favorable	ADJ
aiua-9854	221	26	-	-	PUNCT
aiua-9854	221	27	risk	risk	NOUN
aiua-9854	221	28	prostate	prostate	NOUN
aiua-9854	221	29	cancer	cancer	NOUN
aiua-9854	221	30	.	.	PUNCT
aiua-9854	222	1	j	j	PROPN
aiua-9854	222	2	clin	clin	PROPN
aiua-9854	222	3	oncol	oncol	PROPN
aiua-9854	222	4	.	.	PUNCT
aiua-9854	223	1	2015	2015	NUM
aiua-9854	223	2	;	;	PUNCT
aiua-9854	223	3	33:3379	33:3379	NUM
aiua-9854	223	4	-	-	SYM
aiua-9854	223	5	85	85	NUM
aiua-9854	223	6	.	.	PUNCT
aiua-9854	223	7	30	30	NUM
aiua-9854	223	8	.	.	PUNCT
aiua-9854	224	1	newcomb	newcomb	PROPN
aiua-9854	224	2	lf	lf	PROPN
aiua-9854	224	3	,	,	PUNCT
aiua-9854	224	4	thompson	thompson	PROPN
aiua-9854	224	5	i	i	PROPN
aiua-9854	224	6	m	m	PROPN
aiua-9854	224	7	,	,	PUNCT
aiua-9854	224	8	jr	jr	PROPN
aiua-9854	224	9	.	.	PROPN
aiua-9854	224	10	,	,	PUNCT
aiua-9854	224	11	boyer	boyer	PROPN
aiua-9854	224	12	hd	hd	PROPN
aiua-9854	224	13	,	,	PUNCT
aiua-9854	224	14	et	et	PROPN
aiua-9854	224	15	al	al	PROPN
aiua-9854	224	16	.	.	PUNCT
aiua-9854	225	1	outcomes	outcome	NOUN
aiua-9854	225	2	of	of	ADP
aiua-9854	225	3	active	active	ADJ
aiua-9854	225	4	surveillance	surveillance	NOUN
aiua-9854	225	5	for	for	ADP
aiua-9854	225	6	clinically	clinically	ADV
aiua-9854	225	7	localized	localize	VERB
aiua-9854	225	8	prostate	prostate	NOUN
aiua-9854	225	9	cancer	cancer	NOUN
aiua-9854	225	10	in	in	ADP
aiua-9854	225	11	the	the	DET
aiua-9854	225	12	prospective	prospective	ADJ
aiua-9854	225	13	,	,	PUNCT
aiua-9854	225	14	multi	multi	ADJ
aiua-9854	225	15	-	-	ADJ
aiua-9854	225	16	institutional	institutional	ADJ
aiua-9854	225	17	canary	canary	NOUN
aiua-9854	225	18	pass	pass	NOUN
aiua-9854	225	19	cohort	cohort	NOUN
aiua-9854	225	20	.	.	PUNCT
aiua-9854	226	1	j	j	PROPN
aiua-9854	226	2	urol	urol	PROPN
aiua-9854	226	3	.	.	PROPN
aiua-9854	226	4	2016	2016	NUM
aiua-9854	226	5	;	;	PUNCT
aiua-9854	226	6	195:313	195:313	NUM
aiua-9854	226	7	-	-	SYM
aiua-9854	226	8	20	20	NUM
aiua-9854	226	9	.	.	PUNCT
aiua-9854	227	1	correspondence	correspondence	NOUN
aiua-9854	227	2	mohammad	mohammad	PROPN
aiua-9854	227	3	hout	hout	PROPN
aiua-9854	227	4	,	,	PUNCT
aiua-9854	227	5	md	md	PROPN
aiua-9854	227	6	mh21@aub.edu.lb	mh21@aub.edu.lb	PROPN
aiua-9854	227	7	ali	ali	PROPN
aiua-9854	227	8	merhe	merhe	PROPN
aiua-9854	227	9	,	,	PUNCT
aiua-9854	227	10	md	md	PROPN
aiua-9854	227	11	am134@aub.edu.lb	am134@aub.edu.lb	PROPN
aiua-9854	227	12	nassib	nassib	NOUN
aiua-9854	227	13	fares	fare	NOUN
aiua-9854	227	14	heidar	heidar	PROPN
aiua-9854	227	15	,	,	PUNCT
aiua-9854	227	16	md	md	PROPN
aiua-9854	227	17	na192@aub.edu.lb	na192@aub.edu.lb	PROPN
aiua-9854	228	1	jose	jose	PROPN
aiua-9854	228	2	m	m	PROPN
aiua-9854	228	3	el	el	PROPN
aiua-9854	228	4	-	-	PUNCT
aiua-9854	228	5	asmar	asmar	PROPN
aiua-9854	228	6	,	,	PUNCT
aiua-9854	228	7	md	md	PROPN
aiua-9854	228	8	je56@aub.edu.lb	je56@aub.edu.lb	PROPN
aiua-9854	228	9	wassim	wassim	PROPN
aiua-9854	228	10	wazzan	wazzan	PROPN
aiua-9854	228	11	,	,	PUNCT
aiua-9854	228	12	md	md	PROPN
aiua-9854	228	13	ww04@aub.edu.lb	ww04@aub.edu.lb	PROPN
aiua-9854	228	14	bassel	bassel	NOUN
aiua-9854	228	15	bachir	bachir	VERB
aiua-9854	228	16	,	,	PUNCT
aiua-9854	228	17	md	md	PROPN
aiua-9854	228	18	bb12@aub.edu.lb	bb12@aub.edu.lb	PROPN
aiua-9854	228	19	albert	albert	PROPN
aiua-9854	228	20	el	el	PROPN
aiua-9854	228	21	-	-	PROPN
aiua-9854	228	22	hajj	hajj	PROPN
aiua-9854	228	23	,	,	PUNCT
aiua-9854	228	24	md	md	PROPN
aiua-9854	228	25	ae67@aub.edu.lb	ae67@aub.edu.lb	PROPN
aiua-9854	228	26	muhammad	muhammad	PROPN
aiua-9854	228	27	bulbul	bulbul	PROPN
aiua-9854	228	28	,	,	PUNCT
aiua-9854	228	29	md	md	PROPN
aiua-9854	228	30	,	,	PUNCT
aiua-9854	228	31	clinical	clinical	ADJ
aiua-9854	228	32	professor	professor	NOUN
aiua-9854	228	33	(	(	PUNCT
aiua-9854	228	34	corresponding	corresponding	ADJ
aiua-9854	228	35	author	author	NOUN
aiua-9854	228	36	)	)	PUNCT
aiua-9854	228	37	mb30@aub.edu.lb	mb30@aub.edu.lb	PROPN
aiua-9854	228	38	department	department	NOUN
aiua-9854	228	39	of	of	ADP
aiua-9854	228	40	urology	urology	NOUN
aiua-9854	228	41	,	,	PUNCT
aiua-9854	228	42	american	american	PROPN
aiua-9854	228	43	university	university	PROPN
aiua-9854	228	44	of	of	ADP
aiua-9854	228	45	beirut	beirut	PROPN
aiua-9854	228	46	medical	medical	ADJ
aiua-9854	228	47	center	center	NOUN
aiua-9854	228	48	riad	riad	PROPN
aiua-9854	228	49	el	el	PROPN
aiua-9854	228	50	-	-	PUNCT
aiua-9854	228	51	solh	solh	PROPN
aiua-9854	228	52	1107	1107	NUM
aiua-9854	228	53	2020	2020	NUM
aiua-9854	228	54	beirut	beirut	PROPN
aiua-9854	228	55	,	,	PUNCT
aiua-9854	228	56	lebanon	lebanon	PROPN
aiua-9854	228	57	rola	rola	PROPN
aiua-9854	228	58	jaafar	jaafar	PROPN
aiua-9854	228	59	,	,	PUNCT
aiua-9854	228	60	md	md	PROPN
aiua-9854	228	61	rj29@aub.edu.lb	rj29@aub.edu.lb	PROPN
aiua-9854	228	62	department	department	NOUN
aiua-9854	228	63	of	of	ADP
aiua-9854	228	64	surgery	surgery	NOUN
aiua-9854	228	65	,	,	PUNCT
aiua-9854	228	66	american	american	PROPN
aiua-9854	228	67	university	university	PROPN
aiua-9854	228	68	of	of	ADP
aiua-9854	228	69	beirut	beirut	PROPN
aiua-9854	228	70	medical	medical	ADJ
aiua-9854	228	71	center	center	NOUN
aiua-9854	228	72	,	,	PUNCT
aiua-9854	228	73	beirut	beirut	PROPN
aiua-9854	228	74	,	,	PUNCT
aiua-9854	228	75	lebanon	lebanon	PROPN